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Abstract  
 
Green chemistry has been applied to all aspects of the life cycle of chemically related 
products, including design, usage, manufacturing, analysis, and disposal. In this thesis, I 
focus on the green chemistry applications in organic synthesis and analytical chemistry. 
More specifically, allylic and chiral alcohols are abundant in natural sources such as in 
essential oils, and widely utilized as starting materials. They are also major components in 
food, fragrance, biocides and the pharmaceutical compounds. In this thesis, I report the 
first Ru-catalysed asymmetric transfer hydrogenation (ATH) of prochiral allylic alcohols. 
This reaction provides chiral secondary alcohols in excellent enantioselectivities and yield. 
This new reaction is much safer, more economical and environmentally friendly for the 
asymmetric reduction of allylic alcohols compared to the high-pressure gaseous 
hydrogenations. Mechanistic studies through a series of deuterium-labeled experiments 
provided a new mechanism for the ATH reaction. Specifically, a tandem enantioselective 
isomerization-transfer hydrogenation process occurs. The asymmetric induction step 
occurs during the Ru-assisted 1,3-hydrogen shift isomerization through an enal 
intermediate prior to transfer hydrogenation. Reaction conditions were optimized using 
chiral ruthenium complexes. 
 
The thermodynamic characteristics of the enantioseparation of the chiral benzyl alcohols 
under ACN-free RP-HPLC were also investigated. The enantiomers of various benzyl 
alcohols were separated on derivatized cellulose and amylose chiral stationary phases with 
methanol/water or ethanol/water as mobile phases. Enantioseparation was optimized by 
varying the percentage of organic modifier and column temperature. Baseline resolution 
Ḱ˪
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was achieved in 10 min of elution time for most of the selected enantiomers. The effects 
of the mobile phase composition, column temperature and structural moieties of α-
substituents on the enantioseparation were investigated. For all enantiomeric pairs, the 
experimental van’t Hoff plots (ln k' vs 1/T and ln α vs 1/T) of each mobile phase/stationary 
phase set were linear in the temperature range between 10 to 40 oC. The corresponding 
thermodynamic parameters were then calculated. Our studies indicate that chiral separation 
of benzyl alcohols is controlled by enthalpy. However, bi-aromatic benzyl alcohols showed 
greater selectivities at higher temperature, indicating that the chiral recognition process is 
entropy-driven. A linear relationship between changes in enthalpy and entropy, also known 
as entropy-enthalpy compensation, was observed for all analytes in a wide range of mobile 
phases. This resulted in relatively constant enantioselectivities under various mobile phase 
eluting strengths. 
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Chapter 1: Green Chemistry Applications in Asymmetric Transfer 
Hydrogenations 
1.1  Introduction 
Green chemistry, or sustainable chemistry, has emerged as one of the most active topics in 
chemical research. It involves the development and engineering of chemical processes and 
products that minimizes the use and/or generation of hazardous substances to the 
environment.1 India PRwire reported that the green chemical industry will soar to $98.5 
billion by 2020. There are generally twelve accepted principles of green chemistry,2 these 
include:  
1. Prevent Waste  
2. Maximize Atom Economy  
3. Design of Less Hazardous Chemical Synthesis  
4. Design Safer Chemicals and Products  
5. Use Safer Solvents/Reaction Conditions  
6. Increase Energy Efficiency  
7. Use Renewable Feedstocks  
8. Avoid Chemical Derivatives  
9. Use Catalysts  
10. Design for Degradation  
11. Analyze in Real-Time to Prevent Pollution  
12. Minimize the Potential for Accidents 
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In the first part of the thesis, I will discuss the applications of green chemistry related to 
the concept of asymmetric transfer hydrogenation which uses isopropanol in place of the 
hazardous hydrogen gas as hydrogen donor.  In the second chapter, I will discuss the study 
of the acetonitrile-free reversed-phase HPLC enantioseparation. This method utilizes green 
solvents such as water and ethanol, to separate the chiral benzyl alcohols on 
polysaccharides-based HPLC columns.  
 
Asymmetric hydrogenation (AH) has been of great interest since its discovery in 1968 by 
Dr. Knowles and Prof. Horner.3 Since then, the strong demand and findings for new and 
efficient methods to conduct asymmetric syntheses has become one of the most popular 
topics for organic chemists. The most obvious evidence for this is the 2001 Nobel Prize in 
Chemistry, awarded to three distinguished researchers: Dr. William S. Knowles and Prof. 
Ryoji Noyori for their pioneering work on catalytic asymmetric hydrogenations and to 
Prof. Barry K. Sharpless for his research on catalytic asymmetric epoxidations. Among 
various enantioselective synthetic methodologies, asymmetric transfer hydrogenation 
(ATH) has risen as one of the most active fields in asymmetric synthesis. It can be applied 
to a wide range of substrates with experimental simplicity and a high level of 
chemoselectivity and enantioselectivity. Most importantly, it utilizes “green” (economical 
and environmentally friendly) hydrogen sources such as isopropanol or formate, and the 
reaction process is much safer than the traditional asymmetric hydrogenation with 
hydrogen gas.4 The ATH method has been employed in the asymmetric reduction of many 
unsaturated organic molecules in high yields and with impressive enantioselectivity. The 
substrate scope includes: ketones/aldehydes,5 imines,6 olefins7 and heterocyclic aromatic 
compounds8 (Scheme 1.1). 
麀@
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Scheme 1.1. Examples of asymmetric transfer hydrogenation with different substrates. 
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Figure 1.1. Chiral drugs containing chiral alcohols as building blocks. 
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Chiral alcohols are widely used as chiral building blocks for many enantiomeric 
pharmaceuticals (Figure 1.1).9 Asymmetric reduction of prochiral ketones is the most 
common method to produce these important substrates. Allylic alcohols, which have been 
broadly used as raw materials and major components in cosmetics, essential oils, foods, 
ઐҖ
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fragrances and the pharmaceutical industry (Figure 1.2), can also be alternative sources of 
chiral alcohols via asymmetric reactions.10 However, there are only limited examples of 
asymmetric gaseous hydrogenation of allylic alcohols to produce chiral alcohols,11 
(Scheme 1.2) and no published accounts of ATH reactions of these important substrates. 
In 2007, Cadierno et al. reported a non-enantioselective reduction of allylic alcohols via a 
Ru-catalyzed isomerization-transfer hydrogenation mechanism (Scheme 1.3).12 In my 
studies, I’ve discovered a new enantioselective tandem isomerization-transfer 
hydrogenation mechanism that provides a promising alternative method to prepare chiral 
alcohols by ATH. It is also possible to expand the substrate scope for enantioselective 
transfer hydrogenations using this new reaction mechanism. 
Figure 1.2. Examples of allylic alcohols. 
Geraniol
OH
Nerol
OH OH
Farnesol
OH
Linalool
Scheme 1.2. Examples of asymmetric gaseous hydrogenation of allylic alcohols. 
OH OH
Ru(OCOCH3)2[(R)-BINAP]
IPA
H2 (100 atm)
OH OH
S-tol-BINAP
IPA
D2
Ru(COD)Cl2 D
D
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Scheme 1.3. Ru-catalyzed achiral isomerization-transfer hydrogenation. 
OH OH
OH O
Ru catalyst
IPA
Isomerization
Transfer hydrogenation
 
 
1.1.1 History and development in asymmetric hydrogenation 
Almost all biomolecules are chiral, such as DNA/RNA, enzymes, antibodies, hormones, 
etc. Therefore, it is well known that enantiomers can have distinctly different physiological 
and biological effects in living organisms,13 which has led to extensive research and 
development efforts in the fields of pesticide,14 food,15 flavor,16 and pharmaceuticals.17  
Especially since 1992, the U.S FDA required that each single enantiomer of a chiral drug 
be studied separately.18 The tragedy of the Thalidomide case is one of the well-known 
examples. It is an anti-nausea and sedative medicine that was first approved in the late 
1950s.19 Thalidomide (Figure 1.3) has a chiral center that forms as a pair of enantiomers. 
It wasn’t until the early 1960s, after many different forms of birth defects were reported, 
that doctors and scientists found the R- enantiomer as a safe medicine, while the S-
enantiomer behaved as a teratogen and had devastating effects.20 Moreover, even if only 
the safe form (R-enantiomer) is taken by the patients, it quickly racemizes in the human 
body to produce both enantiomers equally.21 
 Ҭ
 22 
Asymmetric synthesis has had a broad impact on academia and industrial R&D for several 
decades, especially in the pharmaceutical field where selective and specific biological 
effects can be utilized and developed commercially. In 2011, seven out of ten best-selling 
drugs in United States were chiral molecules (Figure 1.4).22 Global Industry Analysts, Inc. 
estimates that the global market for chiral technology enabling products at $5.1 billion by 
the year 2017.23 
Figure 1.3. Structure of Thalidomide enantiomers. 
N
O
O
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O
O N
O
O
NH
O
O
R-Thalidomide S-Thalidomide
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Figure 1.4. Chiral drugs among the top selling drugs in 2011. 
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In 2001, Dr. William S. Knowles and Prof. Ryoji Noyori were awarded the Nobel Prize in 
Chemistry for their research achievements in the area of asymmetric hydrogenations 
catalyzed by transition metal-chiral ligand complexes. Asymmetric reduction has been a 
valuable and powerful synthetic tool that has significant impacts in both academia and 
industry. This reduction reaction involves the addition of hydrogen(s) selectively across 
unsaturated double bonds of olefin, carbonyl, and imine groups. The field of asymmetric 
ઐҖ
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reductions of olefins such as allylic alcohols involves the addition of hydrogen to a sp2 
hybridized pro-chiral carbon to form a chiral sp3 hybridized tetrahedral carbon center.  
 
In 1968, the discovery of asymmetric hydrogenation was first reported by Knowles and 
Horner, respectively. Dr. Knowles at Monsanto Company, St. Louis reported that the RhCl3 
(-)-methylpropylphenylphosphine chiral complex (69% ee) could reduce a prochiral 
substrate α-phenylacrylic acid to a chiral product (+) hydratropic acid in enantiomeric 
excess (15% ee) at 60 0C. Another substrate itaconic acid could also be reduced to succinic 
acid but in a much lower ee (3%) (Scheme 1.4).3a Prof. Horner, also in 1968, published 
another example of asymmetric catalytic hydrogenation of α-ethylstyrene and α-
methoxystyrene, using the same optically active phosphine-rhodium complex in 
homogeneous solution, to produce the (S)-(+)-2-phenylbutane in 8 % ee and (R)-(+)-1-
methoxy-1-phenylethane in 4 % ee, respectively (Scheme 1.4).3b The 
tris(triphenylphosphine)rhodium complex, also known as Wilkinson’s catalyst, was first 
introduced by Prof. Wilkinson in 1966 for non-chiral homogeneous hydrogenation of 
unsaturated compounds containing non-activated olefin and alkynes.24 
 
Since then, it has been of great interest to develop more efficient catalysts to expand the 
substrate scope, improve the selectivity and increase the ee. In 1972, Knowles developed 
o-anisylmethylcyclohexylphosphine (CAMP),25 representing another class of optically 
active phosphine ligands that were used for asymmetric hydrogenation of α-
acylaminoacrylic acids to produce the corresponding amino acids in much higher 
enantioselectivity (up to 90% ee) (Scheme 1.5). With only 95% ee optical purity of the new 
phosphine ligand, the reaction required much lower catalyst loading (about 0.05 mole%) 
 Ҭ
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and milder reaction conditions (atmospheric pressure of H2 gas at room temperature) 
compared with the original version of the rhodium-phosphine catalysts mentioned above. 
 
Scheme 1.4. Knowles and Horner asymmetric hydrogenation. 
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Scheme 1.5. Asymmetric Hydrogenation with CAMP and DIPAMP. 
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Scheme 1.6. Asymmetric Synthesis of L-DOPA by CAMP and DIPAMP. 
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One of the most significant impacts of the Rh-CAMP catalyst was its application in the 
synthesis of well-known anti-Parkinson drug L-DOPA.26 The key step in L-DOPA 
synthesis, the asymmetric hydrogenation of intermediate 4 by Rh-CAMP catalyst, could 
achieve good enantioselectivity (88% ee) and about 70% isolated yield (Scheme 1.6). This 
was a ground-breaking milestone since it was the first example of industrial catalytic 
asymmetric synthesis. Knowles commented on this development “for the past hundred 
years it had been almost axiomatic among chemists that only nature’s enzymes could ever 
do this job.”27 A further improvement was introduced by a new type of phosphine ligand, 
1,2-bis(pheny1orthoanisylphosphino)ethane (DIPAMP) (Scheme 1.6), which further 
improved the enantioselectivity of the key hydrogenation step to 95% ee in 80% yield. In 
addition, DIPAMP is much easier to prepare and more stable than CAMP.27 With these 
advanced catalysts, the asymmetric hydrogenation was performed efficiently with just 5 
mmol% catalyst loading. Notably, the catalysts can also be prepared in situ by effectively 
adding the stable solid form of a Rh source, such as [Rh(1,5-COD)Cl2]BF4 and chiral 
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phosphine ligand separately in the reaction matrix to avoid complicated metal chiral 
complex formation and elevated costs. 
 
Further development of efficient chiral ligands remained very active in asymmetric 
synthesis. The bidentate phosphine ligands that emerged in the early 1970s had a 
significant impact on catalytic efficiency, reactivity and enantioselectivity. Prof. Kagan 
discovered DIOP, 4,5-Bis-[(diphenylphosphanyl)-methyl]-2,2-dimethyl-[1,3]dioxolane 
which is the first chiral bisphosphine ligand successfully applied in asymmetric 
hydrogenation.28 The asymmetric hydrogenation of α,β-unsaturated carboxylic acids using 
Rh-DIOP catalyst made in situ by [Rh(COD)2C1]2 and DIOP resulted in up to 72 % ee and 
95% yields (Scheme 1.7). Since then, many bidentate bisphosphine ligands were reported 
all over the world, for example, Chiraphos from Prof. Bosnich,29 the ferrocene ligand 
BPPFOH from Kumada,30 BPPM from Achiwa,31 Garphos from Ogata,32 and DiPAMP 
from Knowles27 (Scheme 1.7). The initial efforts on C2 chiral bisphosphine ligand studies 
were primarily placed in the design of new rhodium-based chiral complexes. However, 
little progress was made on exploring other transition metals or broadening the reactant 
scope, since only enamides and α,β-unsaturated esters/acids were suitable for asymmetric 
hydrogenation under Rh-biphosphine catalysts. Other olefins, such as α-arylacrylic acids, 
allylic alcohols/amines, and non-activated olefins, generally gave poor enantioselectivity 
or no hydrogenation was observed.28-33 
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Scheme 1.7. Examples of chiral bidentate bisphosphine ligands. 
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Until the early 1980s, the next noticeable milestone in asymmetric hydrogenation was the 
invention of a new chiral phosphine ligand, 2,2’-bis(diphenylphosphino)-1,1’-binaphthyl 
(BINAP), by Prof. R. Noyori from Japan (Scheme 1.8).34 This new type of ligand enabled 
the possibility to employ other transition metals, such as Ru, Ir and Pd, to perform 
asymmetric hydrogenation with significantly different reactivities and selectivities. It also 
proved be very beneficial for versatile substrates of different structures, especially for 
complex organic molecules with multiple unsaturated groups.35 The Ru-BINAP catalyst 
can be applied to an expanded scope of alkenes for asymmetric hydrogenation, such as α-
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arylacrylic acids, unsaturated carboxylic acids, allylic/homoallylic alcohols and amines, 
etc. These were inactive or non-enantioselective with Rh catalyst since it usually requires 
an α−amido group to activate the C=C for hydrogenation (Scheme l.8).36 In 1994, the 
reactants for Ru-BINAP catalyzed asymmetric hydrogenation were further expanded to 
functionalized ketones and aldehydes, with excellent enantioselectivities (up to 98-99% 
ee).37 The configurations of the resulting chiral alcohols were determined to be directed by 
the coordination of the Ru metal with the heteroatoms (N, O, P, S, Cl, Br, etc.) adjacent to 
the α-carbon. The Ru-BINAP type catalyst has been introduced in asymmetric 
hydrogenation of many commercial products, for example, the preparation of the anti-
inflammatory drug, S-Naproxen, from the α-arylacrylic acid, in up to 98 % ee with Ru-
BINAP type catalyst (Scheme 1.8).38 The Ru-BINAP catalyst was considered as a nearly 
universal asymmetric hydrogenation system due to its broad substrate scope but the major 
limitation was that this asymmetric catalytic process performed poorly for non-
functionalized olefins and ketones and any improvement in this area could be beneficial. 
For example, citronellol, a natural acyclic monoterpenoid used in perfumes, insect 
repellents, mite attractants and food flavors, can also be prepared through asymmetric 
hydrogenation of geraniol or nerol by a Ru-BINAP catalyst, in up to 98 % ee. This reaction 
showed great selectivities, without over-reduction to the dihydrocitronellol (Scheme 1.3).39 
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Scheme l.8. Examples of Ru(BINAP) catalyzed asymmetric hydrogenation. 
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It is interesting to point out that, the BINAP-type ligands can coordinate with both Rh(I) 
and Ru(II) metals to form active catalysts for asymmetric hydrogenation, but produce 
reduced products with opposite configurations.40 This behavior can be explained by the 
different reaction mechanisms. During the catalytic cycle of Rh(I)-BINAP complex, 
oxidative addition of H2 on Rh (I) forms a chiral Rh(III)-dihydride-substrate chelate 
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complex intermediate. Then the two hydrides are shifted to reduce the coordinated 
substrate and Rh(III) returns to Rh(I). The whole process is also called +1/+3 redox 
transformation (Scheme 1.9). 
 
Scheme 1.9. Mechanism of Rh(I)-BINAP catalyzed asymmetric hydrogenation. 
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While in the case of Ru(II), the oxidation state remains at +2 during the whole catalytic 
process (Scheme 1.10).41 The catalytic reaction mechanism of Ru(II)BINAP has been 
found to undergo a monohydride-ruthenium intermediate 2 followed by heterolytic bond-
breaking of molecular H2 associated with the starting Ru(II) complex 1. Then the complex 
2 coordinates with the β-keto ester substrate to construct the intermediate 3. Due to the 
orientation of the BINAP chiral ligand, the key step is the enantioselective hydride transfer 
from the metal to the substrate’s carbonyl group to form the reduced chiral 
substrate/catalyst complex 4. After protonation, the Ru(II)-BINAP catalyst dissociates and 
the chiral β-hydroxy ester is generated with the starting Ru catalyst 5. 
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Scheme 1.10. Mechanism of Ru(II)-BINAP catalyzed asymmetric hydrogenation. 
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An adjacent heteroatom, usually a halide, is required to bring the substrate in close 
proximity to coordinate with the metal center for hydrogen transfer. Noticeably, under the 
Ru-BINAP type catalytic environment, the metal center will coordinate with the bi-dentate 
diphosphine ligand, which occupies two of the six coordination sites. It is proposed that 
during the asymmetric hydrogenation of functionalized olefins or ketones, the Ru-BINAP-
catalyst intermediates should be in the trans geometry (Scheme 1.10).42  
 
It wasn’t until the late 1990s, with the invention of a new type of catalyst, Ru-BINAP-
diamine chiral complexes, either pre-made or made in situ, that the hydrogenation of non-
functionalized ketones and olefins can be performed efficiently. The family of Ru-BINAP-
diamine type catalysts, unlike other Ru-BINAP complexes, required stronger bases such 
as KOH, KOtBu present during the hydrogenation process. For example, RuCl2(xyl-
BINAP)(Diapen), one of the most popular catalysts in the category, has been used widely 
in asymmetric hydrogenation of aromatic/heteroaromatic, and conjugated olefinic ketones 
(Scheme 1.11). One of the most significant applications is the hydrogenation of 
 Ҭ
 32 
acetophenone derivatives to produce the chiral alcohols in up to 97 % ee (Scheme 1.11) 
which was previously unaccomplished in any catalytic system.43 Moreover, excellent 
selectivities have also been shown in the hydrogenation of conjugated unsaturated 
ketones/aldehydes to generate the chiral allylic alcohols with a weak inorganic base such 
as sodium carbonate (Scheme 1.11).44 It is believed that the higher reactivity and selectivity 
of the Ru-BINAP-diamine complex is due to a bi-functional-ligand mechanism which is 
different from the Ru-BINAP catalytic cycle.45 The Ru-BINAP-diamine type catalyst 
system has also been applied to many commercial processes. 
 
Scheme 1.11. Examples of Ru-xylBINAP-diamine type catalyst applied in asymmetric 
hydrogenation. 
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1.1.2 Asymmetric isomerization of allylic alcohols 
Isomerization of allylic amines to the corresponding enamines, especially in the 
asymmetric process, has been heavily studied and implemented in the synthesis of many 
important chemically and pharmaceutically active chiral molecules.9c, 46 For example, the 
key step in the industrial synthesis of (-)-menthol from myrcene is the Rh-BINAP catalyzed 
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asymmetric isomerization of an imine to an allylic amine (Scheme 1.12).47 The 
transformation of various allylic alcohols to the corresponding ketones/aldehydes is a 
widely-used synthetic route, which typically involves a two-stage sequential redox process. 
The study of the isomerization reaction of allylic alcohols has also gained increasing 
interest in recent years.2, 12 In the 1960s, the early stage of allylic alcohol isomerization was 
observed as a side reaction during the hydroformylation with metal carbonyl hydride 
complexes such as HCo(CO)4 (Scheme 1.13).48 A similar example was reported by 
Emerson and Pettit that the isomerization of π-allyl-iron-tricarbonyl complexes in water 
could afford the ketones via a mechanism involving allylic alcohol intermediates.49 This 
unexpected discovery provided a tempting route to complete the internal redox 
reaction/double-bond migration in a one-pot catalytic process. These findings were utilized 
and developed by Damico and Logan, where the isomerization of sec-allylic alcohols to 
the corresponding ketones/aldehydes were catalyzed by Fe(CO)5 in about 80% yield, while 
the yield of cyclic and primary allylic alcohols can be improved to 60% with the help of 
UV light (Scheme 1.13).50 The reaction mechanism was investigated by Rosenburg in 1968 
using deuterium –labeling (Scheme 1.14).51 The process involves formation of a π-allyl 
metal complex followed by a suprafacial 1,3-hydride intramolecular  migration52 which is 
then followed by elimination of the metal complex to release the ketone/aldehyde product. 
The tautomerization of homoallylic alcohols/ethers, and those with carbon-carbon double 
bonds remote from the OH group, was also studied by Iranpoor in late 1980’s, where 
Fe2(CO)9 and Fe3(CO)12, instead of Fe(CO)5 were utilized for rearrangement to the 
corresponding ketones/aldehydes/enol ethers, respectively, through a carbon-carbon 
double bond migration mechanism under milder reaction conditions in yields of up to 
90%.53 Under similar conditions, some sterically hindered allylic alcohols, such as bi- or 
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tri-cyclic allylic alcohols were also efficiently racemized with higher catalyst loading 
(Scheme 1.14).53 However, further development of iron-carbonyl complex catalysts were 
stalled due to the emergence of more efficient and safer catalysts. It wasn’t until the early 
2000s, Grée re-examed these old catalysts and re-developed the reaction conditions 
associated with photochemical activation in hydrocarbon solvents.54 Under these universal 
conditions, many substituted allylic alcohols, especially trisubstituted allylic alcohols, 
could undergo effective rearrangement to saturated carbonyl products in high yield.54 
However, the conditions were inactive for allylic alcohols with strong electronic 
substituents (CF3, NO2, etc.), and usually gave low yields for primary allylic alcohols 
without α-substituents. For polyunsaturated molecules, unwanted carbon-carbon double 
bond migration side reactions occurred. 
 
Scheme 1.12. Takasago menthol synthesis by asymmetric isomerization of allylic amine. 
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Scheme 1.13. Allylic alcohol isomerization catalyzed by metal carbonyl complexes. 
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Scheme 1.14. Allylic alcohol isomerization mechanism study. 
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As mentioned above, since the 1970s, the research effort was focused on metal carbonyl-
free conditions due to the high toxicity and poor performance of these complexes. 
Strohmeier et al. explored the Rh catalysts, such as RhH(CO)(PPh3) and RhCl3, which 
quantitatively isomerized methallyl alcohol and 1-octen-3-ol within 3 hours.55 The 
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complexes [Rh(CO)2Cl]2 and [Rh(CO)2(OH)]2 were also employed but were only effective 
for non-sterically hindered allylic alcohols. In addition, Rh-diphosphine complexes, which 
had a long history of being used for isomerization of allylic amines, also showed excellent 
catalytic activity with low catalyst loading. These were especially useful for isomerization 
of allylic alcohols, especially multi-substituted olefins.56 Since then, a few Rh-phosphine 
catalysts, especially coordinated with triphenyl phosphine derivatized ligands, were 
developed in the 1990’s. These included Rh(CO)(PPh3)3,57 Rh[P(OPh3)]4,58 
Rh(acac)(CO)(PR3),59 Rh(SULPHOS)(COD),60 and modified Wilkinson’s catalyst 
Rh(PPh3)3(PF6) (Figure 1.5).61 In the early 2000’s, Uma reported a Rh hydride catalyst, 
RhH(PPh3)3 prepared in-situ from Rh(PP3)3Cl and n-BuLi. It showed exceptional 
efficiency for a wide scope of sec-allylic alcohols, including highly sterically hindered 
examples with multiple alkyl substituents and/or strong electron withdrawing group (CF3) 
on the olefin carbons, which usually inhibit catalytic reactions (Scheme 1.15).62 The 
complex RhH(PPh3)4 had also been developed and showed a broad reactant scope on the 
isomerization of allylic alcohols, especially silyl allylic alcohols.63 However, the high 
sensitivity to air and moisture and complicated operational procedures limited the 
application of these versatile Rh-hydride catalysts. Later on, the Rh(COD)2BF4/(PPh3)2 
was found to be an effective alternative catalyst for β-silyl allylic alcohols.64 About the 
same period, de Bellefon demonstrated another more promising Rh catalyst system made 
in situ with TPPS ligand (a sulfonated triphenylphosphine), which could rapidly and 
quantitatively isomerize a vast scope of allylic alcohols (except geraniol) (Scheme 1.16).65 
These catalysts can be recycled and were suitable for industrial high-throughput-screening 
(HTS) and micro-reactor applications.65 During the development of the Rh-mediated 
process, Bosnich conducted mechanism studies by NMR that revealed an enol intermediate 
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was involved.66 Unlike iron carbonyl catalysts, Rh catalysts did not lead to carbon-carbon 
double bond migrations and remained inactive towards the homoallylic alcohols.   
 
Figure 1.5. Structures of Rh-phosphine type catalysts used in the isomerization of allylic 
alcohols. 
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Scheme 1.15. RhH(PPh3)3 Catalyzed isomerization of allylic alcohols. 
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Scheme 1.16. Rh/TPPTS Catalyzed Isomerization of Allylic Alcohols for High 
Throughput Screening. 
 
Ruthenium complexes are well studied metal catalysts in this field. The early cases of Ru 
catalyzed isomerization of allylic alcohols were reported in the 1960’s using RuCl3.67 
However, practical examples had not been shown until the 1980’s by the use of RuCl3 with 
NaOH in 1:1 ratio.68 Ru(acac)3 was proven to be an excellent catalyst for the transposition 
of α-substituents in allylic alcohols. With less than 1 mol% catalyst loading, the 
isomerization reaction was completed within 15 min at 100 0C. The complex Ru(acac)3 can 
also be used as a pre-catalyst by incorporation with another ligand, such as Ph3P, 1-10-
phenanthroline, butadiene, etc., to modify its catalytic activity.69 The complexes 
Ru(H2O)6(tos)2 and Ru(H2O)6(trif)2 can be used to isomerize both the allylic ethers and 
alcohols under mild conditions (Figure 1.6).70 The complex Ru3O(Ac)6, an oxo-bridged Ru 
catalyst was developed by Sassons in the 1970’s for efficient isomerization of unsubstituted 
sec-allylic alcohols in a bi-phasic environment (alkane/aqueous) and the catalyst can be 
recycled.71 The triphenylphosphine ligand was again employed as a very effective ligand 
for Ru-based catalysts. One of the early examples demonstrated Ru(PPh3)2Cl2, as a 
homogeneous and heterogeneous catalyst. The latter incorporated the Ru catalyst within a 
polystyryldiphenylphosphine resin as reported by Sassons in the 1980’s for the 
tautomerization and kinetic studies of sec-allylic alcohols (Scheme 1.17).72 Trost 
demonstrated a selective RuCp(PPh3)2Cl catalyst, which did not migrate or tautomerize 
homoallylic alcohols or olefinic alcohols with remote carbon-carbon double bonds.73 The 
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mechanism was investigated also by deuterium-labeled studies and two new types of 
catalytic cycles were proposed (Scheme 1.18).73 However, a challenge remains for 
substrates such as geraniol and cyclic allylic alcohols due to sterically hindrance. In order 
to improve their catalytic reactivities, certain additives were used to modify the catalyst. It 
was shown that the addition of AgOTs with RuCp(PPh3)2Cl could greatly accelerate the 
tautomerization of certain sec-allylic alcohols by about ten-fold vs the catalyst alone.74 The 
AgPF6 salt has also been added as a co-catalyst with RuCl2(PPh3)2 and effectively 
transformed sec-allylic alcohols to their corresponding ketones in faster reaction rates (~10 
fold). However, for primary allylic alcohol substrates, the strong Lewis acid properties of 
this catalyst would also transformed the aldehyde products to acetals in alcoholic 
solvents.75 The complex Ru(PPh3)3Cl2 and RuCl2(p-cymene) have also shown significant 
improvements with just trace amounts of weak base present (e.g., K2CO3).76 Several Ru-
hydride complexes, RuHCl(PPh3), RuH2(PPh3), RuH4(PPh3)3 and K[Ru3H(CO)11], were 
also explored for the isomerization of sec- and homo-allylic alcohols (Scheme 1.19).77 
However, the expensive and air sensitive catalyst required immediate preparation and 
could not be recycled. The reaction was inactive towards primary allylic alcohols and also 
was not selective for allylic alcohols since other olefins could also isomerize. The substrate 
scope for sec-allylic alcohols was expanded by Dedieu and Pasca with the previously 
discussed catalysts such as RuCl2(PPh3)2 and RuHCl(PPh3)3 under a continuous flow 
process.78 The RuVII oxidant, Pr4NRuO4, was explored and showed improved activity for 
the isomerization of primary allylic alcohols, such as 1-decanol and geraniol.79 In the late 
1990s, Sowa and co-workers reported the isomerization of allylic alcohol, geraniol (3,7-
dimethyl-2,6-octadiene-1-ol) to the homoallylic alcohol γ-geraniol with the catalyst 
[Ru(S)-tol-BINAP)Cl2]2N(C2H5)3.80 
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Figure 1.6. Structures of Ru(H2O)6(tos)2 mediated isomerization intermediates (observed 
by 1H and 13C NMR). 
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Scheme 1.17. Kinetic study of isomerization of allylic alcohols by homogenous and resin 
supported RuCl2(PPh3)3 and RhCl(PPh3)3 and IrCl(CO)(PPh3)3. 
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Homogeneous RuCl2(PPh3)3                                 9.0                                   10.5                                 8.7                                   
Resin Supported RuCl2(PPh3)3                                        2.6                                    2.2                                  2.1
Homogeneous RhCl(PPh3)3                                  6.2                                     6.7                                  6.0
Resin Supported RhCl(PPh3)3                               2.2                                    1.7                                   1.7
(Reaction condition: 0.8M substrate conc.; catalyst loading 0.016mol%; 140 oC; Argon pretected)
 
Scheme 1.18. Proposed mechanism of the RuCp(PPh3)2Cl catalytic cycle. 
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Other transition metal catalysts were also explored. For example, in the late 1970s, Felkin 
et al. developed improved conditions for tautomerization of aliphatic allylic alcohols using 
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the [Ir(Ph2MeP)2(cod)]+PF6- catalyst with up to 100% conversion rate (Scheme 1.20).81 
This process is limited to cyclic and highly-branched allylic alcohols. The Ni(DPPB)2 
catalyst, conveniently prepared in situ from Ni(COD)2 and DPPB, combined with acid 
additives such as HCN or CF3COOH, was also proven to be an efficient catalyst for the 
tautomerization of allylic alcohols.82 The cobalt complex CoH(CO)4 was studied about the 
same time as Fe-carbonyl complex in early 1960s as one of the earliest examples.83 Since 
then, there has been limited development of the Co catalyst. The Pt and Pd metals were 
also introduced into these types of reactions.84 For example, the PtH(PR3)2(Me2CO) 
catalyst usually works well for simple primary allylic alcohols which were challenging 
substrates for the other transition metal (Ru, Rh, Fe, etc.) catalyzed processes.85 
Scheme 1.19. Allylic alcohol isomerization by RuHCl(PPh3)3. 
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Scheme 1.20. Allylic alcohol isomerization by [Ir(Ph2MeP)2(cod)]+PF6-. 
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Asymmetric isomerization of allylic amines to enamines, especially with the development 
of Ru-BINAP type catalysts, has been recognized and studied extensively in academia and 
industry.9c, 46, 47, 86, 87 However, similar reactions on allylic alcohols have not seen 
comparable success. As discuss above, although the isomerization of allylic alcohols has 
been extensively studied in the past fifty years, so far there are very few publications 
regarding the enantioselective version of this reaction. Asymmetric isomerization of allylic 
alcohols was first reported in the 1970’s when a Rh-phosphine type catalyst was 
introduced, though the enantioselectivities were very low (<4% ee).88 The improvement on 
enantioselectivities was soon reported by Tani with the Rh-BINAP chiral complex. 
(Scheme 1.21).87,89 In 2000, Fu demonstrated a [Rh+(COD)2]BF4- with Fe-
phosphaferrocene combined catalyst that enantioselectively isomerized primary allylic 
alcohols to chiral aldehydes in high yields and good ee (up to 91%) (Scheme 1.22).90 A 
comprehensive deuterium-labeled study revealed a Rh(1)-mediated intramolecular 1,3-
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hydride transfer mechanism, involving a C-H activation (hydride migration from substrate 
to Rh metal), which was the key chiral induction step (Scheme 1.23).91 In 2005, Ikariya 
published a new series of of Ru catalysts with tertiary phosphine–primary amine ligands 
(P-N), such as Cp*RuCl[Ph2P(CH2)2NH2]. With this catalyst, the isomerization of a wide 
range of sec-allylic alcohols proceeded quantitatively with moderate ee (50 - 74%).92 More 
recently, Ir catalysts have been extensively studied by Mazet et al. with very encouraging 
results.93 For example, by using cheap and readily available dialkylphosphine and serine 
(L or D), a new class of cationic Ir-phosphine chiral catalysts can be prepared and applied 
to isomerization of 3,3-disubstituted allylic alcohols in high yield and excellent ee (Scheme 
1.24). 
 
Kinetic resolution, using racemic allylic alcohols as substrates to produce chiral 
compounds, has also been sporadically reported. One of the earliest examples was 
asymmetric isomerization of rac-3-buten-2-ol to the chiral allylic alcohols in less than 2% 
ee.94 Improved results of this process were reported in the 1990’s, using [HRu(R-
BINAP)(CH3CN)(THF)2]BF4 as catalyst in THF/CH2Cl2, in 50% conversion and 42% ee. 
Higher yields and ees for kinetic resolution of allylic alcohols have been shown for cyclic 
compounds, such as 4-hydroxy-2-cyclopentenone, with a Rh-BINAP catalyst in 72% 
conversion and 91% ee.95  
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Scheme 1.21. Asymmetric isomerization of allylic alcohols by a Rh-BINAP catalyst. 
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Scheme 1.22. Rh+ catalyzed asymmetric isomerization of allylic alcohols. 
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Scheme 1.23. d-labeled mechanism study of Rh+ catalyzed asymmetric isomerization of 
allylic alcohols. 
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Scheme 1.24. Ir-phosphine catalyzed asymmetric isomerization of allylic alcohols. 
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1.1.3 Green chemistry and asymmetric transfer hydrogenation  
As mentioned in section 1.1, Prof. Noyori and Dr. Knowles were awarded the 2001 Nobel 
Prize in Chemistry for their significant achievements in asymmetric hydrogenations. 
However, this reaction required gaseous hydrogen, which has substantial safety concerns, 
especially for industrial large scale and high pressure hydrogenation processes. Therefore, 
in recent years a growing interest is to develop hydrogen gas-free asymmetric reduction: 
asymmetric transfer hydrogenation (ATH). These reactions use alcohols or formates as 
hydrogen sources instead of hydrogen gas. This improvement fits well within the concept 
of green chemistry since the hazardous hydrogen gas is omitted. As mentioned above, the 
substrate scope for ATH reactions has also been extensively expanded in recent years 
(Scheme 1.1). The first example of asymmetric transfer hydrogenations was published in 
the 1950’s, when Doering and Young, developed a modified Meerwein–Pondorf–Verley 
enantioselective reduction process. It required the use of a chiral hydrogen donor and 
achiral catalyst for the asymmetric reduction of ketones.96 Further development had not 
been reported until 1970s, when Sinou showed a new catalytic condition in the ATH, by 
complexation of RuCl2(PPh3)3 with (+)-neomenthyldiphenylphosphine.97 The progress of 
the ATH reaction was greatly accelerated in the early 1990’s. Pfaltz introduced the C2-
symmetric ligand, tetrahydrobis(oxazole), coupled with iridium(I), that were found useful 
in catalytic ATH of aryl alkyl ketones yielding up to 91% ee.98 About the same time, Genêt 
reported the ATH of aryl ketones with chiral diphosphine-Ru(II) catalysts in 62% ee.99 A 
few years later, C2 symmetric chiral ligands, diphenylethylenediamines, coordinated with 
rhodium, demonstrated success in the ATH of ketones.100 The substrate scope was 
expanded to aliphatic prochiral carbonyl compounds with good to excellent ees (88-98%). 
It was also observed that higher enantiomeric excess with an increase of conversion rate. 
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Meanwhile, Evans illustrated a chiral tridentate samarium(III) complex at ambient 
temperatures in 2-propanol for the asymmetric Meerwein-Ponndorf-Verley reduction of 
aryl methyl ketones in up to 97% ee.101 However, the ee was significantly lowered when 
the methyl substituent became larger. The milestone accomplishment in the ATH reaction 
was later developed in the 1990’s. Noyori brought the chiral Ru complex made in situ from 
refluxing RuCl2(ƞ6-mesitylene) and monotosylated 1,2-diamines (TsDPEN) in organic 
solvent. These conditions were used in the ATH reaction of a variety of aryl alkyl ketones 
in excellent yields and ees with high substrate/catalyst ratio (up to 1000:1) (Scheme 
1.25).102 In addition to IPA, the HCO2H/Et3N azeotrope can be employed as a hydrogen 
donor with Ru-TsDPEN.103 Meanwhile the same group discovered the amino alcohol 
ligand, (1S,2S)-2-methylamino-1,2-diphenylethanol, that can also form an active catalytic 
complex with Ru(II) for the ATH of acetophenone derivatives in IPA, resulting in (S)-
enriched benzyl alcohols in up to 92% ee and in > 90% yield.104 The substrate scope of 
these chiral complexes have been extended to imines,105 α, β-acetylenic ketones,106 
benzyls,107 benzaldehydes,108 etc. The mechanism of this enantioselective and “universal” 
catalytic ATH system has been extensively studied and has been shown to undergo a novel 
Ru-chiral ligand bifunctional process (Scheme 1.26).109 Since then, remarkable progress in 
ligand design for the ATH reaction has led to many new and efficient chiral catalytic 
complexes. These include the C2-symmetrical diaminoferrocenyl derivatives, 2-
amino(sulfonamido)cyclohexane,110 2-azanorbornyl alcohol (8),111 β-amino alcohol 
(1S,2R)-N-(4-biphenylmethyl)norephedrine (7),112 2-amino alcohol and 1,2-
monotosylated diamine derivatives of indanes (5, 6),113 tridentate 
bis(oxazolinylmethyl)amine (9, 10),114 bidentate and tridentate Schiff base derived from 
(S)-2-amino-2′-hydroxy-1,1′-binaphthyl (NOBIN) and 2-pyridinecarbaldehyde (3, 4), 115 
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C2-symmetric diphosphine/diamine tetradentate ligands (e.g., N,N‘-bis[o-
(diphenylphosphino)benzylidene]cyclohexane-1,2-diamine and N,N‘-bis[o-
(diphenylphosphino)benzyl]cyclohexane-1,2-diamine) (1, 2),116 structurally rigid 
“tethered” ligands (11),117 amino acid and small peptides derivatives,118 cycloruthenated 
primary and secondary amines,119 broad substrate scope ligands such as BINOL-derived 
diphosphonites (12, 13),120 2-(aminomethyl)pyridine−phosphine (Figure 1.7). 121 
 
Scheme 1.25. ATH of aryl alkyl ketones with Ru-TsDPEN. 
R1
O
O
Allylic alcohols ee/yield (%)
[RuCl2(mesitylene)]2
(S,S)-TsDPEN
KOH
IPA
97/95
97/94
91/53
98/98
93/95
96/96
72/53
91/45
O
X
R1
OH
X
S
O
O
Cl
O
Cl
O
O
O
O
O
O
O
O
O
98/98
93/92
98/93
 
뚀˰
 49 
Scheme 1.26. Proposed mechanism of Ru catalyzed ATH system. 
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Figure 1.7. Structures of common ligands used in ATH. 
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Some attention has been dedicated to the development of green ATH processes. These 
include: recycling of chiral catalysts through immobilization on solid supports and more 
environmental friendly catalytic systems using organocatalytic and biomimetic 
conditions.4d 
 
However, despite all these examples, there remain no published cases of the ATH of allylic 
alcohols. As mentioned above, Cadiero developed a Ru-catalyzed non-asymmetric transfer 
hydrogenation process to reduce allylic alcohols to racemic alcohols. Further studies 
revealed that the mechanism involved isomerization of allylic alcohols to the 
ketone/aldehyde intermediate which was isolated and identified, prior to transfer 
hydrogenation.12 Until the late 2000s, Sowa’s group presented in several conference 
precedings that, by using either Ru(COD)Cl2/(S)-Tol-BINAP catalyst made in situ or pre-
made chiral complexes, the ATH of geraniol to citronellol in 98% ee and 90% isolated 
yield.122 The chirality, ee and yield are equivalent to the gaseous asymmetric hydrogenation 
which requires high pressures of hydrogen gas up to 100 atm.123 Notably, the ATH 
conditions were considered as green processes since they use economical, environmentally 
benign and a safer hydrogen donor, isopropanol, instead of hydrogen gas. 
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1.2  Results and Discussion  
1.2.1 Asymmetric transfer hydrogenation of primary allylic alcohols 
Members from Prof. Sowa’s group developed an asymmetric transfer hydrogenation of 
geraniol to (R)-citronellol by using an in situ prepared Ru chiral catalyst (mixture of 
[Ru(COD)Cl2]n and (S)-tol-BINAP) in IPA.15 After three freeze-pump-thaw degassing 
cycles, the reaction was completed in 2 hours at 100 oC in a sealed reactor to produce (R)-
citronellol in 78% isolated yield and 98% ee. (Scheme 1.27, (S)-tol-BINAP = (S)-(-)-2,2’-
bis(di-p-tolylphosphino)-1,1’-binaphthyl; cod = cyclooctadienyl).15 
Scheme 1.27, Initial ATH condition of geraniol to citronellol. 
 
The reaction conditions mentioned above required a substrate/catalyst molar ratio of 10:1 
for complete conversion. A certain amount of base (2 equiv. per Ru), such as KOH, is 
required for the reaction to proceed as previously reported in asymmetric transfer 
hydrogenations or gaseous asymmetric hydrogenations. The optimized reaction conditions 
(chiral Ru-complex prepared in situ) use a molar ratio of allylic alcohol/Ru/ligand/base of 
10:1:2:2. The concentration of the substrate in solvent (IPA) should be 0.01 M and the 
hydrogenation reaction was completed in 2 hours at 100 oC. It should also be noted that the 
catalytic reaction is very air sensitive, which required at least three freeze-pump-thaw 
cycles to degas the reaction system.  
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Further efforts have been made in order to optimize the reaction conditions for scale-up 
and green chemistry applications. For example, upon direct utilization of commercially 
available pre-made chiral Ru complexes, such as Ru[(S)-BINAP]Cl2 and Ru[(S)-tol-
BINAP]Cl2(p-cymene), the ratio of substrate/catalyst ratio can be improved to 33:1, and a 
more concentrated IPA solution can be used (up to 0.1 M). The reaction was also completed 
in 2 hours at 100 oC (with Ru[(S)-tol-BINAP]Cl2) or in 16 hours reflux in IPA (83 oC, with 
Ru[(S)-tol-BINAP]Cl2(p-cymene)) (Scheme 1.28). The conversion, yield and ee are still 
comparable to the chiral Ru-complex prepared in situ method mentioned above. Moreover, 
no freeze-pump-thaw process is required to degas the reaction system (Scheme 1.28). 
Scheme 1.28. Improved conditions for ATH of geraniol to citronellol. 
[(S)-tol-BINAP]RuCl2
   KOH, IPA
   100 oC, 2 h
95% conversion
93% ee
OHOH
[(S)-tol-BINAP]RuCl2(p-
cymene)
   KOH, IPA
   83 oC, 16 h
90% yield
92% ee
OHOH
 
Several primary allylic alcohols were studied under the above optimized conditions 
(catalyst made in situ or pre-made) and good to excellent yields (all 100% conversion) and 
ee (>72%) have been obtained for nerol, 3-phenyl-2-buten-1-ol and trans-trans-farnesol 
(Table 1.1, entries 1 to 7),124 with the same stereochemical configuration as the products 
obtained from the gaseous hydrogenation conditions.1 However, for some other types of 
olefins, such as homoallylic alcohols, α,β-unsaturated acids, α,β-unsaturated ketones, 
substituted styrenes, etc., low enantioselectivity and/or poor yield has been found under the 
previous optimized ATH conditions (catalyst made in situ, Table 1.1, entries 8-14). It 
should be noticed that for these substrates, much better results (yield/ee) have been 
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obtained with the gaseous asymmetric hydrogenation method.2 This unexpected 
discrepancy  between the primary allylic alcohols and the other olefinic substrates indicates 
that the Ru-based catalytic asymmetric transfer hydrogenation system works best for 
primary allylic alcohols. This may be due to a unique catalytic pathway, since the ATH 
reaction affords the same chirality of the products as the gaseous asymmetric 
hydrogenation, but with a much narrower substrate scope (limited to primary allylic 
alcohols only). It is with great interest that I’ve performed these mechanistic studies for the 
ATH reaction as described in my thesis.  
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Table 1.1. ATH of various substrates with Ru(COD)Cl2 and chiral ligand (S)-tol-BINAP 
(A) and (S,S)-iPr-DuPhos (B) in IPA with molar ratio of substrate/[Ru]/ligand/base = 
10:1:2:2. 
 
Entry Substrate Product Ligand Time 
(h) 
 
%Producta 
[% Conva] 
ee, configc 
1 
      
A 2  98 (78)b 
[100] 
98, R 
2 
  
B 2  50 [100] 84, R 
3 
  
A 2  96 (70)b 
[100] 
93, S 
4 
  
B 24  62 [100] 83, R 
5 
 
 
A 12  99 (90)b 
[100] 
72, S 
6 
  
B 2  99 [100] 93, R 
7 
  
Af 16g 82(65)b 
[100] 
81, R 
8 
  
A 2  
6  
19 [41] 
36 [51] 
34, R 
33, R 
9e 
  
A 2  
6  
64 [88] 
64 [87] 
7, R 
8, R 
10c 
  
A 96  93 [98] 12, R 
11 
  
B 2 96 [100] 9, R 
12 
   
OH
 
A 48  23  
6 
[97] 
17,cis SR 
16, trans RR 
13 
 
OH
 
B 1  34  
9 
[98] 
8, cis SR 
14,trans RR 
 14 
 
 
B 24  18 [18] 0 
aConversions and yield determined by GC. bIsolated yield. cee of entries 1-4 and 8-9 were measured by HPLC with the (R)-Mosher ester 
on an OJ-H column or GC column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25 m; ee of entries of 5-6 was measured with the acetate on 
an OJ-H column; ee of entries of 10, 11 and 14 measured directly on an OJ-H column; for entries of 12-13 the cis/trans isomers were 
measured by GC on a DB-23 column (J&W Scientific, 15 m x 0.32 mm) and the ee of the trans isomer was measured by proton 
decoupled 13C NMR; ee of entry 7 was obtained by polarimeter, or a 2D chiral GC technique has been reported [124]. d2.5 equiv. of 
KOH per substrate was used. e4 equiv of KOH per substrate was used. fRuCl2((S)-tol-BINAP)(p-cymeme) as catalyst. gReaction temp 
is 83 ºC. 
 
ઐҖ
 55 
1.2.2 Mechanism study of ATH of geraniol 
Deuterium-labeling techniques have been widely employed in many reaction mechanism 
studies.15 It is well-known that gaseous asymmetric hydrogenations of geraniol by the Ru-
BINAP catalyst in d8-isopropanol produced 2,3-d2-citronellol (Reaction 1, Scheme 1.29). 
These results indicate a direct hydrogenation mechanism.3  In our preliminary mechanistic 
investigations, the ATH of geraniol with [Ru(COD)Cl2]n/(S)-tol-BINAP in d8-isopropanol 
gave 1,2,2-d3-citronellol as product (Reaction 2, Scheme 1.29).15 These results implied that 
the mechanism of ATH is different from that of the well-known gaseous asymmetric 
hydrogenation. 
Scheme 1.29. ATH of geraniol with in d8-isopropanol. 
 
 
As mentioned earlier, an example of the Ru-catalyzed non-asymmetric transfer 
hydrogenation of allylic alcohols via an isomerization-transfer hydrogenation mechanism 
was reported by Cadierno,12 and a few reports regarding the asymmetric isomerization of 
allylic alcohol to carbonyl compounds via an enantioselective intramolecular 1,3-hydride 
transfer process were published.89-92 The ATH of allylic alcohols could also occur via an 
enantioselective tandem isomerization-transfer hydrogenation process. We have designed 
a series of deuterium-labeled ATH of geraniol experiments, and the reulting deuterated 
products were evaluted by GC/MS, 1H, 13C, DEPT135, 2H and 2D NMR techniques. 
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To begin the mechanistic investigations, the deuterium-labeled geraniol was synthesized. 
In this case, 1-d-geraniol and 1-d-nerol were obtained by reduction of citral (trans/cis 
mixture) by 4 equiv. of NaBD4 and 2 equiv. of CeCl4·7H2O in MeOH (Scheme 1.30).4 The 
product resulted in a mixture of 1-d-geraniol and 1-d-nerol which can be separated and 
purified by silica column chromatography (EtOAc/pentane = 5:95). The yield was 32% for 
2-d-geraniol and 31% for 2-d-nerol. The GC/MS(EI) data (Figure 1.8, m/z 155.14) 
indicates a mono-deuterated product. 1H-NMR of the two isomer products (Figure 1.9 and 
1.10) shows that only one proton at δH ~4.1 (d, J=6.62 Hz, 1H) present on the C1 carbon.125 
Scheme 1.30. Synthesis of 1-d-geraniol and 1-d-nerol from citral. 
 
 
Figure 1.8. GC-MS(EI) of 1-d-geraniol. 
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Figure 1.9. 1H NMR of 1-d-geraniol. 
 
Figure 1.10. 1H NMR of 1-d-nerol. 
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The key deuterium-labeled mechanistic study was subsequently performed. The ATH 
experiment of 2-d-geraniol, with 5 mol% of [Ru-(S)-tol-BINAP](p-cymene), 0.1 eq of 
KOH in 0.1 M IPA solution at 83 oC for 18 hours produced a mixture of products containing 
1-d-citronellol and 3-d-citronellol in about a 1:3 ratio (Scheme 1.31). To evaluate the 
mixture of products, the only molecular ion found in the GC/MS is 157 (Figure 1.11) which 
corresponds to the mono-deuterated citronellol. The 1H-NMR showed an increased amount 
of hydrogen (σ = 3.5 ppm, from 1.0 to 1.3) on C1 (Figure 1.12 and Figure 1.13); the 13C 
and DEPT135 NMR clearly displayed a mixture of products (Figure 1.14 and Figure 1.15) 
with a singlet peak of C1 (with 2 hydrogens, also showing negative signal in the DEPT135) 
in 3-d-citronellol and a triplet signal of C1 (with one hydrogen and one deuterium, also 
showing a positive signal on DEPT135) in 1-d-citronellol. The 2H-NMR (Figure 1.16) 
showed the presence of deuterium at C3, which demonstrated that an intramolecular 1-3 
hydrogen shift occurred.  
 
Scheme 1.31. Mechanism study with ATH of 1-d-geraniol. 
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Figure 1.11. GC/MS of ATH of 1-d-Geraniol. 
 
 
 
 
Figure 1.12. 1H NMR of ATH of 1-d-Geraniol. 
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Figure 1.13. COSY-NMR of ATH of 1-d-Geraniol. 
 
 
Figure 1.14. The 13C NMR of product from ATH of 1-d-geraniol. 
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Figure 1.15. DEPT 13C NMR of ATH product of 1-d-Geraniol. 
 
 
 
 
 
 
 
Figure 1.16. The 2H NMR of ATH product of 1-d-geraniol. 
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Another important deuterium-labeling experiment was performed by the ATH of geraniol 
in iPrOD (monodeuterated IPA, 0.1 M solution), with 5 mol% of [Ru(S)-tol-BINAP](p-
cymene), 0.1 eq KOH, at 83 oC for 18 hours, which produced 2,2-d2-citronellol as the 
product (Scheme 1.32). The GC/MS showed a molecular ion peak of 158 corresponding to 
di-deuterated citronellol. The 1H-NMR, COSY and DEPT135 results (Figure 1.17 – Figure 
1.20) indicated the hydrogen on the C2 position was undetectable (no hydrogen signal on 
C2 carbon was detected by 1H-NMR and COSY); 13C-NMR (Figure 1.19) showed a quintet 
signal of C2 which disappeared on the DEPT135 (Figure 1.20), indicating two deuterium 
atoms on the C2 carbon. This experiment suggested that the ATH reaction involved a 
tautomerization of enol to aldehyde process which exchanged the hydrogen on C2 carbon 
from the substrate to the protic deuterium from the solvent iPrOD. 
Scheme 1.32. Mechanistic study with ATH of geraniol in iPrOD. 
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Figure 1.17. The 1H-NMR of ATH product of geraniol in iPrOD. 
 
 
Figure 1.18. COSY-NMR of ATH product of geraniol in iPrOD. 
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Figure 1.19. The 13C-NMR of ATH product of geraniol in iPrOD. 
 
 
Figure 1.20. The DEPT135 of ATH product of geraniol in iPrOD. 
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A detailed stepwise mechanism consistent with the deuterium-labeled studies is proposed 
in Scheme 2.1 to 2.6 (Scheme 1.33). The reaction was initiated with the deprotonation of 
the allylic alcohol by the base, KOH, followed by the coordination of the alkoxide anion 
intermediate to the Ru catalyst complex (a–c). Then the Ru-mediated intramolecular 1,3-
hydride transfer takes place when the H (or D in the 1-d-geraniol experiment, Scheme 1.31) 
on C1 first migrate to the Ru metal to afford Ru-hydride enal intermediate d. The chiral 
induction process occurs when the H (or D) shifts enantioselectively from Ru back to the 
substrate’s C3 position to give chiral л-allyl intermediate e, followed by deuteration to form 
enol f. A complete H to D exchange on C2 happens due to enol/aldehyde tautomerization 
and equilibrium with the deuterated alcoholic solvent (such as iPrOD or d8-IPA) to 
sequentially produce deuterated aldehydes g to h. The last step is the [Ru]–D (D from the 
d8-IPA) catalyzed transfer hydrogenation of the aldehyde h to give the alcohol product i. 
This new ATH mechanism demonstrates that allylic alcohol tandem isomerization 
(intramolecular 1,3-hydrogen shift) is the only chiral induction process. This step helps 
explain why this ATH reaction only gives excellent ee for allylic alcohols, while low or no 
enantioselectivity for other olefin substrates. 
Scheme 1.33. Proposed mechanism for the ATH of geraniol. 
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1.2.3 ATH of secondary allylic alcohol and α, β-unsaturated carbonyl compounds 
Our initial research focused on primary allylic alcohols, such as geraniol, nerol, 3-phenyl-
2-buten-1-ol and farnesol. According to the ATH reaction mechanism proposed previously 
(Scheme 1.33), it is highly likely that the substrate scope can be expanded to other 
functionalized olefins, such as secondary allylic alcohols, and α, β-unsaturated carbonyl 
compounds (Scheme 2.8).  
Scheme 1.34. Proposed mechanism of ATH of sec-allylic alcohols and α, β-unsaturated 
carbonyls. 
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For secondary allylic alcohols, according to the proposed mechanism (Scheme 1.34), the 
stereo-induction step would occur in the transfer hydrogenation (reduction) step. Kinetic 
resolution can be applied since the stereocenter on allylic carbon in the substrate is 
tautomerized to the carbonyl, followed by asymmetric transfer hydrogenation to restore 
chirality (Scheme 1.34).  
 
Racemic α-vinylbenzyl alcohol was selected for the ATH of sec-allylic alcohols (Scheme 
1.35). Several Ru-phosphine chiral catalysts were screened with various amount of base 
(KOH, 0.1 to 1 equiv.) in IPA using the previously optimized conditions (molar ratio of 
substrate/catalyst/base = 33:1:2, 0.1 M solution in IPA). The results are summarized in 
Table 1.2. The ATH reaction is clean and completed in 16 hours at 83 0C with higher than 
95% isolated yield. However, unlike the high ee we observed with the prochiral primary 
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allylic alcohols in our previous studies, higher enantioselectivity was only obtained after 
extensive development by Chris Shoola in the Sowa group.31h The discrepancy between 
primary and secondary allylic alcohols is likely due to the differences in the mechanism of 
the chiral induction step (tandem isomerization for primary allylic alcohols vs transfer 
hydrogenation for sec-allylic alcohols), which requires different types of Ru chiral 
complexes to perform the highly enantioselective process.31h 
Scheme 1.35. ATH of α-vinylbenzyl alcohol 
 
Table 1.2. ATH of 1-phenylprop-2-en-1-ol under different conditions. 
Entry  Catalyst  Base (eq.)  eea 
1  [(S)-tol-BINAP]RuCl
2
(p-cymene)  0.1  26%  
2  [(S)-BINAP]RuCl
2
(p-cymene) 0.1  16%  
3  [(S)-xyl-BINAP]RuCl
2
(p-cymene) 0.1  12%  
4  [(S)-tol-BINAP]RuCl
2
(p-cymene) 1.0  14%  
5  [Ru(COD)Cl
2
]
n
 + (S)-BINAP  0.2  0%  
6  Ru(p-cymene)Cl
2
 + (S)-BINOL
 
 0.2  13%  
a ee is determined by HPLC, Chiralpak® IB (25 cm x 4,6 mm, 5 µm), 20 oC, MeOH/Water = 60:40, 0.6 mL/min, 30 min.  
 
1.3 Conclusions 
A novel asymmetric transfer hydrogen process has been developed to enantioselectively 
reduce prochiral primary allylic alcohols with high yield and excellent enantioselectivity. 
A screening process was established to prepare the chiral catalytic complex in situ by 
adding a metal source and a chiral bidentate phosphine ligand separately in a protic solvent. 
Also, the reaction conditions can be optimized using commercially available pre-made 
chiral metal-ligand complexes. The stereochemical configuration of the ATH product is 
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the same as in the gaseous hydrogenation, so it would be straightforward to develop the 
ATH process from the known gaseous hydrogenation conditions. A series of deuterium-
labeled mechanistic studies suggest that the ATH reaction involves a stepwise 
enantioselective tandem isomerization/transfer hydrogenation process which is a new 
sequential combination of mechanisms and can be potentially applied to other activated 
olefinic substrates. In comparison with high-pressure gaseous hydrogenation, this new 
ATH condition is green and propitious since it can also give high yield and excellent 
enantioselectivity while potentially hazardous hydrogen gas is omitted.  
 
Experimental Section 
Materials 
All reagents and solvents were purchased from commercial sources and were used without 
further purification. HPLC mobile phases were comprised of methanol (JT Baker HPLC 
grade), acetonitrile (Fisher HPLC grade) and water (Fisher HPLC grade), with either 
trifluoroacetic acid (Sigma-Aldrich) or formic acid (Sigma-Aldrich) as the mobile phase 
additives. The following catalysts used for the ATH studies were from Strem Chemicals: 
[(S)-tol-BINAP]RuCl2(p-cymene) (95%), [(S)-BINAP]RuCl2 (95%), [(S)-xyl-
BINAP]RuCl2(p-cymene) (95%), [Ru(COD)Cl2]n (95%), (S)-BINAP (97%), (S)-tol-
BINAP (97%), (R)-BINAP (97%), (R)-tol-BINAP (97%),  Ru(p-cymene)Cl2 (95%). The 
following chemicals used for the ATH studies were from Sigma-Aldrich: geraniol (98%), 
(S)-BINOL (95%), trans,trans-farnesol (96%), (R)-(+)-β-citronellol (98%), (S)-(−)-β-
citronellol (>99%), KOH (technical grade). The following solvents used for ATH reaction 
and purification were purchased from JT Baker: isopropanol (anhydrous), hexanes (ACS 
Grade), pentane (ACS Grade) and EtOAc (ACS Grade). The deuterated chemicals, NaBD4, 
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d8-IPA and iPrOD, d1-chloroform (NMR) were purchased from Aldrich with isotopic 
purities of 99%, 98% and 99%, 99.96%, respectively. 
 
Instrumentation 
GC/MS (EI): The GC-MS analysis was performed on Hewlett-Packard 6890 GC system 
equipped with HP 5973 Mass Selective Detector (MSD), operated with ChemStation 
software, 70 eV electron-impact (EI) ion source. The GC column used was a DB-5ms, 
J&W Scientific, 30 m x 0.32 mm x 0.25 µm. 
 
ESI-MS (ESI): The ESI-MS analysis was performed on Waters 3100 Mass Detector, 
operated with MassLynx mass spectrometry software. 
 
GC: The GC purity of the ATH products and reaction conversion rate were analyzed on an 
Agilent 6890 GC system equipped with a flame ionization detector (FID) and a 7683B auto 
injector. A typical GC method is given below: 
GC column: J&W Scientific DB-5, 30 m x 0.32 mm x 0.5 µm 
Inlet temperature: 250 0C 
Injection volume: 1 µL split (split ratio 50:1) 
Column temperature: 60 - 175 oC at 3 0C/min 
Carrier Gas: He, constant flow, 1 mL/min 
Detector: FID, 250 0C. 
 
The chiral analysis (ee) of the ATH products was obtained on an Agilent 6890 GC system 
equipped with FID and a 7683B autoinjector. The chiral GC method used is as follows: 
Chiral GC column: Restech RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25 µm 
Injection volume: 5 µL (split ratio 50:1) 
Inlet temperature: 200 0C 
Column temperature: isothermal 80 0C 
Carrier Gas: He, constant pressure, 15 psi 
Detector: FID, 200 0C 
Run time: 120 min. 
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HPLC: Agilent 1200 series HPLC systems equipped with Diode-Array detector (DAD) 
was used to monitor reaction completion and to check for purity. A general HPLC method 
is: 
HPLC column: Waters X-BridgeTM C18, 100x3 mm, 3.5 µm 
Mobile phase: 10 – 90 % method/water with 0.1% formic acid, 20 min. 
Flow rate: 1.00 mL/min 
UV detection: 215 nm  
Column Temperature: 25 oC 
 
The chiral analysis (ee) of the ATH products was obtained on an Agilent 1200 series HPLC 
systems equipped with Diode-Array detector (DAD). A general chiral HPLC method is:  
Chiral HPLC column: Chiralpak® IB, 25 cm x 4.6 mm, 5 µm.  
Mobile phase: method/water 60:40 (v/v). 
Flow rate: 0.60 mL/min 
UV detection: 215 nm  
Column Temperature: 15 0C 
Run time: 30 min 
 
NMR (1H NMR, 13C NMR, COSY, 2H NMR, DEPT135, etc.): 
For all the NMR analyses (1H, 2H, 13C, COZY, etc.) of ATH and deuterium-labeled 
experiment products citronellol (2, 13, 15 and 16), and intermediates 4, 7 and 14, a Brucker 
500 MHz NMR with TopSpinTM software was used. The samples were prepared in CDCl3, 
except for 2H NMR (with CHCl3 as solvent). The standard for chemical shift is dilute 
tetramethylsilane (TMS) in CDCl3. Abbreviations for multiplicities and descriptors are: s 
= singlet, dd = doublet of doublets, d = doublet, dt = doublet of triplets, t = triplet, q = 
quartet, quint = quintet, m = multiplet (denotes complex pattern). 
 
The polarimeter we used is a Jasco P-2000 Polarimeter. 
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Procedures 
Preparation of 3-phenyl-2-buten-1-ol (4): 
A 250 mL 3-neck, round bottom flask equipped with magnetic stir bar, thermometer, and 
condenser, was charged with methyl diethylphosphonoacetate (15.5 mL, 88 mmol) 
followed by THF (130 mL).  The flask was cooled to 5 0C and sodium hydride (60 % in 
mineral oil, directly used) (3.5 g, 88 mmol) was added in portions over 30 min.  The flask 
was warmed to about 25 0C and to this clear solution was added acetophenone (10.4 mL, 
88 mmol) by an addition funnel.  The flask was heated to reflux for 8 h then cautiously 
quenched slowly with water. Caution: Vigorous gas evolution!  The contents of the flask 
were then poured into water and extracted with ether and washed with 0.1 N HCl and brine.  
The organic layer was dried over MgSO4, filtered, and concentrated to obtain 15 g of a 
crude oil suitable for further preparations.  Vacuum distillation and flash chromatography 
(100 % hexanes) of a subsequent batch provided 540 mg of clear, colorless oil (4.2% yield, 
96% GC purity).  
 
Alternate preparation of 3-phenyl-2-buten-1-ol (4): 
A 250 mL 3-neck, round bottom flask equipped with a magnetic stirbar and thermometer, 
was charged with methyl 3-phenyl-2-butenoate (14 g, 80 mmol), and 125 mL ether.  The 
flask was cooled in an ice bath to 2 0C and lithium aluminum hydride (95 %) (3 g, 320 
mmol) was slowly added in portions so that a gentle reflux was obtained.  The reaction was 
monitored by GC for the disappearance of starting material.  Next, the flask was cooled in 
an ice bath to 5 °C then quenched slowly with 50 mL of saturated aqueous Na2SO4.  
Caution: Vigorous gas evolution!  The contents were transferred to a separatory funnel, 
diluted with ether and washed with water and brine.  The organic layer was dried over 
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MgSO4, filtered, and concentrated to obtain 10 g of an oil.  Purification by flash 
chromatography with a Biotage 40XL cartridge (10 % ethyl acetate/hexanes) yielded 1.7 g 
clear colorless oil (14.3% yield, 99 % purity GC). The spectral data was identical to those 
from literature.126 
 
Preparation of 3-phenyl-2-butenoic acid (7): 
A 50 mL single neck round bottom flask was charged with methyl 3-phenyl-2-butenoate 
(600 mg, crude), THF (2 mL), and 2 M NaOH (2.4 mL, 4.8 mmol) and refluxed for 3 h.  
The contents were diluted with ether and acidified with conc. HCl, extracted twice, washed 
with brine, dried over MgSO4, filtered, and concentrated to obtain 270 mg white solid 
(59.6% yield, 99 % purity GC).  1H NMR (500 MHz, CDCl3) δ 7.52-7.49 (m, 2H), 7.42-
7.39 (m, 3H), 6.19 (q, 1H), 2.62 (d, J = 2 Hz, 3H); MS (ESI): m/z 162. 
 
Preparation of 2-d-geraniol (14) 
A 250 mL single neck round bottom flask was charged with 3.04 g (20 mmol) of citral, 8.2 
g (20 mmol) of CeCl4(H2O)7  and 50 mL of MeOH. Then 1.0 g (24 mmol) of NaBD4 was 
slowly added and the resulting mixture was stirred at 25 oC for 5 hours. The reaction was 
monitored by TLC (Hexanes/EtOAc 9:1). 200 mL of MTBE and 200 mL of water was 
added. The organic layer was concentrated and was purified by silica column 
chromatography (0-10% EtOAc/pentane). 0.97 g of 2-d-geraniol 14 was obtained (31.8% 
yield). 1H-NMR (500 MHz, CDCl3) δ 5.41 (d, J=6.94 Hz, 1H), 5.10 (t, J=6.62 Hz, 1H), 
4.11 (d, J=6.62 Hz, 1H), 2.10 (t, J=7.41 Hz, 2H), 2.03 (m, 2H), 1.68 (s, 6H); 1.18 (s, 1H); 
GC/MS(EI): m/z 155.14. 
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General procedure of ATH with in situ prepared Ru chiral catalyst: 
With positive nitrogen flow protection, a degased solution of geraniol (0.01 M, 10 mL) in 
isopropyl alcohol (IPA), [Ru(COD)Cl2]n (0.001 M), KOH (0.002 M), and chiral ligand 
(0.002 M) (such that the substrate/catalyst/base/ligand mole ratio = 10/1/2/2) were added 
to a Schlenk flask (or three-neck round-bottom flask) equipped with a magnetic stirbar and 
covered with a fresh rubber septum. Three freeze-pump-thaw cycles with liquid nitrogen 
to degas the reaction system were performed and the flask was transferred to an oil bath at 
100 0C and stirred in a closed system for the allotted time (the three freeze-pump-thaw 
cycles degas process can be omitted by adequate nitrogen protection with two separate 
nitrogen flows, one going into the solution and the other going into the flask from the top). 
Products were isolated by evaporation of the solvent under vacuum and subsequent 
purification by chromatography on silica gel (40 µm particle size) with pentane/ethyl 
acetate (95:5) as the eluent. The combined fraction was concentrated by evaporation of 
solvents under vacuum. The reaction progress and GC yields were also determined by a 
GC method mentioned above with an Agilent 6890 GC and a DB-5 column (J&W 
Scientific, 15 m x 0.32 mm). Commercially available (R)-(+)-β-Citronellol (98%), (S)-(−)-
β-Citronellol (>99%) (from Sigma-Aldrich) were obtained as standards for analytical 
method development and comparison with the ATH products. Enantiomeric purity (ee) of 
the ATH products was determined by the chiral GC method in the instrumentation section 
above. 
 
General procedure of ATH with commercially available Ru chiral complexes: 
Under an atmosphere of nitrogen protection using two separate nitrogen flows (one into 
the solution and the other into the flask from the top), a degased solution of primary allylic 
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alcohol (0.10 M, 10 mL) in IPA, [(S)-tol-BINAP]RuCl2(p-cymene) (0.005 M, or Ru[(R)-
BINAP]Cl2), KOH (0.01 M) (such that the substrate/catalyst/base molar ratio = 1/0.05/0.1) 
were added to a three-neck flask equipped with a magnetic stirbar and covered with a fresh 
rubber septum, digital thermometer and nitrogen inlet/outlet. The reaction mixture was 
heated up to 83 °C (internal temperature, reflux) and stirred in a closed system for the 
allotted time (usually 16 to 18 hours). The reaction progress was monitored by a TLC (silica 
gel 60 F254 pre-coated plates, 0.25 mm) with hexane/EtOAc (20:1, v/v) as the eluent 
mixture. Products were isolated by evaporation of the solvent under vacuum and 
purification by chromatography on silica gel (40 µm particle size) with pentane/ethyl 
acetate (95:5) as the eluent. The combined fraction was concentrated by evaporation of 
solvents under vacuum. Commercial available (R)-(+)-β-Citronellol (98%), (S)-(−)-β-
Citronellol (>99%) (from Sigma-Aldrich) were obtained as standards for analytical method 
development and comparison with the ATH products. Enantiomeric purity (ee) of the ATH 
products was determined by chiral GC (for citronellol), chiral HPLC (for propyl benzyl 
alcohol), or polarimetry (for trans,trans-farnesol) in the instrumentation section above. The 
1H and 13C NMR spectra were recorded on a FT-NMR spectrometer at 500 and 125 MHz, 
respectively.  
R-citronellol: 1H-NMR (500 MHz, CDCl3/D2O) δ 5.13 (t, 1H, J=6.5 Hz), 3.64 (t, 2H), 1.92 
(m, 2H), 1.76 (s, 3H), 1.64 (s, 3H), 1.57–1.12 (overlapping m, 5H), 0.91 (d, 3H, J=5 Hz). 
13C NMR (125 MHz, CDCl3) δ: 131.4, 126.3, 61.2, 40.0, 37.5, 29.3, 25.8, 25,5, 19.8, 17.5; 
GC/MS: m/z 156.15. 
2,2-d2-citronellol: 1H-NMR (500 MHz, CDCl3/D2O) δ 5.13 (t, 1H, J=6.5 Hz), 3.65 (m, 2H), 
1.93 (m, 2H), 1.77 (s, 3H), 1.63 (s, 3H), 1.56 (m, 1H), 1.37 (m, 1H), 1.21 (m, 1H), 0.91 (d, 
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3H, J=5 Hz); 13C NMR (125 MHz, CDCl3) δ: 131.4, 126.3, 61.2, 40-39(m), 37.4, 29.2, 
25.8, 25.5, 19.8, 17.5; GC/MS: m/z 158.16. 
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Part II: Enantioseparation of Chiral Benzyl Alcohols under RP-HPLC 
 
2.1 Introduction 
The long history of chiral analysis and separation can be dated back to 1820, when Biot 
observed that optical isomers can rotate plane polarized light in different directions.1 The 
first chiral separation was reported in 1848, when Pasteur successfully isolated racemic 
sodium ammonium tartrate under a microscope to optically active D and L isomers by 
manually splitting up the different enantiomorphous crystals.2 The terminology of 
‘chirality’ was initially introduced by Kelvin in 1873.3 The origin of chirality was proposed 
in 1874 by van't Hoff and Le Bel independently, that the existence of the asymmetric 
carbon, a tetravalent atom with tetrahedral configuration attached to four different 
substituents would produce two different arrangements that have a nonsuperimposable 
mirror image relationship.4 In the 1890’s, the absolute configuration of enantiomers was 
assigned by Fischer for the stereochemical determination of all known sugars, such as D-
(+)-glucose.5 For this discovery, he was also awarded the Nobel Prize in Chemistry in 1902. 
Since then the interest and effort on chiral chemistry has grown substantially in both 
academia and industry, and many new techniques were developed for chiral analysis and 
separation, such as nuclear magnetic resonance (NMR), chromatography, polarimetry, 
isotopic dilution, calorimetry, enzymatic resolution and chemical resolution. Among the 
separation techniques, chromatography is generally considered as the most advantageous 
for chiral separation.6 In 1939, examples of chromatographic enantiomeric separation were 
reported by Henderson and Rule.7 Since then, several chromatography technologies have 
been studied and developed for enantiomeric separations. Thin layer chromatograph (TLC) 
was used for chiral separation in the early 1950’s to separate chiral amino acids.8 The first 
chiral stationary phase for gas chromatography was developed by Gil-Av in 1966.9 In 1985 
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supercritical liquid chromatography (SFC) was introduced to separate enantiomeric pairs 
of phosphine oxide.10 The application of capillary electrophoresis (CE) in chiral separation 
emerged in 1988 when cyclodextrins (CDs, Figure 2.1) were used as chiral selectors in 
capillary-isotachophoresis (CITP) and capillary-gel-electrophoresis (CGE), respectively.11 
Silica supported chiral stationary phase, which has been broadly used in chiral high 
performance liquid chromatography (HPLC) and preparative liquid chromatography (prep 
LC), appeared in the 1960s, when Klem and Reed developed (+)-(2,4,5,7-tetranitro-9-
fluorenylideneamino-oxy)propionic acid modified silica to partially resolve the 
enantiomeric pairs of naphthyl ether and phenanthrene on HPLC.12 Since then, most 
chromatographic chiral separations were accomplished via direct resolution using a chiral 
stationary phase (CSP). In this technique, a chiral selector, usually a chiral molecule such 
as amino acids, proteins, small chiral organic molecules or polysaccharides, is physically 
coated or chemically bonded to an inner support (usually polymer or silica) to form a CSP. 
The enantiomers are resolved by the formation of transient diastereomeric complexes 
between the analyte and the chiral selector on the surface of CSP. The CSP based HPLC 
enantioseparation has shown great advantages and is currently the most broadly used 
method for identification, separation and preparation of single enantiomers at both 
analytical and preparative scales.13 The rapid research and development in this field leading 
to many CSPs for the application of HPLC enantioseparation, including crown ethers,14 
chiral cyclodextrins (CDs),15 proteins/macrocyclic antibiotic,16 π complex (also known as 
Pirkle type),17 oligosaccharides,18 polysaccharides19 and helical synthetic polymers.20 
Among the various types of CSPs, polysaccharide-based CSPs, especially the phenylester 
or phenylcarbamate derivatized cellulose and amylose (Figure 2.2), are most prevalent in 
chiral HPLC due to their unique chiral recognition, good chromatographic and 
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enantioselective properties, wide applicability and high loading capacity.21 Many reports 
reveal that for polysaccharides-based CSP, the chiral separation process usually involved 
an essential complexation for primary docking at the chiral cavity on the chiral stationary 
phases which are associated with hydrogen bonding and π-π interactions. On the other 
hand, the hydrophobic interactions do not play a significant role in chiral recognition due 
to the lack of stereospecific interactions.21  
  
Figure 2.1. Three major types of cyclodextrin, α-CD, β-CD and γ-CD. 
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Figure 2.2. Structure of phenylester or phenylcarbamate derivatized cellulose and amylose 
as CSPs. 
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to the pair of enantiomers owning the same chemical and physical properties under achiral 
conditions, it has become one of the most important tests in biological and pharmaceutical 
analysis.22 Since enantiomeric pairs usually possess significant differences in their 
biological, physiological and pharmacological activities, especially unwanted side effects 
and toxicity, regulatory authorities all over the world require validated and effective 
analytical methods to strictly control the enantiomeric purity for the development of new 
chiral drugs.23 In 2011, almost half of the drugs in use were chiral and seven out of the top 
ten best selling drugs world-wide are chiral molecules.24 However, only about a quarter of 
those chiral drugs are used as the single enantiomer. Therefore, it is with great economic 
interests and urgent need to develop new and advanced technology for the separation and 
identification of chiral molecules.  
 
In our studies, we aim to develop and apply the green chemistry concept into chiral 
separations, in which we utilized acetonitrile-free reversed-phase conditions on chiral 
HPLC for enantiomeric separations of chiral benzyl alcohols (Figure 2.3) which are also 
one series of proposed substrates/products in the previous ATH experiments.  
Figure 2.3. Chiral benzyl alcohols. R = alkyl, vinyl, aromatic groups. 
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Chiral benzyl alcohols are a class of important organic molecules which have broad 
applications in the fields of biocides, materials, chemicals, and pharmaceutical industries.25 
They have been crucial structural moieties for a variety of biocides and therapeutic 
pharmaceutical agents, such as Sotalol,26 Terfenadine,27 Metaproterenol,28 Clenbuterol29 
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and Voriconazole30 (Figure 2.4). The synthesis of chiral benzyl alcohols have also been 
extensively explored worldwide.31 Therefore, it is of significant importance to develop new 
and more versatile methods for the determination of the chiral purity of this class of 
molecules.25 In our study, we selected a few representative racemic benzyl alcohols as test 
probes. To the best of our knowledge, this is the first report of acetonitrile-free RP-HPLC 
methods for enantioseparation of chiral benzyl alcohols. 
Figure 2.4. Structures of drugs containing chiral benzyl alcohol moiety. 
 
The exact mechanism of chiral recognition under chromatographic conditions is still 
unclear. However, the famous ‘Three Point Theory’ has been well acknowledged as a 
principle rule for chiral recognition. First proposed by Pirkle, this theory states that to 
achieve chiral separation, a minimum of three simultaneous interactions (hydrogen 
bonding, ionic force, dipole-dipole, dipole-induced dipole, hydrophobic interactions, π-π 
interactions) of which more than one must be stereochemically specific, must occur 
between the enantiomeric pairs and the chiral stationary phase to form a temporary 
diastereomeric analyte-CSP complex.32 The diastereomeric complexes can also exist by 
diffusion of analyte enantiomers into chiral cavities on CSPs, such as cyclodextrins, 
proteins or polymeric CSPs.15, 16, 20 Under such chiral environments, chiral recognition 
occurs when one of the enantiomeric molecules is a better ‘fit’ in the cavities than the other. 
The ‘fit’ appears to be mainly governed by steric effects. The polysaccharide type CSP, 
such as amylose tris(3,5-dimethylphenylcarbamate) and cellulose tris(3,5-
dimethylphenylcarbamate) CSPs are believed to possess both the interactions described in 
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the ‘Three Point Theory’ and the chiral cavities (sterically-fit effect) between the analyte 
and CSP.33 The chiral selector, immobilized on the surface of an inert support by either 
coating or chemical bonding, are composed of many stereogenic active sites or cavities for 
the stereospecific forces between the analyte and the CSP. These are followed by the 
formation of transient analyte-CSP diastereomeric complexes.34 Hydrogen bonding, π-π 
interactions and hydrophobic interactions (London Dispersion Forces) are generally 
considered as the main interactions between the analytes and phenylcarbamate or benzoate 
modified polysaccharides CSPs.19 
 
Figure 2.5. Three point theory in chiral recognition. 
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Hydrogen bonding can be viewed as a high energy form of dipole-dipole interactions but 
can exist between an acidic proton (partially positive charge; also called the hydrogen bond 
donor) in close proximity with an electron pair donor (partially negatively charge; also 
called the hydrogen bond acceptor) such as oxygen in hydroxyl/carbonyl groups, a nitrogen 
in amine groups or halogen atoms (F, Cl). Hydrogen bonding is usually considered as the 
most important interaction for the majority of the CSPs.35 The typical energy of the 
hydrogen bond in the liquid chromatographic phase can be varied between 20 kJ/mol to 
130 kJ/mol, depending on the distance/orientation of the hydrogen bond and the types of 
౺缀
 91 
the hydrogen donor/acceptor atoms or groups involved.36 Scientists used to believe that the 
reversed–phase solvents such as water/alcohols could interrupt the hydrogen bonding 
formation between the chiral analytes and CSPs, thus, reducing the chiral recognition. This 
is the main reason for the emergence of the chiral HPLC in the 1960’s, for more than two 
decades the methods developed were exclusively under normal phase conditions. In 1989, 
Ikeda reported the first example of reversed-phase HPLC enantioseparation on 
polysaccharides-based CSPs, when the enantiomeric pairs of four chiral drugs were 
partially separated (Rs = 1.1 - 1.6) on tris(3,5-dimethylphenyl-carbamate) cellulose 
(Chiralcel® OD) with an aqueous buffer/acetonitrile mobile phase.37 Since then, the interest 
in reversed-phase HPLC enantioseparation has been increasing and chiral separation has 
been achieved with polysaccharide type CSPs under optimized reversed-phase conditions 
(mobile phases, column temperature, column selection, etc.).38 However, although there 
have been many successful cases of separating enantiomeric pharmaceutical 
intermediates/drug molecules using polysaccharide-based CSPs under normal-phase 
solvents, the applications of enantioseparation on these CSPs in aqueous mobile phases 
(reversed-phase) are still limited.39 Reversed-phase chromatographic conditions, which 
account for more than 90% of the HPLC analytical experiments, have a number of 
advantages, for example, good solubility of polar compounds, suitability for bioanalytical 
applications especially the direct analysis of biological matrices (e.g., serum or plasma), 
compatibility for mass spectrometric analysis and more economical and environmental 
friendly solvents. 
 
The global economic downturn between 2007 and 2012 has led to a significant decrease in 
the production of acrylonitrile, affecting the co-product acetonitrile. Acetonitrile is among 
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the most commonly used organic solvents for reversed-phase high performance liquid 
chromatography (RP-HPLC) in the pharmaceutical, food, environmental, cosmetic, 
material and chemical industries. The limit of this supply caused a rapid price surge (ca. 
$400/L) but since the apparent start to the economic recovery in 2015, costs ($70/L) have 
not returned to the pre-2007 level ($30/L).40 The acetonitrile shortage and increasing prices 
have limited its usage and forced scientists to replace acetonitrile with more readily 
available and less expensive solvents such as methanol or ethanol. Herein, we present the 
first comprehensive study on direct RP-HPLC enantioseparation under acetonitrile-free 
reversed phase mode, especially in EtOH and water as mobile phase, which are the most 
ideal green solvents.40 
 
The retention mechanism for the (non-chiral) reversed-phase liquid chromatography has 
been extensively studied in the past few decades. Horvath and co-workers applied the 
solvophobic theory in the 1970s, which proposes that hydrophobic interaction between the 
mobile phase and solutes is the primary cause of retention and the free energy change 
(∆G°). Associated with this theory is the step-wise solute-transfer mechanism as the driving 
force for retention as shown in the thermodynamic study.41 The same group also analyzed 
the results with several C18 columns under different chromatographic conditions in 
reversed-phase mode and found that a linear relationship between the logarithm of the 
capacity factors (log K) and the enthalpy change (∆H) of the retention process at a certain 
experimental temperature, which is called enthalpy - entropy compensation temperature.42 
In their experimental conditions, the enthalpy – entropy compensation behavior supported 
the theory that the intrinsic mechanism of action (MoA) between the analytes and the non-
polar stationary phase (C18) remains the same even under significantly different reversed-
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phase chromatographic conditions (various types and/or concentrations of the organic 
modifiers in the aqueous mobile phase).43 Enthalpy – entropy compensation behavior was 
also observed under normal phase chromatographic conditions (polar stationary phases 
with non-polar mobile phases), but the compensation temperatures calculated through 
thermodynamic studies usually were substantially lower than the values obtained in 
reversed-phase chromatographic conditions.44 Depending on the mobile-phase 
composition, phase transitions of reversed-phase C18 stationary phases and polymeric 
stationary phases were observed by means of thermodynamic characterization.45 The 
thermodynamic study is a suitable tool for the elucidation of chromatographic retention 
mechanisms, especially the enantiospecific retention and recognition of enantiomers on 
chiral stationary phases (CSP).46 The CSPs usually play a decisive role in enantioseparation 
and it is important for analytical chemists to interpret the chiral discrimination process in 
order to develop/optimize chiral separation methods and even to design more new and 
effective CSPs.47 Under chiral chromatographic conditions, retention is governed by mixed 
mechanisms by both of the enantiospecific and non-enantiospecific interactions and the 
mass transfer for the chiral adsorption process is heterogeneous and usually much slower 
than that of non-chiral liquid chromatography.48 
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2.2. Experimental Section: 
2.2.1 Chemicals and reagents 
HPLC-grade methanol and 200-proof ethanol were purchased from Sigma-Aldrich (St. 
Louis, MO, USA) and HPLC grade water was purchased from Fisher Scientific 
(Morristown, NJ, USA). The mobile-phases for HPLC enantioseparations were filtered and 
degassed by sonication before use. Formic acid (ACS-grade) and racemates and 
enantiomers listed in Table 1 were obtained from Sigma–Aldrich (St. Louis, MO, USA) 
except the following:  2-(4-bromophenyl(hydroxymethyl)thiazole and 2,2,2-trifluoro-1-
phenylethanol which were acquired from Combi-blocks (San Diego, CA, USA); ethyl-2-
hydroxy-2-phenylacetate obtained from Alfa-Aesar (Ward Hill, MA, USA); and 2,2,2-
trifluoro-1-phenylethanol from 3B Scientific Corporation (Libertyvill, IL, USA); t-
Butyl(2-hydroxy-2-phenylethyl)carbamate was made from 2-hydroxy-2-phenylethylamine 
(TCI chemicals, Portland, OR, USA) (Table 2.1). 
 
Stock solutions of racemic compounds were prepared in methanol at a concentration 0.3 - 
0.5 mg/mL for chiral HPLC analysis with UV detection.  
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Table 2.1.  Structures and names of chiral benzyl alcohols. 
Structure Name 
OH
 
1-Phenylpropan-1-ol (PPOH)propan-1-ol (P 
OH
  
1-Phenylprop-2-en-1-ol (PVOH) 
CF3
OH
 
2,2,2-Trifluoro-1-phenylethanol (PCF
3
OH) 
OH
O
O
 
Ethyl 2-hydroxy-2-phenylacetate (PAEtOH) 
O H
H
N O
O
 
t-Butyl (2-hydroxy-2-phenylethyl)carbamate (PNBOCOH) 
OH
N
S
Br
 
2-(4-Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) 
OH
F
F
 
(3,5-Difluorophenyl)(phenyl)methanol (DFPPOH) 
 
 
2.2.2 Instrumentations and Chromatographic Conditions  
An Agilent HP1100 series liquid chromatography system (Agilent Technologies, Palo 
Alto, CA, USA) equipped with a quaternary pump was used for chromatographic 
separations. The diode array detector (DAD) was set at 215 nm for UV detection. All HPLC 
chiral separations were performed in isocratic elution mode at temperatures set at 5 0C 
increments, from 10 0C to 40 0C. The chromatographic system was allowed to equilibrate 
at each temperature/mobile phase conditions for at least 1 h prior to injections. The flow 
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rates were 0.40 mL/min (EtOH/water) and 0.60 mL/min (MeOH/water) and mobile phase 
eluting strengths were adjusted in 5% increments relative to the organic modifier from 
45/55 to 70/30). The injection volume was 5.0 µL.  
 
Chiral HPLC analysis of the enantiomers was performed by using stainless-steel chiral 
columns: Chiralpak OD-RH (150 mm × 4.6 mm I.D., 5 µm), Chiralcel AS-RH (150 mm × 
4.6 mm I.D., 5 µm), Chiralcel OJ-RH (150 mm × 4.6 mm I.D., 5 µm), Chiralpak IA (150 
mm × 4.6 mm I.D., 5 µm), Chiralpak IB (150 mm × 4.6 mm I.D., 5 µm), and Chiralpak IC 
(150 mm × 4.6 mm I.D., 5 µm) from Daicel Chiral Technologies (West Chester, PA, USA), 
and Lux Cellulose-3 (150 mm × 4.6 mm I.D., 3.5 µm) from Phenomenex (Torrance, CA, 
USA) (Table 2.2). 
 
Data acquisition and processing were carried out with the ChemStation software (Agilent 
Technologies, Palo Alto, CA, USA) for chiral HPLC/UV data analysis. 
 
The column hold-up times (or void volume, t0) were estimated by the first minor disturbed 
peak appeared in the chromatograms when D2O was injected as blank. The elution order 
was determined by injecting a single enantiomer. The absolute configuration was 
confirmed by polarimetry (Perkin-Elmer polarimeter, Model 241, with Na lamp at 589 nm 
in CHCl3 solvent 23 0C).  
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Table 2.2.  Seven selected chiral columns and CSPs. 
Brand Name Chiral Selector R group Chemical name 
Chiralcel®OD-RH 
O
RO
OR
O
OR
Cellulose derivatives
 
N
H
O
 
Cellulose tris (3,5-dimethylphenyl-
carbamate) 
Chiralpak® IB 
Chiralcel® OJ-RH 
O
 
Cellulose tris(4-methylbenoate) 
LuxTM Cellulose-3  
Chiralpak® IC 
N
H
O
Cl
Cl
 
Cellulose tris (3,5-dichlorophenyl-
carbamate) 
Chiralpak® IA 
O
RO
OR
OR
Amylose derivatives
O
 
N
H
O
 
Amylose tris (3,5-dimethylphenyl-
carbamate) 
Chiralpak®AS-RH 
N
H
O
 
Amylose tris-[(S)-(-methylbenzyl-
carbamate)] 
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2.3 Results and Discussions 
2.3.1 Calculations 
The column void time (to) was derived from the time of the first minor disturbance peak 
when D2O was injected as blank. The void time was found not to change with temperature 
(up to 40 0C) under the experimental conditions.  
 
The calculations of chromatographic parameters were based on the following formulas: 
Eq. 2.1 Retention factor k = (tR – t0)/t0; 
Eq. 2.2 Enantioselectivity α = k2/k1; 
Eq. 2.3 Resolution Rs = 2(tR1 – tR2)/(Wb1 – Wb2); 
where tR1, tR2, k1, k2 were retention time and retention factors for the first and second eluting 
enantiomer, respectively. The terms Wb1, Wb2 were basewidths for the first and second 
eluting enantiomer, respectively. The terms α and Rs are enantioselectivity and resolution 
between the two peaks of the enantiomers, respectively. 
 
In summary, the enantiomers of various chiral benzyl alcohols were separated on 
derivatized cellulose and amylose chiral stationary phases with methanol/water or 
ethanol/water mobile phases. Using different chiral stationary phases, enantioseparation 
was optimized by varying the type and percentage of organic modifier and column 
temperature. Baseline resolution was achieved in 10 min for most of the enantiomers and 
the optimized chromatographic method allowed the accurate determination of the 
enantiomeric purity of the chiral benzyl alcohols.31h This method is advantageous 
compared to the current chiral separation methods because the mobile phase is acetonitrile-
free and the analysis time is comparable or even less with those performed under normal 
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phase conditions. The effects of chiral stationary phase (CSP), mobile phase and column 
temperature on the enantioseparation, mechanism and thermodynamic properties that were 
investigated are discussed below.  
 
2.3.2 Chiral stationary phase (CSP) effect on enantioseparation  
Chiralpak IA, IB and IC columns are immobilized polysaccharides-based CSP (3,5-
dimethylphenylcarbamate or 3,5-dichlorophenylcarbamate derivatized amylose or 
cellulose) chemically bonded on a silica support surface. The immobilization of the 
polymeric selector on the silica matrix allows a chemist to select a broad variety of organic 
solvents (with limited restriction) in the preparation of normal-phase eluents. 
Consequently, the enantioselectivity of the IA CSP can be evaluated in conditions 
prohibited for the coated-type CSPs, which are compatible only with hydrocarbons (usually 
n-hexane and n-heptane), alcohols (usually ethanol, methanol, 2-propanol, and 1-
propanol), acetonitrile (CH3CN) or hydrocarbon/alcohol and CH3CN/alcohol mixtures. 
Applications which show the advantages in the use of ethyl acetate (EA), acetone or 
dichloromethane (CH2Cl2) in combination with polysaccharide-based CSPs at analytical 
and semipreparative scale have been previously reported.49 
 
Optimized chromatographic data for enantioseparation of seven selected chiral benzyl 
alcohols on OD-RH, OJ-RH, Lux C-3, IA, IC and AS-RH are summarized in Table 2.3, 
indicating the strong enantiospecific recognition effect induced by the chiral selectors. In 
our study, all of the selected racemic pairs of chiral benzyl alcohols were separated, and 
six out of the seven pairs can be baseline-separated (Rs > 2.0) on the selected 
polysaccharide-based chiral columns under suitable reversed-phase conditions (Table 2.3).  
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Table 2.3. Enantioseparation of Chiral Benzyl Alcohols under MeOH/water (line 1) and EtOH/water (line 
2). 
 
 
The results show that Chiralcel OD-RH (CSP = Cellulose tris-3,5-
dimethylphenylcarbamate) was the most successful chiral column in our study since five 
out of the seven selected benzyl alcohols were baseline separated. It is interesting to notice 
that Chiralpak IC (CSP = Cellulose tris-3,5-dichlorophenylcarbamate) gave 
complementary (successful) results for Chiralcel OD-RH in separation of the other two 
benzyl alcohols (PNBOCOH and DFPPOH) which could not be resolved on Chiralcel OD-
RH. The racemates of PCF3OH were well-resolved (Rs > 7) on Cellulose tris-4-
methylbenoate CSP-based columns (OJ-RH and LuxTM C-3), which is the highest 
resolution observed in this study. It should be noticed that Chiralcel® OJ-RH and LuxTM 
C-3 column have the same type of CSP, but, with different coating technology (according 
to the vendors’ statement) and particle size (OJ-RH: 5 µm; LuxTM C-3: 3.5 µm). The results 
showed that they had very similar enantioseparation abilities but LuxTM C-3 usually had 
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better resolution probably due to smaller particle size (3 µm vs 5 µm). In contrast, the 
amylose tris-[(S)-α-methylbenzylcarbamate]-based Chiralpak® AS-RH, possessing a 
unique CSP due to an extra  stereocenter present at the derivatization group, showed poor 
efficiency with only partial enantioseparation for five out of the seven benzyl alcohols. As 
mentioned earlier, Chiralpak® IA, where the CSP is amylose tris(3,5-
dimethylphenylcarbamate) immobilized on 5 µm silica, showed enantio-recognition on six 
benzyl alcohols (only PCF3OH didn’t resolve). However, only baseline separation was 
achieved with BPthiOH. The representative chromatograms of enantioseparation of the 
seven selected chiral benzyl alcohols on the polysaccharide-based chiral columns under the 
optimized conditions are shown in Figure 2.6. 
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Figure 2.6. Example chromatograms for enantioseparation of Chiral Benzyl alcohols under optimized 
conditions. 
 
 
 
2.3.3 Example of Method Validation 
To expand the application of this method, we performed the method validation according 
to ICH guidelines - Q2 Analytical Validation. We used the compound PCF3OH on the 
column of LuxTM Cellulose-3 (150x4.6 mm, 3µm) under the mobile phase 70:30 
MeOH/water, 0.60 mL/min, column temperature at 40 0C, UV detection at 215 nm, 10 min 
runtime as an example (Figure 2.6). The method is selective and robust with baseline 
separation (Rs = 4.81) of the enantiomers at 0.5 mg/mL injection concentration and small 
changes in mobile phase composition did not significantly affect the separation. The Limit 
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of Quantitation (LOQ) for both enantiomers was 1.0 µg/mL (S/N = 65 and 48 for the first 
and second-eluting enantiomers, respectively) which was confirmed by the determination 
of the relative standard deviation (% RSD = 1.2% and 1.6% for the first and second-eluting 
enantiomers, respectively) for six consecutive injections of the sample solution at the LOQ 
level. The linearity was determined by the correlation co-efficients for the relationships 
between the level of LOQ and 120% sample concentration (0.001 to 0.6 mg/mL, R2 = 
0.9997 and 0.9996, for the first and second-eluting enantiomers, respectively). The 
repeatability (within-day precision, n = 5) for first and second-eluting enantiomers, 
represented as RSD, was 0.2 and 0.3%, respectively. The reproducibility (inter-day 
precision, n = 3) for the first and second-eluting enantiomers, respectively, represented as 
RSD, was 0.9 and 1.1%, which confirms the good precision of the method.  The above 
method validation results indicated that the optimized methods can be validated and 
applicable for food and pharmaceutical development. 
 
2.3.4 Influence of organic modifiers 
The retention behavior in reversed-phase chiral HPLC is very much like that in achiral RP 
HPLC. By increasing the organic content of the MP, its eluting strength is increased, the 
hydrophobic interactions between analytes and CSP are weakened and retention decreases. 
However, there are certain details of the retention mechanism that might be different and 
will be further discussed in the Section 3.6. In most cases, the resolution will improve with 
lower solvent strength since the retention increases. If only partial resolution is achieved 
with retention times longer than 20 min, further decreasing the organic modifier content in 
the MP usually had limited effect to improve the resolution toward inducing baseline 
separation. In some cases it reduced the resolution. The latter phenomenon have been seen 
in many cases that the peak broadening effect associated with excessive increased retention 
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sometimes counterbalances the small gain in selectivity. Two representative examples are 
shown in Figure 2.7. By decreasing the percent of MeOH in the mobile phase, the retention 
and resolution of propylbenzylalcohol on the Chiralcel® OD-RH column increases. While 
for the compound PNBOCOH on LuxTM Cellulose 3, a higher Rs was achieved at 50/50 
EtOH/water rather than with 45/55 EtOH/water at 15 0C due to band broadening effects 
with longer retention (Figure 2.7). It should be noticed that in both examples, the selectivity 
(α) remained unchanged with various eluting strengths. This phenomenon will be discussed 
in Section 3.6. 
 
The summary in Table 2.5 demonstrates that methanol (in comparison with ethanol) may 
induce different selectivity. Using methanol/water and ethanol/water as mobile phases 
generally exhibits similar enantioseparation effect, but, for substrates such as PAEtOH and 
BPthiOH, better chiral recognition was observed with MeOH/water as the mobile phase. 
For example, under optimized chromatographic conditions, up to Rs = 1.0 - 1.2 was 
observed when racemates of PAEtOH and BPthiOH were injected on Chiralpak® IA and 
Chiralpak® AS-RH columns, respectively. However, when EtOH/water used as the mobile 
phase, no enantioseparation was found with the above analytes. 
 
Compared with the aprotic solvent acetonitrile, Figure 2.8 – 2.11 shows that methanol and 
ethanol, as protic solvents, exhibited similar enantioseparation effects, which indicated that 
MeOH and EtOH as organic modifiers do not further reduce the hydrogen bonding between 
analytes and polysaccharide-based CSP, an important interaction that affects the enantio-
recognition in chiral HPLC.  
Figure 2.7. Influence of organic modifiers on retention, enantioselectivity and resolution. 
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Figure 2.8. Comparison of Enantioseparation of 1-Phenylpropanol (PPOH) on Chiralpak® IB column (250 
x 4.6 mm, 5 µm), under EtOH/water and ACN/water as mobile phases. 
 
 
 H2O/ACN 75:25, 25 °C, 1.0 mL/min, α = 1.05, Rs = 1.7        
 
 
 
 
 
 
H2O/EtOH 50:50, 25 °C, 0.5 mL/min, α = 1.05, Rs = 1.5 
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Figure 2.9. Comparison of Enantioseparation of 1-Phenylpropanol (PPOH) on Chiralpak® IA column (250 
x 4.6 mm, 5 µm), under EtOH/water and ACN/water as mobile phases. 
 
 
H2O/ACN 75:25, 20 °C, 1.0 mL/min, α = 1.03, Rs = 0.7         
 
 
H2O/EtOH 50:50, 20 °C, 0.5 mL/min, α = 1.05, Rs = 1.3 
 
 
H2O/MeOH 45:55, 20 °C, 0.7 mL/min, α = 1.03, Rs = 0.7 
 
 
Figure 2.10. Comparison of Enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on Chiralpak® IA column 
(250 x 4.6 mm, 5 µm), under MeOH/water, EtOH/water and ACN/water as mobile phases. 
 
 
H2O/ACN 75:25, 20 °C, 1.0 mL/min, α = 1.03, Rs = 0.7        
 
 
 
 
 
 
H2O/EtOH 50:50, 20 °C, 0.6 mL/min, α = 1.03, Rs = 0.8 
 
 
H2O/MeOH 45:55, 20 °C, 0.7 mL/min, α = 1.02, Rs = 0.5 
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Figure 2.11. Comparison of Enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on Chiralpak® IB column 
(250 x 4.6 mm, 5 µm), under EtOH/water and ACN/water as mobile phases. 
 
 
H2O/ACN 75:25, 20 °C, 1.0 mL/min, α = 1.06, Rs = 2.1        
 
 
 
 
 
 
H2O/EtOH 50:50, 20 °C, 0.5 mL/min, α = 1.05, Rs = 1.7 
 
 
2.3.5 Influence of column temperature 
Chromatographic conditions, such as type and content of organic modifier in the aqueous 
mobile phase, CSP on stationary phase and column temperature affect the chromatographic 
parameters that describe the retention and the enantioseparation of benzyl alcohols. The 
influence of column temperature (T) from 10 to 40 0C on the separation was investigated 
using various percentages of methanol and EtOH modifiers. Although reversal of the 
enantiomers elution order has not been seen within our studied temperature range (10 – 40 
oC), literature has reported that the enantiomeric elution order can be temperature 
dependent.50 Figure 2.12- 2.15 shows some examples of enantioseparation of chiral benzyl 
alcohols under various temperatures due to faster mass transfer in chromatographic 
conditions. The retention factor (k) increased with decreasing column temperature at the 
range of 10 – 40 oC in all cases. However, the enantioselectivity (α) and resolution (Rs) of 
benzyl alcohols has no discernable trend. In most cases, Rs decreased with increasing 
temperature, but, there are some examples that Rs diminished while reducing temperature 
since the band broadening effect at lower T outpaced the effect of prolonged retention on 
Rs (Figure 2.12 and Figure 2.13). For all mono-aromatic benzyl alcohols, the higher α was 
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observed with decreasing T suggesting an enthalpy driven enantio-recognition process. It 
is believed that for a defined enantiomeric pair and chiral HPLC conditions, if the chiral 
separation favors low temperature, i.e., enthalpy driven process, hydrogen bonding 
dominates the enantioseparation mechanism (Figure 2,14).51 On the other hand, for the bi-
aromatic benzyl alcohols, a higher α was observed with increasing T, suggesting an entropy 
driven enantio-recognition process (Figure 2.15). Chiral separation favoring high 
temperature is likely driven by entropy, in which π-π interaction plays significant role in 
the enantioseparation.51 
Figure 2.12. Enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on Chiralcel® OD-RH (150x4.6mm, 
5µm) at various temperatures with 55:45 MeOH/water, 0.6mL/min, 20min. 
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Figure 2.13. Enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on Chiralcel® IC (250 x 4.6 mm, 5 µm) 
at various temperatures with 60:40 MeOH/water, 0.6mL/min, 30min . 
 
 
Figure 2.14. Enantioseparation of 2,2,2-Trifluoro-1-phenylethanol (PCF3OH) on Chiralcel
® OJ-RH (150 x 
4.6 mm, 5 µm) at various temperatures with 70:30 MeOH/water, 0.6mL/min, 20min. 
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Figure 2.15. Enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak® 
AS-RH (150 x 4.6 mm, 5 µm) at various temperatures with 55:45 MeOH/water, 0.6mL/min, 30min. 
 
 
 
2.3.6 Mechanistic aspects of enantioseparation by thermodynamic characterization. 
The major goal of this study is to better understand the retention and the chiral recognition 
mechanisms of polysaccharides-based CSPs with the secondary benzyl alcohols under 
reversed-phase conditions. So far only a few publications discuss the thermodynamic 
parameters on polysaccharide type CSPs under reversed-phase conditions.52 The retention 
mechanism in reversed-phase liquid chromatography (RP-LC) has been examined over a 
few decades. Although there is still a debate whether the hydrophobic effect is a 
satisfactory explanation for the retention process in all RPLC systems, many studies reveal 
that the hydrophobic effect dominates the retention process for water-rich and/or hydrogen-
bonded mobile phases, such as alcohol/water. Moreover, the solvation of the stationary 
phase by the organic component in the mobile phase becomes more significant to the 
retention process in water-rich mobile phases.53 
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The retention process is different between the regular RP-HPLC and chiral RP-HPLC, 
primarily due to the differences in the stationary phase. The effects of temperature and 
mobile-phase composition have also been studied and discussed previously in the sections 
2.3.4 and 2.3.5. Examination of analytes retention profile (RT) as a function of column 
temperature (T) is a valuable method for evaluating the retention mechanism in 
chromatography. Further progress in enantioseparation by LC requires a better 
understanding of the chiral recognition mechanisms involved. For an understanding of 
retention, enantiomeric selectivity, and the chiral recognition mechanism on these selected 
polysaccharides-based CSPs, the thermodynamic parameters were calculated using 
constructed van't Hoff equations as follows 
Eq. 2.4     ln k = -(∆Ho/RT) + (∆So/R) + ln Φ 
Eq. 2.5      ln α = ∆∆Go/RT = -(∆∆Ho/RT) + (∆∆So/R) 
 
In equation 2.4, k is the retention factor as calculated in Eq. 2.1. ∆Ho is the excess in 
standard enthalpy, or called standard molar enthalpy of adsorption (molar enthalpy change 
transfer of the benzyl alcohols from the mobile phase to the stationary phase) and ∆So is 
the excess in standard enthalpy, also known as adsorption entropy (molar entropy change 
transfer of the benzyl alcohols from the mobile phase to the stationary phase). R is the gas 
constant and T is the absolute temperature under the experimental conditions. Ø is the 
column phase ratio.51  
 
If within the temperature range for the columns under investigation, the retention 
mechanism remains unchanged; ∆Ho is invariant with temperature which is usually the case 
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for conventional reversed-phase chromatographic conditions. Under this assumption, there 
is a linear correlation between the logarithms of the capacity factors (k), measured at an 
appropriate reference temperature range, and the reciprocal of corresponding temperature 
(1/T) for the particular chromatographic process should be established. (The plot, ln k vs 
1/T, is also known as van't Hoff plot). This expression shows when a linear van't Hoff plot 
is obtained, the plot has a slope of -∆Ho/R and an intercept of ∆So/R + ln Ɵ. This provides 
a convenient way of calculating the thermodynamic constants ∆Ho and ∆So for a 
chromatographic system (provided that the phase ratio Ɵ is known or can be calculated) 
which are critical in predicting the kinetic driving force for retention. However, in many 
cases ∆So was usually not calculated individually since there is disagreement about the 
evaluation of the column phase ratio Ɵ, especially for porous silica-supported columns. 
However, the trend of ∆So under different chromatographic conditions can still be observed 
since column phase ratio Ɵ is generally constant. When the van't Hoff plot is non-linear 
(∆Ho changes under different temperatures), it is very likely that a change in the retention 
mechanism occurs under the experimental column temperature range. Phase transitions of 
stationary phases usually induce non-linear van't Hoff plot behavior, while morphological 
changes in the surface layer (bonded or coated) may not generate variance in the 
fundamental interaction between the analytes and the stationary phase.53 
 
In Eq. 2.5, under our chiral separation studies, α is the enantioselectivity between the pair 
of enantiomers, as shown in Eq. 2.2. The term ∆∆Ho is the difference in excess enthalpy 
change between the enantiomeric pairs (∆Ho2 - ∆Ho1), and ∆∆So is the difference of excess 
entropy change between the two racemates (∆So2 - ∆So1). If under the studied column 
temperature range, the enantio-recognition mechanism remains unchanged (∆∆Ho remains 
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constant under the selected temperature range), the plots of ln α versus 1/T (another form 
of van’t Hoff plot, as shown in Eq. 2.5) should be linear, from which the slope and intercept 
of the plot were ∆∆Ho/RT and ∆∆So/R, respectively. Compared with Eq. 2.4, the column 
phase ratio term (ln Ɵ) is omitted since the effect is cancelled out between the two 
enantiomeric pairs. Eq. 2.5 gives a very convenient way to calculate the crucial 
thermodynamic values (∆∆Ho and ∆∆So) to characterize the thermodynamic behavior as 
well as intrinsic properties of enantioseparation.  
 
In this study, retention data (Appendix I, Table 2.4 – Table 2.33) has been obtained over a 
narrow temperature range (10 to 40 0C), and the retention diagram (ln k vs 1/T, (Appendix 
II, Figure 2.16 to Figure 2.270), also known as van't Hoff plots, have been constructed. The 
shapes and thermodynamic parameters obtained from two forms of van't Hoff plot (Eq. 2.4 
and Eq. 2.5) have been used to assess changes in the retention process and 
enantioseparation mechanism as a function of temperature and mobile-phase composition. 
As mentioned earlier, the standard molar enthalpy of adsorption ∆H° (molar enthalpy 
change transfer of the benzyl alcohols from the mobile phase to the stationary phase) 
usually remains constant under the relevant temperature range under chromatographic 
conditions. Under this hypothesis, a plot (van't Hoff plot) of ln k against 1/T enables the 
calculation of ∆H° from the slope and possibly adsorption entropy ∆S° (molar entropy 
change transfer of the benzyl alcohols from the mobile phase to the stationary phase) from 
the intercept with the ordinate axis. The analysis of the seven selected chiral benzyl 
alcohols (Table 2.1) in reversed-phase HPLC with various polysaccharide-based chiral 
columns (Table 2.2) under a wide range of conditions (percentage and type of organic 
modifier), showed a linear van’t Hoff plot (ln k vs 1/T) relationship over the studied 
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temperature ranges 10 0C to 40 0C (Appendix II, Figure 2.16 to Figure 2.27, the retention 
diagrams, the correlation of determination (r2) for the linear fit of these plots were usually 
higher than 0.98), while the only exception is when racemic 1-phenylprop-2-en-1-ol 
(PVOH) injected on Chiralpak IA column with MeOH/water as mobile phase. It is believed 
that the even for non-linear retention diagrams (ln k vs 1/T, van’t Hoff plots) a change in 
the retention mechanism, might affect both enantiomers in the same way so there should 
be no overall impact for enantioseparation.54 
 
For reversed-phase chromatography, with the higher amount of organic modifier in the 
aqueous mobile phase, the hydrophobic interactions between the enantiomers and the CSP 
is diminished and the adsorption process becomes less exothermic. As a result, the  
enthalpic change (∆Ho) reduces and the retention decreases. In this study, it was found that 
∆Ho values usually became more negative as the water content of the mobile phase was 
increased (Appendix III, Table 2.34 - 2.39, the columns of mobile phase composition vs 
∆Ho). This indicates that it is energetically more favorable for the solute to be in the 
stationary phase under these conditions. The decrease in ∆Ho value with lower elution 
strength (higher water content) was attributed to increased solvophobic interactions of the 
enantiomeric solute with the mobile phase, which is a typical phenomenon in reversed 
phase chromatographic conditions. However, in some cases, a small gain in ∆Ho was noted 
when the water content was decreased. For example, in Appendix III, Table 2.40, four 
racemic benzyl alcohols PPOH, PVOH, PAEtOH and PCF3OH analyzed on Chiralpak® 
AS-RH (150x4.6mm, 5µm), when the mobile phase changed from MeOH/H2O 55:45 to 
MeOH/H2O 50:50, a small increase in ∆Ho (less negative value) was obtained. Similar 
results was also found in the LuxTM Cellulose-3 column when the mobile phase changed 
Ҩ
 115 
from MeOH/H2O 65:35 to MeOH/H2O 60:40 (Appendix III Table 2.36) and the Chiralpak® 
IA column when the mobile phase changed from MeOH/H2O 60:40 to MeOH/H2O 55:45 
(Appendix III Table 2.37) This non-conventional reversed-phase behavior suggested that 
these chiral CSPs might favor only minor conformational changes and/or higher order 
structures under specific variation of mobile phase compositions.53 This transition on the 
surface layer (bonded or coated), however, might be just morphological, which may not 
generate variance in the fundamental interactions between the analytes and the CSPs.53 
With the above chromatographic conditions (chiral columns and mobile phase composition 
range), the enantioselectivity (α) remained the same, as shown in Appendix III, Table 2.34 
– 2.39. It should be noted that the above non-conventional reversed-phase behavior was 
not observed on column Chiralcel® OJ-RH, although it consists of the same CSP was used 
by the LuxTM Cellulose-3 column.  Since all of the calculated values of ∆Ho are negative 
(where the van’t Hoff plots for all studied chromatographic systems showing negative 
slopes), which summarizes the interactive forces between the first eluted enantiomer and 
the CSP. This suggests that the retention process is enthalpically favored and this 
temperature dependence corresponds to the conventional exothermic adsorption 
behavior.55 
 
As previously mentioned, ∆So values were not determined individually due to the 
uncertainty in the determination of column phase ratio, but the trend in the intercepts of the 
van't Hoff plots showed that ∆So increases for higher water content mobile phases. 
Correspondingly, a decreased order of the system occurs when the solute is in the stationary 
phase rather than the mobile phase is also very common with the reversed phase 
chromatographic environment.  
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The linear correlation with a standard deviation high than 0.98 implies that both ∆Ho and 
∆So are temperature independent, indicating that the interactions between the enantiomers 
and CSP are associative and the equilibria of the solvation-desolvation process does not 
interfere with the association step of the enantiomers and the CSP.56 The linear van’t Hoff 
plot (In k vs 1/T) is also an indication that no major conformational changes on the CSP 
was found to occur in the temperature range studied and retention mechanism is not 
temperature dependent. However, interactions among the enantiomeric analytes and CSP 
are usually multi-dimensional, and the preferred configuration may be temperature 
dependent.57 
 
According to Eq. 2.5, similar to the ln k1 vs 1/T discussed above, for the chiral benzyl 
alcohol/chiral columns pairs under various mobile phase compositions were found to 
exhibit adequate enantioseparation. The van’t Hoff plots for enantioseparation (In α vs 1/T) 
also display a linear correlation (Appendix II Figure 16 to 270, van’t Hoff plot of 
enantioseparations), which suggests that the chiral recognition mechanism for each set of 
enantiomers/CSP stays the same within the experimental temperature range and ∆∆H°, 
∆∆S° does not change with temperature. 
 
Our studies indicate that except BPthiOH, under the column temperature range (10 0C – 40 
0C), chiral separation of the selected benzyl alcohols when ∆∆Ho is compared to T∆∆So 
(Appendix III Table 2.34 – 2.39), the magnitude (absolute value) of ∆∆Ho is larger than 
that of T∆∆So, which indicates that enthalpy plays a greater role in the enantio-recognition 
process (enthalpy-controlled enantioseparation), and higher enantioselectivity was 
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observed when the temperature decreases. This behavior usually indicates that hydrogen 
bonding plays a significant role in the chiral recognition force and hydrogen bonding often 
is the major contributor to ∆∆Ho.58 In the case of BPthiOH, a bi-aromatic benzyl alcohol, 
when analyzed on Chiralpak AS-RH and OD-RH columns, showed an increased 
enantioselectivity with higher temperature, and the magnitude of ∆∆Ho was smaller than 
that of T∆∆So. This phenomenon suggests that the entropy plays a greater role and the chiral 
recognition process, which has often been seen when π-π interactions dominate the enantio-
specific interaction between the analytes and the CSP.58  
 
The entropy change (∆So) reflects the changes in the degree of disorder through a process 
within a defined system.59 If the system becomes more random, its entropy value increases. 
As we can expect, under reversed-phase conditions, the absorption process involves a 
positive ∆So since an increase in disorder is due to water or polar organic molecules 
released from the bound state on the CSP (binding sites chiral cavities) to the dissolved 
state in the mobile phase. While ∆∆So measures the difference between the ∆So of the two 
enantiomers. Therefore, the negative values of ∆∆So reveals that for the absorption process 
of the longer retained enantiomer is less disordered compared with the first eluting 
enantiomer. Negative values of entropy in these systems is expected due to better ordering 
of chiral benzyl alcohols on the CSPs, through interactions and complexation by hydrogen 
bonding, hydrophobic interaction and π-π stacking.60 
 
The enthalpy term (∆∆H° or ∆H°) measures the strength of forces between the enantiomers 
and the CSP, which reflects the total of each individual interaction between the functional 
groups within the analytes and chiral selectors.61 Since these functional groups may vary 
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in the position between the enantiomers, the strength of the interactions with the chiral 
selector on CSP may be different. As mentioned early, according to the three-point theory 
in chiral separation, at least one of the three interactive forces between the enantiomers and 
the chiral selector is enantio-specific and contribute to ∆∆Ho, while other interactions (not 
related to enantio-selectivity α) afford to chromatographic retention and give ∆Ho. 
Modifications in the mobile phase eluting strength that moderates the non-enantioselective 
interactions effectively might also affect the enantioselective interactions. For method 
development, it is important to select the proper type and adjust the composition of the 
organic modifier to yield adequate ∆∆H° and good enantio-resolution (Rs > 2) while 
minimizing the non-enantioselective interactions to shorten the retention time (runtime). 
However, compared to the relatively consistent changes in ∆H° when the mobile phase 
composition changed, the thermodynamics of the enantioseparation are lacking a trend in 
solvent strength variation so the change in ∆∆H° can be the same, the opposite, or remain 
the same as percentage of organic modifier is varied. (Appendix III Table 2.34 to Table 
2.39) Moreover, ∆∆H° is not the only contributor to ∆∆G°, which governs the 
enantioselectivity (Eq. 2.5). The value of ∆∆Go and enantioselectivity α are hardly 
influenced by the organic modifier contents (Appendix III Table 2.36 –Table 2.37), as 
mentioned in Section 3.3 when the mobile phase composition effect was discussed. This 
phenomenon is due to the enthalpy-entropy compensation effect. The same negative sign 
and linear correlation of ∆∆So and ∆∆Ho diminishes the changes in ∆∆Go while adjusting 
the eluting strength, which will be discussed in Section 3.7. 
 
Elucidation of the enantioselective chromatographic behavior at a molecular level and the 
structural features related to the chiral recognition mechanism can be explained as below. 
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When the enantiomeric pair (R and S) passes through the polysaccharides chains, the 
molecules will replace several polar solvent molecules. Under the reversed phase 
conditions, when the relatively non-polar analytes, such as chiral benzyl alcohols in our 
study, are inserted into the aqueous mobile phases (hydrogen-bonded, polar environment) 
this causes a decrease in entropy due to an increase in order for the mobile phase 
(surrounding the analytes). This phenomenon (a decrease of ∆So) is well-known as the 
hydrophobic effect.62 When the non-polar enantiomers are dissolved in an aqueous polar 
mobile phase then they move in close proximity and are absorbed onto the chiral cavity, a 
relatively non-polar region on the polysaccharides-based CSP surface, the ordered water 
or polar organic adjacent to the surface of CSP are expelled, and a less ordered mobile 
phase system is formed, representing an increase in entropy (∆So). Since the ∆So arises 
from the chiral cavity on the surface of CSP and is enantio-specific, ∆∆So, the difference 
of ∆So between each enantiomeric pair, originates from the discrepancy in perturbing the 
ordered structure of the water molecules surrounding the enantiomers and the chiral cavity 
on the CSP surface. For example, a higher value of entropy change (∆So) for one 
enantiomer than the other through the absorption process can be explained by a better fit 
of one enantiomer into the chiral cavity than the other, which could pull more polar 
molecules out from the CSP surface and a less ordered structure is obtained. The same 
theory also applies to enthalpy change (∆Ho), a larger magnitude of enthalpy change of one 
enantiomer results from a better fit of the enantiomer into the chiral cavity than the other, 
since hydrogen-bond and л-л interactions are orientation dependent. Hydrophobic 
interactions, which are not orientational-dependent, may not contribute to the ∆∆Ho.63 
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2.3.7 Enthalpy-entropy Compensation in Reversed-phase Chiral HPLC 
As mentioned earlier, ∆∆Go, the difference in Gibbs free energy between the enantiomeric 
pair, which is a combination of all enantio-specific interactions between the enantiomers 
and the CSP. This accounts for the enantioselectivity (α, Eq. 2.5) in chiral liquid 
chromatography, which was found to be a constant negative value even under different 
mobile phase composition. In other words, the value of enantioselectivity (α) is hardly 
influenced by the organic modifier contents. 
 
The phenomenon that the change in percentage of organic modifier does not lead to 
variation in enantioselectivity (α) may be explained by the hydrophobic effect driven 
retention mechanism under RP-LC.64 The change in retention of a solute following a 
change in mobile-phase conditions is most likely due to changes in solute-solvent (non-
chiral) interactions in the mobile phase and lesser interactions in the chiral stationary 
phase.65 Thus, such interaction is not stereo-specific and does not affect the 
enantioselectivity. In contrast, a change in the type of chiral stationary phase (CSP) would 
usually cause a significant variation in α due to the changes in the solute-CSP retention 
mechanism is enantiomerically related. 
 
In this study we again used the thermodynamic characterization method to investigate the 
behavior that enantioselectivity is mobile phase composition independent. According to 
Eq. 2.5, the enantioselectivity is directly correlated to ∆∆G°, which consists of two terms, 
the enthalpy term (∆∆H°) and the entropy term (∆∆S°). It is usually difficult to rationalize 
enantio-specific entropy changes which may involve differences in the solvation process 
and statistical structural mobility at the molecular level.66 As mentioned earlier, the 
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thermodynamic data shown in Appendix III Table 2.34 to 2.39, the same negative sign of 
∆∆So and ∆∆Ho diminishes the changes in ∆∆Go while modifying the solvent compositions. 
While the enthalpy-entropy compensation plots (∆∆S
o
 vs ∆∆H
o
) were constructed for each 
set of enantiomeric pairs/column under different types and compositions of mobile phases 
(typically methanol/H2O 50:50 to 70:30 and EtOH/H2O 45:55 to 65:35) when adequate 
enantioseparation was observed. As shown in Figure 2.271 – 2.272, the linear correlation 
(R2 > 0.99) of the enthalpy-entropy plots indicates that compensation behavior is present 
in the analytes enantiomers on the CSPs, which supports the assumption that the solute-
CSP enantioselective interaction mechanism is consistent same under the range of organic 
modifier changes (typically methanol/H2O 50:50 to 70:30 and EtOH/H2O 45:55 to 65:35), 
even when the type of organic modifier changed from MeOH to EtOH.  
 
Linear behavior between the enthalpy and entropy changes has been recognized in various 
chemical or physical processes, which is known as enthalpy-entropy compensation.67 
Melander et al. suggested in liquid chromatography with aqueous mobile phase and small 
molecule analytes, such behavior is caused by solute-induced free volume changes in the 
aqueous mobile phase.46, 68 According to the Melander’s study, the compensation effect 
also exists in different kinds of analytes even without eluent modifiers. The slope of the 
enthalpy vs entropy compensation plot over a range of mobile phase composition changes, 
also known as compensation temperature, is a constant if the processes occur through the 
same mechanism. Therefore, if under a set of various percentages of organic modifiers in 
the mobile phase, the analyte exhibits linear enthalpy-entropy compensation, the retention 
mechanism of the analyte on the stationary phase remains consistent.46  
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Within our experimental temperature range (10 to 40 0C), for  pre-defined enantiomeric 
pairs/chiral stationary phase combination, this enthalpy-entropy compensation behavior 
lead to a relatively constant Gibbs free-energy (∆∆Go), under different eluent types (MeOH 
or EtOH) and various percentage of the organic solvent in the aqueous mobile phase. This 
fact suggests that the enantiomeric recognition process is governed by the intrinsic 
mechanism of the chiral specific interactions between the enantiomeric analytes and the 
CSP, which was invariant even under substantially different mobile phases.69 The 
enantioselectivity only depends on the temperature and CSP, which implies that the chiral 
cavities on polysaccharides-based CSP surface serves as the primary docking site for the 
analytes in chiral separation process, and the essential complexation associated mainly with 
hydrogen bonding and π-π interactions.70 On the other hand, the hydrophobic interactions 
do not play significant role in chiral recognition due to the lack of stereo-specific 
interactions.63 
 
As mentioned previously, the thermodynamics of the enantioseparation (∆∆H° and ∆∆S°) 
have no strict trend with the variation of organic modifier content. Appendix IV Table 2.41, 
2.42 and 2.45 show that relatively constant of ∆∆H° and ∆∆S°, when the compositions of 
MeOH or EtOH varied, this led to consistent ∆∆G° and α value. While in Appendix IV, 
Table 2.43, 2.44 and 2.46, fluctuation of ∆∆H° and ∆∆S° was observed under different 
mobile phase compositions. However, the ∆∆G° and α are hardly changed due to enthalpy-
entropy compensation effects. Two examples of enthalpy-entropy compensation plots are 
shown in Figure 2.271 – 2.272. The slope is called the compensation temperature.  
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A surprising discovery was observed for the chiral column Chiralcel® OD-RH. A linear 
correlation (R2 > 0.999) was observed for the enthalpy-entropy compensation plot of 
enantioseparation of different racemic benzyl alcohols (PPOH, PVOH, PCF3OH, PAEtOH, 
BPthiOH on (150 x 4.6 mm, 5 µm) under various EtOH/H2O or MeOH/H2O composition, 
as shown in Figure 2.273. A similar finding was also noted for the column Chiralpak AS-
RH. These results suggest that the intrinsic mechanism of enantio-recognition process for 
these benzyl alcohols on the CSP is identical. The common benzyl alcohol moiety 
(containing α-phenyl hydroxy group) interacts with the chiral cavities on the surface of 
CSP through hydrogen-bonding and л-л stacking also contributes to the enantio-
recognitions. While the other α-substituents in the molecule did not participate in the 
achiral interactions and only afford nonenantio-specific retention.  
 
However, in other cases, the other four chiral columns did not display such broad enthalpy-
entropy compensation for the chiral benzyl alcohol analytes (Figure 2.275). These 
observations indicate that the mechanism of enantioseparation for these benzyl alcohols on 
the CSP is different. This may suggest that the different α-substituents in the benzyl 
alcohols are also engaged in the enantio-specific interactions with the CSP, and, thus, 
contribute to the enantio-recognition. 
 
On a molecular level, Lipkowitz proposed that both the enantiomeric analytes and chiral 
selector (the surface of CSP) stay under constricted minimum energy configurations 
surrounded by solvent molecules, before they confront each another.71 Once the 
interactions begin, the stabilized configuration might be disturbed to accommodate the 
(possible) maximum attractive interactions (hydrogen bonding, π-π interaction, 
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hydrophobic interactions, etc.) between the related functional groups within the individual 
enantiomer and the chiral selector.72 The transformation from the individual lowest energy 
configurations is promoted by an increase in energy (enthalpy) and entropy through 
docking to form transient adducts. The better fitting adduct (longer retention), which has 
higher affinity and stronger binding, should have greater ∆H° of the two enantiomers. 
However, according to Lipkowitz’s theory,71 the enantiomer which forms the more stable 
adduct with the chiral selector, shows increased ‘unraveling’, which also contributes to a 
higher ∆S°.73 Thus, higher ∆H° (longer retained enantiomer) would induce increased ∆S°, 
which is at the origin of the enthalpy-entropy compensation factor, as we observed in our 
study.  
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Figure 2.271. Enthalpy-Entropy compensation diagram of enantioseparation of racemic BPthiOH on 
Chiralcel® OD-RH (150x4.6mm, 5µm), under various composition of EtOH/H2O (0.4mL/min) and 
MeOH/H2O (0.6ml/min). 
 
 
 
Figure 2.272. Enthalpy-Entropy compensation plot of enantioseparation of racemic PAEtOH on Chiralpak® 
AS-RH (150x4.6mm, 5µm), under various composition of EtOH/H2O (0.4mL/min) and MeOH/H2O 
(0.6ml/min). 
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Figure 2.273. Enthalpy-Entropy compensation plot of enantioseparation of racemic PPOH, PVOH, PCF3OH, 
PAEtOH, BPthiOH on Chiralcel® OD-RH(150 x 4.6mm, 5 µm) with various EtOH/H2O (0.4mL/min), 
MeOH/H2O (0.6ml/min). 
 
 
 
Figure 2.274. Enthalpy-Entropy compensation plot of enantioseparation of racemic PPOH, PAEtOH and 
BPthiOH,  on Chiralpak® AS-RH(150 x 4.6mm, 5 µm) with various EtOH/H2O (0.4mL/min) , MeOH/H2O 
(0.6ml/min). 
 
 
 
  
y = 8.3098x - 0.012
R² > 0.9999
-40
-35
-30
-25
-20
-15
-10
-5
0
-5 -4 -3 -2 -1 0
∆
∆
S
o
(
J
/
m
o
l·
K
)
∆∆Ho(kJ/mol)
Enthalpy - Entropy
y = 3.126x + 0.579
R² = 0.9993
-4
-2
0
2
4
-1.5 -1 -0.5 0 0.5 1
∆
∆
S
o
(
J
/
m
o
l·
K
)
∆∆Ho(kJ/mol)
Enthalpy - Entropy
 127 
Figure 2.275. Enthalpy-Entropy compensation plot of enantioseparation of racemic PPOH, PAEtOH, PVOH, 
PCF3OH, and PNBOCOH, on Chiralcel® OJ-RH (150 x 4.6mm, 5 µm) with various EtOH/H2O (0.4mL/min) 
, MeOH/H2O (0.6ml/min). 
 
 
 
 
2.4 Conclusions 
In this thesis, acetonitrile-free enantioseparation of chiral benzyl alcohols under reversed-
phase mobile phase conditions on polysaccharide-based chiral columns was examined. 
Good to excellent enantioseparation was observed under optimized chromatographic 
conditions. The optimized methods have been validated and applicable for chemical and 
pharmaceutical development. This method provides a green and economical alternative 
approach to analyze chiral compounds. 
 
Thermodynamic characterization is an important and powerful tool to investigate 
chromatographic mechanism study. Linear van’t Hoff plots (ln k1 vs 1/T and ln α vs 1/T) 
were established for almost all sets of analyte/column pair with mobile phase of 
EtOH/water or MeOH/water compositions. This indicates under the experimental 
temperature range, the retention and enantioseparation mechanism remains unchanged and 
the thermodynamic parameters (∆Ho, ∆∆Ho, ∆∆So) were then calculated. Morphological 
changes of the CSPs under specific mobile phase composition variation were detected 
when minor gains in enthalpy occurred with decreased organic content. Linear plots of 
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∆∆Ho vs ∆∆So indicating the entropy-enthalpy compensation effect were observed for all 
analytes in a wide range of mobile phase compositions. This resulted in relative constant 
in enantioselectivity with respect to solvent strength of the mobile phase. 
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Appendix I 
Table 2.4 – 2.33 Chromatographic data of Enantioseparation of PPOH, 
PVOH, PCF3OH, PNBOCOH, PAEtOH, BPthiOH and DFPPOH on 
Chiralpak® AS-RH, IA, IC, Chiralcel OD-RH, OJ-RH and LuxTM 
Cellulose-3 columns  
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Table 2.4 Chromatographic data of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column under different MeOH/water or EtOH/water mobile phase 
Mobile phase Temp. (0C) K1 Α Rs 
MeOH/H2O (60:40, v/v), 0.6 
mL/min 
40 0.75 1.068 0.6 
35 0.81 1.074 0.64 
30 0.89 1.075 0.66 
25 0.97 1.082 0.68 
20 1.06 1.087 0.74 
15 1.17 1.091 0.75 
10 1.26 1.097 0.73 
MeOH/H2O (55:45, v/v), 0.6 
mL/min 
40 1.13 1.075 0.78 
35 1.28 1.082 0.95 
30 1.47 1.089 1.06 
25 1.68 1.096 1.12 
20 1.9 1.103 1.17 
15 2.13 1.107 1.19 
10 2.39 1.11 1.17 
MeOH/H2O (50:50, v/v), 0.6 
mL/min 
40 1.61 1.074 0.98 
35 1.81 1.079 1.06 
30 2.04 1.085 1.13 
25 2.3 1.09 1.13 
20 2.63 1.096 1.18 
15 2.96 1.101 1.19 
10 3.35 1.105 1.19 
MeOH/H2O (45:55, v/v), 
0.6mL/min 
40 2.47 1.076 1.07 
35 2.92 1.083 1.2 
30 3.4 1.09 1.3 
25 4.03 1.097 1.37 
20 4.68 1.105 1.41 
15 5.38 1.11 1.42 
10 6.26 1.117 1.43 
EtOH/H2O (55:45, v/v), 0.3 
mL/min 
40 0.65 1.085 0.73 
35 0.69 1.093 0.87 
30 0.73 1.097 0.95 
25 0.76 1.106 1.01 
20 0.81 1.11 1.07 
15 0.86 1.116 1.11 
10 0.9 1.119 1.11 
EtOH/H2O (50:50, v/v), 0.3 
mL/min 
40 0.87 1.086 0.96 
35 0.96 1.093 1.06 
30 1.05 1.1 1.18 
25 1.14 1.108 1.28 
20 1.24 1.119 1.38 
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15 1.36 1.129 1.47 
10 1.5 1.137 1.53 
EtOH/H2O (45:55, v/v), 0.3 
mL/min 
40 1.3 1.087 1.17 
35 1.45 1.095 1.31 
30 1.61 1.105 1.43 
25 1.79 1.114 1.56 
20 2.03 1.123 1.63 
15 2.27 1.133 1.63 
10 2.6 1.143 1.72 
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Table 2.5 Chromatographic data of enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 Α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 0.69   
35 0.75   
30 0.83   
25 0.9   
20 0.99   
15 1.09   
10 1.2   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.01   
35 1.16   
30 1.33   
25 1.56   
20 1.72   
15 1.94   
10 2.19   
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 1.42   
35 1.6   
30 1.81   
25 2.04   
20 2.35   
15 2.66   
10 3.02   
MeOH/H2O (45:55, 
v/v), 0.6mL/min 
40 2.12   
35 2.5   
30 2.92   
25 3.46   
20 4.03   
15 4.65 1.028 0.42 
10 5.43 1.03 0.44 
EtOH/H2O (55:45, v/v), 
0.3 mL/min 
15 0.86   
10 0.92   
EtOH/H2O (50:50, v/v), 
0.3 mL/min 
40 0.82   
35 0.89   
30 0.97   
25 1.06   
20 1.16   
15 1.31   
10 1.46   
 
EtOH/H2O (45:55, v/v), 
0.3 mL/min 
40 1.19   
35 1.33   
30 1.47 1.024 0.38 
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25 1.65 1.032 0.49 
20 1.86 1.038 0.55 
15 2.09 1.043 0.57 
10 2.42 1.047 0.58 
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Table 2.6 Chromatographic data of enantioseparation of Ethyl 2-hydroxy-2-phenylacetate (PAEtOH) 
on Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. 
(0C) 
K1 Α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 0.68 1.074 0.62 
35 0.74 1.081 0.65 
25 0.93 1.089 0.67 
20 1.04 1.093 0.67 
15 1.16 1.097 0.66 
10 1.3 1.099 0.64 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 0.99 1.077 0.68 
35 1.16 1.08 0.83 
30 1.36 1.082 0.88 
25 1.5 1.084 0.86 
20 1.85 1.086 0.88 
15 2.13 1.087 0.85 
10 2.47 1.089 0.69 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 1.4 1.077 0.93 
35 1.6 1.082 0.98 
30 1.85 1.086 1.00 
25 2.14 1.089 1.00 
20 2.51 1.091 0.98 
15 2.91 1.095 0.96 
10 3.37 1.098 0.91 
MeOH/H2O (45:55, 
v/v), 0.6mL/min 
40 2.11 1.073 0.97 
35 2.52 1.077 1.02 
30 3.05 1.082 1.07 
25 3.7 1.085 1.07 
20 4.45 1.089 1.07 
15 5.25 1.092 1.06 
10 6.34 1.095 1.01 
EtOH/H2O (55:45, v/v), 
0.3 mL/min 
40 0.59 1.07 0.61 
35 0.65 1.072 0.63 
30 0.7 1.074 0.64 
25 0.75 1.076 0.65 
20 0.82 1.077 0.65 
15 0.89 1.078 0.65 
10 0.97 1.079 0.64 
EtOH/H2O (50:50, v/v), 
0.3 mL/min 
40 0.78 1.071 0.67 
35 0.87 1.073 0.73 
30 0.96 1.077 0.81 
25 1.08 1.078 0.85 
20 1.2 1.08 0.87 
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15 1.35 1.082 0.87 
10 1.54 1.083 0.85 
EtOH/H2O (45:55, v/v), 
0.3 mL/min 
40 1.09 1.073 0.88 
35 1.24 1.075 0.94 
30 1.41 1.076 0.98 
25 1.61 1.077 1.00 
20 1.87 1.079 1.00 
15 2.14 1.081 0.96 
10 2.5 1.082 0.93 
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Table 2.7 Chromatographic data of enantioseparation of 2,2,2-Trifluoro-1-phenylethanol (PCF3OH) 
on Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 Α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
 
40 0.72   
35 0.78   
30 0.86   
25 0.95   
20 1.05   
15 1.16   
10 1.28   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
 
40 1.11   
35 1.28   
30 1.48   
25 1.72   
20 1.97   
15 2.26   
10 2.62   
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
 
40 1.69   
35 1.92   
30 2.19   
25 2.5   
20 2.9 1.024 0.35 
15 3.35 1.03 0.4 
10 3.82 1.035 0.44 
MeOH/H2O (45:55, 
v/v), 0.6mL/min 
 
40 2.74   
35 3.23   
30 3.85   
25 4.64 1.024 0.39 
20 5.49 1.032 0.47 
15 6.42 1.037 0.51 
10 7.68 1.042 0.54 
EtOH/H2O (55:45, v/v), 
0.3 mL/min 
15 0.89   
10 0.96   
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Table 2.8 Chromatographic data of enantioseparation of t-Butyl (2-hydroxy-2-phenylethyl)carbamate 
(PNBOCOH) on Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile 
phases. 
Mobile phase Temp. (0C) K1 Α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
 
40 0.94   
35 1.05   
30 1.2   
25 1.37   
20 1.55   
15 1.76   
10 1.99   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
 
40 1.55   
35 1.87   
30 2.27   
25 2.77   
20 3.28   
15 3.87   
10 4.66   
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
 
40 2.48   
35 2.96   
30 3.51   
25 4.19   
20 5.08   
15 6.07   
10 7.25   
EtOH/H2O (55:45, v/v), 
0.3 mL/min 
15 1.10   
10 1.20   
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Table 2.9 Chromatographic data of enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl)thiazole 
(BPthiOH) on Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 Α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
 
40 1.99 1.054 0.62 
35 2.22 1.05 0.57 
30 2.5 1.044 0.5 
25 2.83   
20 3.19   
15 3.63   
10 4.1   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
 
40 3.16 1.069 0.91 
35 3.74 1.072 0.93 
30 4.44 1.075 0.9 
25 5.3 1.074 0.83 
20 6.22 1.07 0.71 
15 7.29 1.065 0.61 
10 8.65 1.057 0.55 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
 
40 5.05 1.067 0.96 
35 5.94 1.065 0.9 
30 7 1.064 0.81 
25 8.22 1.062 0.7 
20 9.85 1.058 0.61 
15 11.77 1.055 0.51 
EtOH/H2O (55:45, v/v), 
0.3 mL/min 
15 1.8   
10 1.95   
 
 
Table 2.10 Chromatographic data of enantioseparation of (3,5-Difluorophenyl)(phenyl)methanol 
(DFPPOH) on Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile 
phases. 
Mobile phase Temp. (0C) K1 Α Rs 
60%MeOH 0.5ml/min 40 3.33   
 35 3.76   
 30 4.31   
 25 4.94   
 20 5.62   
 15 6.45   
55%MeOH 0.5ml/min 40 5.72   
 35 6.88   
 30 8.37   
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Table 2.11 Chromatographic data of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 AS-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 Α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
 
40 1.08 1.02 0.34 
35 1.19 1.025 0.44 
30 1.3 1.029 0.49 
25 1.44 1.031 0.52 
20 1.59 1.033 0.54 
15 1.76 1.036 0.56 
10 1.91 1.038 0.56 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.57 1.025 0.48 
35 1.7 1.028 0.51 
30 1.87 1.031 0.54 
25 2.06 1.033 0.55 
20 2.25 1.036 0.56 
15 2.49 1.037 0.56 
10 2.73 1.039 0.55 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 2.33 1.025 0.5 
35 2.61 1.027 0.53 
30 2.92 1.029 0.54 
25 3.25 1.03 0.55 
20 3.61 1.032 0.54 
15 4.03 1.033 0.53 
10 4.39 1.034 0.53 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.81 1.051 0.62 
35 0.87 1.055 0.75 
30 0.94 1.058 0.87 
25 1.00 1.065 0.95 
20 1.09 1.069 1.03 
15 1.15 1.073 1.07 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.12 1.05 0.8 
35 1.22 1.053 0.87 
30 1.33 1.056 0.94 
25 1.44 1.057 0.97 
20 1.56 1.06 1.01 
15 1.65 1.063 1.01 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 1.64 1.044 0.81 
35 1.79 1.045 0.85 
30 1.95 1.047 0.89 
25 2.14 1.049 0.92 
20 2.35 1.051 0.94 
15 2.65 1.052 0.94 
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Table 2.12 Chromatographic data of enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
 
40 0.91   
35 1.01   
30 1.11   
25 1.2 1.021 0.38 
20 1.32 1.024 0.42 
15 1.47 1.025 0.43 
10 1.61 1.027 0.43 
 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.29 1.019 0.34 
35 1.4 1.021 0.41 
30 1.54 1.023 0.45 
25 1.7 1.024 0.47 
20 1.87 1.025 0.48 
15 2.06 1.026 0.48 
10 2.27 1.027 0.46 
 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 1.87 1.018 0.38 
35 2.1 1.021 0.44 
30 2.34 1.024 0.48 
25 2.63 1.025 0.5 
20 2.93 1.026 0.5 
15 3.27 1.026 0.49 
10 3.61 1.027 0.49 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
 
 
 
 
 
40    
35 0.78 1.027 0.44 
30 0.82 1.031 0.5 
25 0.89 1.035 0.54 
20 0.96 1.038 0.57 
15 1.02 1.04 0.59 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 0.96 1.028 0.49 
35 1.04 1.031 0.53 
30 1.14 1.033 0.56 
25 1.22 1.035 0.58 
20 1.34 1.037 0.59 
15 1.45 1.038 0.6 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
 
40 1.36 1.026 0.51 
35 1.48 1.028 0.55 
30 1.63 1.031 0.57 
25 1.79 1.033 0.59 
20 1.97 1.034 0.59 
15 2.22 1.035 0.6 
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Table 2.13 Chromatographic data of enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl)thiazole 
(BPthiOH) on Chiralpak
®
 IA column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (70:30, 
v/v), 0.6 mL/min 
 
40 1.78  1.175  2.21 
35 2.06  1.199  2.35 
30 2.34  1.207  2.31 
25 2.62  1.217  2.24 
20 2.92  1.226  2.11 
15 3.31  1.235  1.96 
10 3.72  1.242  1.79 
MeOH/H2O (65:35, 
v/v), 0.6 mL/min 
 
40 2.73 1.182 2.39 
35 3.06 1.193 2.33 
30 3.43 1.204 2.21 
25 3.8 1.215 2.07 
20 4.25 1.225 1.93 
15 4.79 1.236 1.75 
EtOH/H2O (60:40, v/v), 
0.4 mL/min 
 
40 1.42 1.184 3.13 
35 1.54 1.193 2.85 
30 1.69 1.201 2.85 
25 1.827 1.208 2.82 
20 2 1.216 2.74 
15 2.16 1.225 2.63 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 2.02 1.199 3.12 
35 2.25 1.207 3.19 
30 2.49 1.216 3.22 
25 2.75 1.223 3.18 
20 3.08 1.231 3.07 
15 3.35 1.238 2.92 
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Table 2.14 Chromatographic data of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA column under different MeOH/water or 
EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:35, 
v/v), 0.6 mL/min 
 
40 0.97 1.087 0.92 
35 1.07 1.093 0.87 
30 1.19 1.096 0.79 
25 1.3 1.101 0.69 
20 1.44 1.104 0.62 
15 1.6 1.106 0.56 
10 1.73 1.103 0.49 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.61 1.085 1.05 
35 1.85 1.091 1.04 
30 2.1 1.096 1.01 
25 2.42 1.101 0.99 
20 2.76 1.106 0.91 
15 3.19 1.109 0.81 
10 3.55 1.11 0.7 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.64 1.085 1.08 
35 2.99 1.088 1.01 
30 3.41 1.094 0.95 
25 3.9 1.099 0.86 
20 4.43 1.102 0.71 
15 5.09 1.104 0.61 
10 5.78 1.106 0.56 
EtOH/H2O (60:40, v/v), 
0.4 mL/min 
 
 
 
 
 
 
40 0.72   
35 0.78   
30 0.85   
25 0.93   
20 1.02   
15 1.09   
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 1.04   
35 1.15   
30 1.28   
25 1.41   
20 1.58   
15 1.72   
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 1.57 1.024 0.42 
35 1.73 1.025 0.43 
30 1.96 1.026 0.42 
25 2.17 1.026 0.41 
20 2.47 1.025 0.38 
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15 2.8   
 
Table 2.15 Chromatographic data of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralpak
®
 IA column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
 
40 0.87 1.046 0.6 
35 0.97 1.051 0.64 
30 1.08 1.054 0.7 
25 1.21 1.06 0.8 
20 1.36 1.063 0.84 
15 1.54 1.067 0.86 
10 1.71 1.072 0.86 
 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.25 1.053 0.79 
35 1.38 1.056 0.85 
30 1.55 1.06 0.89 
25 1.73 1.064 0.91 
20 1.93 1.068 0.92 
15 2.17 1.072 0.9 
10 2.43 1.074 0.84 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 1.83 1.065 1.12 
35 2.09 1.071 1.19 
30 2.39 1.076 1.23 
25 2.71 1.081 1.22 
20 3.06 1.086 1.21 
15 3.48 1.09 1.15 
10 3.92 1.094 1.1 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
 
 
 
 
 
40 0.66   
35 0.72   
30 0.79   
25 0.87   
20 0.96   
15 1.04   
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 0.89   
35 0.98   
30 1.08   
25 1.18   
20 1.32   
15 1.43   
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Table 2.16 Chromatographic data of enantioseparation of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak
®
 IA column under different EtOH/water 
mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
EtOH/H2O (60:40, v/v), 
0.4 mL/min 
 
 
 
 
 
 
40 1.61 1.044 0.68 
35 1.77 1.047 0.68 
30 1.96 1.048 0.75 
25 2.15 1.05 0.77 
20 2.39 1.053 0.8 
15 2.63 1.055 0.79 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 2.47 1.044 0.81 
35 2.92 1.047 0.98 
30 3.13 1.048 0.88 
25 3.49 1.051 0.89 
20 3.97 1.054 0.91 
15 4.36 1.056 0.89 
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Table 2.17 Chromatographic data of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralpak
®
 IA column under different EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 0.754   
35 0.826   
30 0.906   
25 0.998   
20 1.103   
15 1.231   
10 1.343   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.15   
35 1.27   
30 1.4   
25 1.54   
20 1.67   
15 1.87   
10 2.06   
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 0.645   
35 0.691   
30 0.744   
25 0.8   
20 0.867   
15 0.917   
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 0.941   
35 1.014   
30 1.11   
25 1.195   
20 1.322   
15 1.432   
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Table 2.18 Chromatographic data of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralpak
®
 IC column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
30 0.21   
25 0.22   
20 0.24   
15 0.25   
10 0.27   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 0.28   
35 0.3   
30 0.32   
10 0.42   
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.6   
35 0.64   
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
20 0.32   
15 0.35   
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Table 2.19 Chromatographic data of enantioseparation of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH)  on Chiralpak® IC column under different MeOH/water 
or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 0.74 1.035 0.41 
35 0.79 1.04 0.5 
30 0.85 1.044 0.53 
25 0.91 1.047 0.55 
20 0.99 1.051 0.58 
15 1.06 1.053 0.58 
10 1.12 1.056 0.58 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.23 1.043 0.6 
35 1.35 1.047 0.63 
30 1.49 1.049 0.65 
25 1.65 1.054 0.67 
20 1.84 1.058 0.75 
15 2.00 1.059 0.78 
10 2.21 1.064 0.8 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.08 1.045 0.66 
35 2.3 1.047 0.7 
30 2.56 1.05 0.76 
25 2.85 1.052 0.79 
20 3.2 1.055 0.81 
15 3.52 1.057 0.79 
10 3.92 1.061 0.77 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 0.81 1.04 0.54 
35 0.86 1.042 0.57 
30 0.92 1.046 0.6 
25 1.00 1.049 0.62 
20 1.07 1.053 0.63 
15 1.19 1.056 0.65 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 1.27 1.045 0.65 
35 1.4 1.048 0.67 
30 1.54 1.05 0.76 
25 1.7 1.053 0.82 
20 1.86 1.056 0.83 
15 2.1 1.059 0.86 
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Table 2.20 Chromatographic data of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak® IC column under different MeOH/water or 
EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:35, 
v/v), 0.6 mL/min 
40 0.8 1.11 1.26 
35 0.87 1.116 1.28 
30 0.94 1.118 1.28 
25 1.02 1.123 1.25 
20 1.11 1.126 1.17 
15 1.2 1.132 1.09 
10 1.27 1.133 0.93 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.28 1.117 1.57 
35 1.43 1.121 1.58 
30 1.59 1.126 1.58 
25 1.78 1.132 1.57 
20 1.99 1.135 1.52 
15 2.19 1.14 1.42 
10 2.41 1.144 1.34 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.13 1.122 1.78 
35 2.35 1.126 1.76 
30 2.65 1.131 1.72 
25 2.96 1.135 1.64 
20 3.35 1.14 1.56 
15 3.71 1.143 1.46 
10 4.15 1.147 1.36 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 0.9 1.118 1.59 
35 0.98 1.124 1.64 
30 1.06 1.13 1.66 
25 1.16 1.134 1.66 
20 1.27 1.138 1.63 
15 1.41 1.144 1.57 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 1.36 1.125 1.92 
35 1.52 1.13 1.97 
30 1.68 1.135 1.97 
25 1.87 1.14 1.96 
20 2.08 1.144 1.89 
15 2.37 1.149 1.83 
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Table 2.21 Chromatographic data of enantioseparation of racemic 2-(4-Bromophenyl(hydroxy) 
methyl)thiazole (BPthiOH) on Chiralpak IC column under different MeOH/water or EtOH/water 
mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40    
35    
30 1.52   
25 1.68   
20 1.87   
15 2.03   
10 2.44   
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.98 1.021 0.39 
35 2.17 1.022 0.41 
30    
25 2.69 1.021 0.36 
20 3.03 1.02 0.34 
15    
10    
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
 
40 0.69   
35 0.74   
30 0.78   
25 0.84   
20 0.89   
15 0.97   
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
 
40 1.03   
35 1.13   
30 1.22   
25 1.33   
20 1.44   
15 1.6   
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Table 2.22 Chromatographic data of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:35, 
v/v), 0.6 mL/min 
 
40 1.29 1.076 1.16 
35 1.44 1.078 1.24 
30 1.59 1.083 1.31 
25 1.76 1.085 1.36 
20 1.96 1.089 1.39 
15 2.17 1.09 1.4 
10 2.45 1.092 1.4 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.93 1.077 1.38 
35 2.18 1.083 1.45 
30 2.44 2.087 1.52 
25 2.72 1.089 1.5 
20 3.03 1.092 1.43 
15 3.22 1.094 1.13 
10 3.62 1.092 1.01 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.88 1.086 1.61 
35 3.26 1.09 1.69 
30 3.82 1.093 1.77 
25 4.15 1.096 1.76 
20 4.7 1.1 1.77 
15 5.41 1.103 1.74 
10 6.11 1.105 1.71 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 1.2 1.081 1.23 
35 1.32 1.085 1.35 
30 1.46 1.092 1.46 
25 1.62 1.097 1.56 
20 1.8 1.104 1.66 
15 1.99 1.11 1.69 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.7 1.084 1.45 
35 1.91 1.09 1.58 
30 2.1 1.097 1.69 
25 2.39 1.104 1.82 
20 2.64 1.11 1.85 
15 2.98 1.116 1.89 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 2.6 1.087 1.69 
35 2.94 1.093 1.82 
30 3.37 1.1 1.95 
25 -   
20 4.51 1.114 2.02 
15 5.4 1.119 1.45 
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Table 2.23 Chromatographic data of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:35, 
v/v), 0.6 mL/min 
 
40 1.5 1.151 2.44 
35 1.69 1.156 2.64 
30 1.88 1.162 2.75 
25 2.11 1.17 2.87 
20 2.38 1.176 2.96 
15 2.67 1.181 2.99 
10 3.06 1.185 2.98 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 2.18 1.155 2.76 
35 2.49 1.162 2.9 
30 2.84 1.168 3.08 
25 3.21 1.174 3.09 
20 3.66 1.181 3.09 
15 3.94 1.185 2.57 
10 4.344 1.188 2.2 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 3.19 1.159 3.05 
35 3.67 1.167 3.26 
30 4.38 1.176 3.47 
25 4.81 1.181 3.42 
20 5.5 1.189 3.52 
15 6.46 1.195 3.46 
10 7.42 1.202 3.38 
EtOH/H2O (60:40, v/v), 
0.4 mL/min 
40 1.03 1.186 2.72 
35 1.15 1.199 2.99 
30 1.27 1.21 3.26 
25 1.42 1.224 3.47 
20 1.58 1.237 3.63 
15 1.74 1.25 3.73 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 1.41 1.185 3.09 
35 1.57 1.2 3.36 
30 1.75 1.212 3.58 
25 1.95 1.226 3.78 
20 2.18 1.239 3.92 
15 2.42 1.254 4.01 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.95 1.188 3.4 
35 2.2 1.199 3.68 
30 2.46 1.212 3.87 
25 2.85 1.226 4.07 
20 3.17 1.238 4.12 
15 3.71 1.247 3.58 
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Table 2.24 Chromatographic data of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (70:30, 
v/v), 0.6 mL/min 
 
40 1.19 1.351 4.83 
35 1.34 1.372 5.23 
30 1.48 1.391 5.56 
25 1.67 1.408 5.86 
20 1.89 1.425 6.00 
15 2.13 1.439 6.03 
10 2.38 1.454 5.97 
MeOH/H2O (65:45, 
v/v), 0.6 mL/min 
40 1.85 1.365 5.75 
35 2.13 1.384 6.09 
30 2.38 1.405 6.42 
25 2.7 1.426 6.62 
20 3.08 1.444 6.63 
15 3.49 1.462 6.64 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 2.91 1.383 6.34 
35 3.4 1.402 6.74 
30 3.94 1.418 7.07 
25 4.51 1.441 7.13 
20 5.2 1.457 7.11 
15 5.63 1.469 6.34 
10 6.27 1.483 5.5 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 4.7 1.402 7.13 
35 5.47 1.428 7.39 
30 6.6 1.442 7.65 
25 7.49 1.47 7.64 
20 8.64 1.497 7.67 
15 10.28 1.518 7.6 
10 12.11 1.539 7.51 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 1.35 1.392 5.75 
35 1.52 1.423 6.24 
30 1.71 1.452 6.58 
25 1.94 1.483 6.96 
20 2.19 1.512 7.12 
15 2.45 1.542 7.14 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.99 1.406 6.59 
35 2.25 1.438 6.99 
30 2.55 1.464 7.21 
25 2.96 1.496 7.52 
20 3.33 1.529 7.55 
15 3.72 1.56 7.6 
40 3.02 1.419 7.3 
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EtOH/H2O (45:55, v/v), 
0.4 mL/min 
35 3.52 1.45 7.55 
30 4.06 1.474 7.82 
25 4.74 1.511 8.17 
20 5.24 1.545 7.71 
15 6.07 1.578 7.51 
 
Table 2.25 Chromatographic data of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column under different MeOH/water or 
EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:45, 
v/v), 0.6 mL/min 
40 0.86 1.03 0.4 
35 0.95 1.044 0.51 
30 1.04 1.052 0.58 
25 1.15 1.058 0.62 
20 1.28 1.067 0.65 
15 1.41 1.076 0.67 
10 1.59 1.085 0.78 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.4 1.044 0.57 
35 1.6 1.048 0.62 
30 1.8 1.053 0.66 
25 2.02 1.062 0.68 
20 2.29 1.067 0.77 
15 2.43 1.073 0.67 
10 2.63 1.081 0.67 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.36 1.049 0.67 
35    
30 3.19 1.06 0.9 
25 3.46 1.067 0.96 
20 3.92 1.074 1 
15 4.57 1.082 1.04 
10 5.16 1.092 1.07 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.65 1.041 0.48 
35 0.72 1.052 0.57 
30 0.79 1.061 0.63 
25 0.89 1.071 0.7 
20 0.972 1.081 0.87 
15 1.07 1.091 0.95 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.01 1.048 0.61 
35 1.13 1.056 0.66 
30 1.26 1.063 0.8 
25 1.44 1.071 0.95 
20 1.61 1.08 1.04 
15 1.8 1.093 1.11 
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EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 1.74 1.049 0.67 
35 1.98 1.054 0.81 
30 2.29 1.062 0.96 
25 2.63 1.072 1.07 
20    
15 3.87 1.088 0.98 
 
Table 2.26 Chromatographic data of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on LuxTM Cellulose-3 column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:45, 
v/v), 0.6 mL/min 
40 0.85   
35 0.96   
30 1.05   
25 1.17 1.033 0.49 
20 1.31 1.041 0.56 
15 1.47 1.048 0.6 
10 1.66 1.053 0.63 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.22   
35 1.38   
30 1.56 1.033 0.5 
25 1.77 1.04 0.57 
20 1.99 1.044 0.59 
15 2.14 1.046 0.56 
10 2.34 1.052 0.55 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.78   
35 2.01 1.026 0.43 
30 2.34 1.033 0.55 
25 2.63 1.039 0.6 
20 2.98 1.043 0.63 
15 3.43 1.049 0.66 
10 3.94 1.054 0.68 
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Table 2.27 Enantioseparation of racemic (3,5-Difluorophenyl)(phenyl)methanol (DFPPOH) on LuxTM 
Cellulose-3 column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (70:30, 
v/v), 0.6 mL/min 10 6.63   
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 4.87   
35 5.73   
30 6.62   
25 7.68   
20 9.05   
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 4.05   
35 4.65   
30 5.32   
25 6.34   
20 7.22   
15 8.00   
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Table 2.28 Chromatographic data of enantioseparation of racemic 2-(4-Bromophenyl(hydroxy)-
methyl)thiazole (BPthiOH) on LuxTM Cellulose-3 column under different MeOH/water or EtOH/water 
mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (65:45, 
v/v), 0.6 mL/min 
40 2.23 - - 
35 2.45 -- - 
30 2.71 - - 
25 3 - - 
20 3.36 - - 
15 3.71 1.02 0.38 
10 4.21 1.025 0.44 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 3.49 - - 
35 3.98 - - 
30 4.51 - - 
25 5.06 1.019 0.39 
20 5.72 1.023 0.45 
15 6.1 - - 
10 6.69 - - 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 5.81 - - 
35 6.58 - - 
30 7.7 1.019 0.43 
25 8.89 1.026 0.53 
20 9.75 1.028 0.53 
15 11.32 1.032 0.56 
10 13.02 1.036 0.59 
EtOH/H2O (60:40, v/v), 
0.4 mL/min 
40 1.55 - - 
35 1.71 - - 
30 1.87 - - 
25 2.1 - - 
20 2.29 - - 
15 2.45 - - 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 2.39 - - 
35 2.68 - - 
30 2.96 - - 
25 3.34 - - 
20 3.71 - - 
15 4.15 - - 
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Table 2.29 Chromatographic data of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.34 1.082 1.05 
35 1.47 1.09 1.23 
30 1.65 1.098 1.29 
25 1.79 1.108 1.45 
20 2.01 1.116 1.49 
15 2.2 1.128 1.63 
10 2.48 1.136 1.64 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.03 1.085 1.31 
35 2.22 1.091 1.41 
30 2.47 1.099 1.52 
25 2.76 1.109 1.63 
20 3.05 1.117 1.72 
15 3.44 1.127 1.79 
10 3.81 1.138 1.83 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 3.09 1.085 1.42 
35 3.37 1.09 1.5 
30 3.83 1.099 1.6 
25 4.21 1.108 1.69 
20 4.76 1.117 1.77 
15 5.33 1.128 1.83 
10 5.99 1.138 1.86 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.9 1.092 1.02 
35 0.98 1.099 1.13 
30 1.05 1.106 1.21 
25 1.14 1.116 1.3 
20 1.24 1.124 1.38 
15 1.35 1.133 1.44 
10 1.44 1.145 1.48 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.26 1.091 1.23 
35 1.38 1.1 1.35 
30 1.5 1.108 1.44 
25 1.65 1.118 1.54 
20 1.8 1.127 1.6 
15 1.99 1.135 1.64 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 1.93 1.092 1.47 
35 2.19 1.102 1.63 
30 2.37 1.109 1.69 
25 2.71 1.119 1.84 
20 3.06 1.129 1.95 
15 3.44 1.138 2.02 
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Table 2.30 Chromatographic data of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.15 1.113 1.43 
35 1.26 1.126 1.66 
30 1.41 1.13 1.72 
25 1.53 1.147 1.96 
20 1.71 1.156 1.97 
15 1.88 1.174 2.21 
10 2.13 1.18 2.15 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.69 1.113 1.73 
35 1.86 1.124 1.88 
30 2.07 1.133 2.03 
25 2.32 1.147 2.18 
20 2.56 1.157 2.27 
15 2.9 1.172 2.38 
10 3.2 1.186 2.45 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 2.53 1.115 1.89 
35 2.77 1.124 1.99 
30 3.13 1.135 2.13 
25 3.48 1.147 2.27 
20 3.97 1.155 2.38 
15 4.41 1.173 2.47 
10 4.98 1.188 2.51 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.82 1.11 1.27 
35 0.89 1.122 1.4 
30 0.96 1.131 1.52 
25 1.04 1.14 1.63 
20 1.13 1.15 1.71 
15 1.24 1.163 1.79 
10 1.33 1.173 1.82 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.11 1.113 1.51 
35 1.22 1.121 1.63 
30 1.32 1.134 1.76 
25 1.47 1.144 1.88 
20 1.61 1.154 1.96 
15 1.78 1.165 2.02 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 1.65 1.112 1.77 
35 1.87 1.123 1.89 
30 2.04 1.132 2.06 
25 2.32 1.145 2.18 
20 2.59 1.155 2.32 
15 2.97 1.166 2.43 
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Table 2.31 Chromatographic data of enantioseparation of racemic 2-(4-Bromophenyl(hydroxy) 
methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column under different MeOH/water or 
EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 2.82 1.102 1.61 
35 3.18 1.108 1.68 
30 3.58 1.113 1.68 
25 4.04 1.12 1.73 
20 4.53 1.125 1.74 
15 5.19 1.131 1.74 
10 5.85 1.138 1.72 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 4.65 1.107 1.82 
35 5.34 1.111 1.87 
30 6.09 1.116 1.89 
25 7 1.122 1.91 
20 8.13 1.129 1.93 
15 9.19 1.135 1.91 
10 11.16 1.141 1.93 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 7.95 1.113 2.03 
35 9.1 1.118 2.05 
30 10.49 1.124 2.07 
25 12.15   
20 14.29   
EtOH/H2O (60:40, v/v), 
0.4 mL/min 
40 1.034 1.103 1.18 
35 1.121 1.106 1.23 
30 1.216 1.110 1.27 
25 1.313 1.113 1.30 
20 1.419 1.119 1.30 
15 1.540 1.124 1.30 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 1.44 1.114 1.45 
35 1.57 1.118 1.51 
30 1.73 1.124 1.54 
25 1.89 1.128 1.56 
20 2.07 1.135 1.53 
15 2.3 1.14 1.52 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 2.19 1.117 1.73 
35 2.44 1.121 1.76 
30 2.72 1.127 1.78 
25 3.18 1.131 1.77 
20 3.59 1.135 1.75 
15 4.03 1.140  1.72 
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Table 2.32 Chromatographic data of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 1.28 1.266 3.16 
35 1.43 1.294 3.51 
30 1.59 1.326 3.83 
25 1.77 1.361 4.08 
20 1.96 1.403 4.32 
15 2.22 1.441 4.51 
10 2.47 1.484 4.59 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 2.04 1.266 3.66 
35 2.32 1.296 3.98 
30 2.6 1.329 4.28 
25 2.95 1.365 4.54 
20 3.38 1.403 4.73 
15 3.75 1.446 4.85 
10 4.19 1.49 4.81 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 3.33 1.263 3.9 
35 3.71 1.293 4.12 
30 4.22 1.325 4.32 
25 4.81 1.36 4.48 
20 5.48 1.401 4.62 
15 6.28 1.438 4.69 
10 7.2 1.486 4.71 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.94 1.202 2.28 
35 1.03 1.222 2.49 
30 1.13 1.244 2.72 
25 1.22 1.268 2.92 
20 1.34 1.292 3.13 
15 1.48 1.317 3.2 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 1.41 1.21 2.78 
35 1.56 1.231 3.04 
30 1.74 1.251 3.27 
25 1.92 1.275 3.45 
20 2.16 1.3 3.66 
15 2.39 1.329 3.7 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 2.37 1.219 3.44 
35 2.67 1.239 3.73 
30 3.02 1.263 3.97 
25 3.43 1.286 4.15 
20 3.97 1.313 4.35 
15 4.56 1.338 4.56 
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Table 2.33 Chromatographic data of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column under different MeOH/water or EtOH/water mobile phases. 
Mobile phase Temp. (0C) K1 α Rs 
MeOH/H2O (60:40, 
v/v), 0.6 mL/min 
40 0.96 1.263 2.82 
35 1.05 1.294 3.18 
30 1.19 1.309 3.83 
25 1.29 1.344 3.68 
20 1.47 1.363 3.72 
15 1.6 1.401 4.04 
10 1.85 1.422 3.96 
MeOH/H2O (55:45, 
v/v), 0.6 mL/min 
40 1.42 1.261 3.34 
35 1.57 1.286 3.62 
30 1.76 1.307 3.83 
25 1.97 1.337 4.05 
20 2.2 1.358 4.23 
15 2.49 1.397 4.35 
10 2.8 1.425 4.41 
MeOH/H2O (50:50, 
v/v), 0.6 mL/min 
40 2.16 1.264 3.62 
35 2.36 1.282 3.85 
30 2.72 1.304 3.98 
25 3.01 1.33 4.21 
20 3.49 1.348 4.26 
15 3.86 1.386 4.37 
10 4.41 1.419 4.38 
EtOH/H2O (55:45, v/v), 
0.4 mL/min 
40 0.62 1.264 2.35 
35 0.68 1.284 2.54 
30 0.74 1.309 2.76 
25 0.8 1.331 2.93 
20 0.88 1.356 3.1 
15 0.98 1.384 3.2 
EtOH/H2O (50:50, v/v), 
0.4 mL/min 
40 0.83 1.268 2.77 
35 0.92 1.288 3.02 
30 1.01 1.311 3.22 
25    
20 1.23 1.361 3.53 
15 1.38 1.386 3.64 
EtOH/H2O (45:55, v/v), 
0.4 mL/min 
40 1.23 1.266 3.28 
35 1.4 1.286 3.61 
30 1.54 1.308 3.76 
25 1.76 1.332 4.00 
20 1.98 1.357 4.10 
15 2.34 1.389 4.15 
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APPENDIX II 
 
Figures 2.16 - 2.270 Retention diagram (In k1 vs 1/T) and van’t Hoff plot 
of enantioseparation (In α vs 1/T) of PPOH, PVOH, PCF3OH, 
PNBOCOH, PAEtOH, BPthiOH and DFPPOH on Chiralpak® AS-RH, 
IA, IC, Chiralcel® OD-RH, OJ-RH and LuxTM Cellulose-3 columns  
 
 
 
Figure 2.16 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.17 Retention diagram (van’t Hoff plot) first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
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Figure 2.18: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.19: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (45:55, v/v), 0.6 mL/min. 
 
 
Figure 2.20: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.3 mL/min. 
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Figure 2.21: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (50:40, v/v), 0.3 mL/min. 
 
 
Figure 2.22: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.3 mL/min. 
 
 
Figure 2.23: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.24: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.25: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.26: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase MeOH/H2O (45:55, v/v), 0.6 mL/min. 
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Figure 2.27: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.3 mL/min. 
 
 
Figure 2.28: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.3 mL/min. 
 
 
Figure 2.29: The van’t Hoff plot of enantioseparation of 1-Phenylpropan-1-ol (PPOH) on Chiralpak
®
 
AS-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.3 mL/min. 
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Figure 2.30: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.31: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.32: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
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Figure 2.33: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (45:55, v/v), 0.6 mL/min. 
 
 
Figure 2.34: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (50:40, v/v), 0.3 mL/min. 
 
 
Figure 2.35: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.3 mL/min. 
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Figure 2.36: The van’t Hoff plot of enantioseparation of 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.3 mL/min. 
 
 
Figure 2.37: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 
0.6 mL/min. 
 
 
Figure 2.38: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 
0.6 mL/min. 
 
 
 
  
y = 94.185x - 0.2854
R² = 0.9755
0.02
0.025
0.03
0.035
0.04
0.045
0.05
0.00325 0.0033 0.00335 0.0034 0.00345 0.0035 0.00355
In
 α
1/T
In α vs 1/T
y = 1943.7x - 6.5972
R² = 0.9992
-0.6
-0.4
-0.2
0
0.2
0.4
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035 0.00355
In
 k
1
1/T
In k
1
vs 1/T
y = 2701.9x - 8.6257
R² = 0.9964
-0.2
0
0.2
0.4
0.6
0.8
1
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035 0.00355
In
k
1
1/T
Ink1 vs 1/T
䬐Җ
 175 
Figure 2.39: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 
0.6 mL/min. 
 
 
Figure 2.40: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (45:55, v/v), 
0.6 mL/min. 
 
 
Figure 2.41: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (55:45, v/v), 
0.3 mL/min. 
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Figure 2.42: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (50:50, v/v), 
0.3 mL/min. 
 
 
Figure 2.43: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (45:55, v/v), 
0.3 mL/min. 
 
 
Figure 2.44: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.45: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.46: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.47: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (45:55, v/v), 0.6 mL/min. 
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Figure 2.48: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.3 mL/min. 
 
 
Figure 2.49: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.3 mL/min. 
 
 
Figure 2.50: The van’t Hoff plot of enantioseparation of 2-hydroxy-2-phenylacetate (PAEtOH) on 
Chiralpak
®
 AS-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.3 mL/min. 
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Figure 2.51: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 
0.6 mL/min. 
 
 
Figure 2.52: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 
0.6 mL/min. 
 
 
Figure 2.53: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 
0.6 mL/min. 
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Figure 2.54: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (45:55, v/v), 
0.6 mL/min. 
 
 
Figure 2.55: The van’t Hoff plot of enantioseparation of 2,2,2-Trifluoro-1-phenylethanol (PCF3OH) on 
Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.56: The van’t Hoff plot of enantioseparation of 2,2,2-Trifluoro-1-phenylethanol (PCF3OH) on 
Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (40:55, v/v), 0.6 mL/min. 
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Figure 2.57: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O 
(60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.58: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O 
(55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.59: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O 
(50:50, v/v), 0.6 mL/min. 
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Figure 2.60: Retention diagram (van’t Hoff plot) of first eluent (k1) of 2-(4-
Bromophenyl(hydroxy)methyl) thiazole (BPthiOH) on Chiralpak
®
 AS-RH column with mobile phase 
MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.61: Retention diagram (van’t Hoff plot) of first eluent (k1) of 2-(4-
Bromophenyl(hydroxy)methyl) thiazole (BPthiOH) on Chiralpak
®
 AS-RH column with mobile phase 
MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.62: Retention diagram (van’t Hoff plot) of first eluent (k1) of 2-(4-
Bromophenyl(hydroxy)methyl) thiazole (BPthiOH) on Chiralpak
®
 AS-RH column with mobile phase 
MeOH/H2O (50:50, v/v), 0.6 mL/min. 
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Figure 2.63: The van’t Hoff plot of enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl) thiazole 
(BPthiOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.64: The van’t Hoff plot of enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl) thiazole 
(BPthiOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.65: The van’t Hoff plot of enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl) thiazole 
(BPthiOH) on Chiralpak
®
 AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
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Figure 2.66 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.67 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.68 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
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Figure 2.69 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.70 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.71 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
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Figure 2.72: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 IA column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.73: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 IA column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.74: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 IA column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
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Figure 2.75: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 IA column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.76: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 IA column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.77: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralpak
®
 IA column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
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Figure 2.78: Retention diagram (van’t Hoff plot) of first eluent (k1) of 1-Phenylprop-2-en-1-ol (PVOH) 
on Chiralpak
®
 IA on Chiralpak AS-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 
mL/min. 
 
 
Figure 2.79: Retention diagram (van’t Hoff plot) of first eluent (k1) of 1-Phenylprop-2-en-1-ol (PVOH) 
on Chiralpak
®
 IA on Chiralpak AS-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 
mL/min. 
 
 
Figure 2.80: Retention diagram (van’t Hoff plot) of first eluent (k1) of 1-Phenylprop-2-en-1-ol (PVOH) 
on Chiralpak
®
 IA on Chiralpak AS-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 
mL/min. 
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Figure 2.81 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.82 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.83 Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-ol 
(PVOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
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Figure 2.84: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.85: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.86: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
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Figure 2.87: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.88: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.89: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralpak
®
 IA column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
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Figure 2.90: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O 
(70:30, v/v), 0.6 mL/min. 
 
 
Figure 2.91: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O 
(65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.92: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O 
(60:40, v/v), 0.4 mL/min. 
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Figure 2.93: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O 
(55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.94: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA column with mobile phase 
MeOH/H2O (70:30, v/v), 0.6 mL/min. 
 
 
Figure 2.95: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA column with mobile phase 
MeOH/H2O (65:35, v/v), 0.6 mL/min. 
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Figure 2.96: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA column with mobile phase 
EtOH/H2O (60:40, v/v), 0.4 mL/min. 
 
 
Figure 2.97: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak
®
 IA column with mobile phase 
EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.97: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (65:35, v/v), 
0.6 mL/min. 
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Figure 2.98: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (60:40, v/v), 
0.6 mL/min. 
 
 
Figure 2.99: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (55:45, v/v), 
0.6 mL/min. 
 
 
Figure 2.100: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (60:40, v/v), 0.4 
mL/min. 
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Figure 2.101: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (55:45, v/v), 0.4 
mL/min. 
 
 
Figure 2.102: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (50:50, v/v), 0.4 
mL/min. 
 
 
Figure 2.103: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (65:35, 
v/v), 0.6 mL/min. 
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Figure 2.104: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (60:40, 
v/v), 0.6 mL/min. 
 
 
Figure 2.105: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (55:45, 
v/v), 0.6 mL/min. 
 
 
Figure 2.106: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.107: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.108: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.109: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
  
y = 1975.5x - 6.0831
R² = 0.9996
0.2
0.4
0.6
0.8
1
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035 0.00355
In
 k
1
1/T
In k
1
vs 1/T
y = 2248x - 6.5568
R² = 0.9978
0.6
0.8
1
1.2
1.4
1.6
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035 0.00355
In
 k
1
1/T
In k
1
vs 1/T
y = 1666.5x - 5.7343
R² = 0.9985
-0.6
-0.4
-0.2
0
0.2
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035
In
 k
1
1/T
In k
1
vs 1/T
樀Җ
 199 
Figure 2.110: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
Figure 2.111: van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
Figure 2.112: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
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Figure 2.113: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralpak
®
 IA column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
Figure 2.114: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (60:40, 
v/v), 0.4 mL/min. 
 
 
Figure 2.115: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (55:45, 
v/v), 0.4 mL/min. 
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Figure 2.116: The van’t Hoff plot of enantioseparation of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak
®
 IA column with mobile phase EtOH/H2O 
(60:40, v/v), 0.4 mL/min. 
 
 
Figure 2.117: The van’t Hoff plot of enantioseparation of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak
® IA column with mobile phase EtOH/H2O 
(55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.118: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
y = 36.867x - 0.0744
R² = 0.9872
0.04
0.045
0.05
0.055
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035
In
 α
1/T
In α vs 1/T
y = 41.266x - 0.0886
R² = 0.9892
0.04
0.045
0.05
0.055
0.06
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035
In
 α
1/T
In α vs 1/T
y = 1709.4x - 5.3099
R² = 0.9988
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.00315 0.0032 0.00325 0.0033 0.00335 0.0034 0.00345 0.0035 0.00355
In
 k
1
1/T
In k
1
vs 1/T
䬐Җ
 202 
Figure 2.119: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 IA with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
Figure 2.120: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.121: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak
®
 IA with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
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Figure 2.122: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak® IC with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.123: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralpak® IC with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.124: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC with mobile phase MeOH/H2O (65:35, 
v/v), 0.6 mL/min. 
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Figure 2.125: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC with mobile phase MeOH/H2O (60:40, 
v/v), 0.6 mL/min. 
 
 
Figure 2.126: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC with mobile phase MeOH/H2O (55:45, 
v/v), 0.6 mL/min. 
 
 
Figure 2.127: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC with mobile phase EtOH/H2O (55:45, 
v/v), 0.4 mL/min. 
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Figure 2.128: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC with mobile phase EtOH/H2O (55:45, 
v/v), 0.4 mL/min. 
 
 
Figure 2.129: The van’t Hoff plot of enantioseparation of racemic 3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC column with mobile phase 
MeOH/H2O (65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.130: The van’t Hoff plot of enantioseparation of racemic 3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC column with mobile phase 
MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.131: The van’t Hoff plot of enantioseparation of racemic 3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC column with mobile phase 
MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
Figure 2.132: The van’t Hoff plot of enantioseparation of racemic 3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC column with mobile phase EtOH/H2O 
(55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.133: The van’t Hoff plot of enantioseparation of racemic 3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on Chiralpak® IC column with mobile phase EtOH/H2O 
(50:50, v/v), 0.4 mL/min. 
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Figure 2.134: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC with mobile phase MeOH/H2O (65:35, v/v), 0.6 
mL/min. 
 
 
Figure 2.135: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC with mobile phase MeOH/H2O (60:40, v/v), 0.6 
mL/min. 
 
 
Figure 2.136: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC with mobile phase MeOH/H2O (55:45, v/v), 0.6 
mL/min. 
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Figure 2.137: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC with mobile phase EtOH/H2O (55:45, v/v), 0.4 
mL/min. 
 
 
Figure 2.138: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC with mobile phase EtOH/H2O (50:50, v/v), 0.4 
mL/min. 
 
 
Figure 2.139: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC column with mobile phase MeOH/H2O (65:35, 
v/v), 0.6 mL/min. 
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Figure 2.140: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC column with mobile phase MeOH/H2O (60:40, 
v/v), 0.6 mL/min. 
 
 
Figure 2.141: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC column with mobile phase MeOH/H2O (55:45, 
v/v), 0.6 mL/min. 
 
 
Figure 2.142: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC column with mobile phase EtOH/H2O (55:45, 
v/v), 0.4 mL/min. 
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Figure 2.143: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on Chiralpak IC column with mobile phase EtOH/H2O (50:50, 
v/v), 0.4 mL/min. 
 
 
Figure 2.144: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH)  on Chiralpak IC with mobile phase MeOH/H2O 
(60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.145: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak IC with mobile phase MeOH/H2O 
(55:45, v/v), 0.6 mL/min. 
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Figure 2.146: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak IC with mobile phase EtOH/H2O 
(55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.147: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralpak IC with mobile phase EtOH/H2O 
(50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.148: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min 
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Figure 2.149: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min 
 
 
Figure 2.150: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min 
 
 
Figure 2.151: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min 
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Figure 2.152: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min 
 
 
Figure 2.153: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min 
 
 
Figure 2.154: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min 
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Figure 2.155: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.156: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.157: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.158: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.159: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.160: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic -Phenylprop-2-en-1-ol 
(PVOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min 
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Figure 2.161: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic -Phenylprop-2-en-1-ol 
(PVOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min 
 
 
Figure 2.162: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic -Phenylprop-2-en-1-ol 
(PVOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min 
 
 
Figure 2.163: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic -Phenylprop-2-en-1-ol 
(PVOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (60:40, v/v), 0.4 mL/min 
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Figure 2.164: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic -Phenylprop-2-en-1-ol 
(PVOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min 
 
 
Figure 2.165: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic -Phenylprop-2-en-1-ol 
(PVOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min 
 
 
Figure 2.166: The van’t Hoff plot of enantioseparation of racemic Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min 
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Figure 2.167: The van’t Hoff plot of enantioseparation of racemic Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min 
 
 
Figure 2.168: The van’t Hoff plot of enantioseparation of racemic Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min 
 
 
Figure 2.169: The van’t Hoff plot of enantioseparation of racemic Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column with mobile phase EtOH/H2O (60:40, v/v), 0.4 mL/min. 
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Figure 2.170: The van’t Hoff plot of enantioseparation of racemic Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.171: The van’t Hoff plot of enantioseparation of racemic Phenylprop-2-en-1-ol (PVOH) on 
LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.172: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (70:30, v/v), 0.6 
mL/min. 
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Figure 2.173: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 
mL/min. 
 
 
Figure 2.174: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 
mL/min. 
 
 
Figure 2.175: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 
mL/min. 
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Figure 2.176: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (60:40, v/v), 0.4 
mL/min. 
 
 
Figure 2.177: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 
mL/min. 
 
 
Figure 2.178: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 
mL/min. 
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Figure 2.179: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (70:30, v/v), 0.6 mL/min 
 
 
Figure 2.180: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min 
 
 
Figure 2.181: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min 
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Figure 2.182: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min 
 
 
Figure 2.183: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (60:40, v/v), 0.4 mL/min 
 
 
Figure 2.184: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min 
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Figure 2.185: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min 
 
Figure 2.186: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O 
(65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.187: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O 
(60:40, v/v), 0.6 mL/min. 
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Figure 2.188: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O 
(55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.189: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O 
(55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.190: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O 
(50:50, v/v), 0.4 mL/min. 
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Figure 2.191: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O 
(45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.192: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O 
(65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.193: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O 
(60:40, v/v), 0.6 mL/min. 
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Figure 2.194: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O 
(55:45, v/v), 0.6 mL/min. 
 
Figure 2.195: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O 
(55:45, v/v), 0.4 mL/min. 
 
Figure 2.196: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O 
(50:50, v/v), 0.4 mL/min. 
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Figure 2.197: The van’t Hoff plot of enantioseparation of racemic t-Butyl (2-hydroxy-2-
phenylethyl)carbamate (PNBOCOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O 
(45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.198: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 
mL/min. 
 
 
Figure 2.199: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 
mL/min. 
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Figure 2.200: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 
mL/min. 
 
 
Figure 2.201: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.202: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.203: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.204: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on LuxTM Cellulose-3 column with mobile phase 
MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.205: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic (3,5-
Difluorophenyl)(phenyl)methanol (DFPPOH) on LuxTM Cellulose-3 column with mobile phase 
EtOH/H2O (50:50, v/v), 0.4 mL/min. 
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Figure 2.206: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on LuxTM Cellulose-3 column with mobile phase 
MeOH/H2O (65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.207: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on LuxTM Cellulose-3 column with mobile phase 
MeOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.208: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on LuxTM Cellulose-3 column with mobile phase 
MeOH/H2O (55:45, v/v), 0.6 mL/min. 
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Figure 2.209: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on LuxTM Cellulose-3 column with mobile phase 
EtOH/H2O (60:40, v/v), 0.6 mL/min. 
 
 
Figure 2.210: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.211: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (65:35, v/v), 0.6 mL/min. 
 
 
Figure 2.212: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralcel® OD-RH on LuxTM Cellulose-3 column with mobile phase MeOH/H2O (60:40, 
v/v), 0.6 mL/min. 
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Figure 2.213: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.214: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.215: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.216: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylpropan-1-ol 
(PPOH) on Chiralcel® OD-RH on LuxTM Cellulose-3 column with mobile phase EtOH/H2O (45:55, v/v), 
0.4 mL/min. 
 
 
Figure 2.217: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.218: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.219: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.220: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.221: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.222: The van’t Hoff plot of enantioseparation of racemic 1-Phenylpropan-1-ol (PPOH) on 
Chiralcel® OD-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.223: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-
ol (PVOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.224: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-
ol (PVOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.225: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-
ol (PVOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.226: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-
ol (PVOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.227: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-
ol (PVOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.228: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 1-Phenylprop-2-en-1-
ol (PVOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.229: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.230: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.231: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.232: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.233: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.234: The van’t Hoff plot of enantioseparation of racemic 1-Phenylprop-2-en-1-ol (PVOH) on 
Chiralcel® OD-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.235: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.236: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH on LuxTM Cellulose-3 
column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
Figure 2.237: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.238: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
EtOH/H2O (60:40, v/v), 0.4 mL/min. 
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Figure 2.239: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.240: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.241: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.242: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.243: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.244: The van’t Hoff plot of enantioseparation of 2-(4-Bromophenyl(hydroxy)methyl)thiazole 
(BPthiOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (60:40, v/v), 0.4 mL/min. 
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Figure 2.245: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
EtOH/H2O (55:45, v/v), 0.4 mL/min. 
 
 
Figure 2.246: The van’t Hoff plot of enantioseparation of racemic 2-(4-
Bromophenyl(hydroxy)methyl)thiazole (BPthiOH) on Chiralcel® OD-RH column with mobile phase 
EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.247: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 
0.6 mL/min. 
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Figure 2.248: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralcel® OD-RH with mobile phase MeOH/H2O (55:45, v/v), 0.6 
mL/min. 
 
 
Figure 2.249: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 
0.6 mL/min. 
 
 
Figure 2.250: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 
mL/min. 
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Figure 2.251: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 
mL/min. 
 
 
Figure 2.252: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic 2,2,2-Trifluoro-1-
phenylethanol (PCF3OH) on Chiralcel® OD-RH with mobile phase EtOH/H2O (45:55, v/v), 0.4 
mL/min. 
 
 
Figure 2.253: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.254: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.255: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.256: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.257: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.258: The van’t Hoff plot of enantioseparation of racemic 2,2,2-Trifluoro-1-phenylethanol 
(PCF3OH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.259: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 
0.6 mL/min. 
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Figure 2.260: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralcel® OD-RH with mobile phase MeOH/H2O (55:45, v/v), 0.6 
mL/min. 
 
 
Figure 2.261: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 
0.6 mL/min. 
 
 
Figure 2.262: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 
mL/min. 
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Figure 2.263: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 
mL/min. 
 
 
Figure 2.264: Retention diagram (van’t Hoff plot) of first eluent (k1) of racemic Ethyl 2-hydroxy-2-
phenylacetate (PAEtOH) on Chiralcel® OD-RH with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
 
 
Figure 2.265: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (60:40, v/v), 0.6 mL/min. 
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Figure 2.266: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (55:45, v/v), 0.6 mL/min. 
 
 
Figure 2.267: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column with mobile phase MeOH/H2O (50:50, v/v), 0.6 mL/min. 
 
 
Figure 2.268: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (55:45, v/v), 0.4 mL/min. 
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Figure 2.269: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (50:50, v/v), 0.4 mL/min. 
 
 
Figure 2.270: The van’t Hoff plot of enantioseparation of racemic Ethyl 2-hydroxy-2-phenylacetate 
(PAEtOH) on Chiralcel® OD-RH column with mobile phase EtOH/H2O (45:55, v/v), 0.4 mL/min. 
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APPENDIX III 
Tables 2.34 – 2.40 Thermodynamic data of reversed phase 
enantioseparation of PPOH, PVOH, PCF3OH, PNBOCOH, PAEtOH, 
BPthiOH and DFPPOH on Chiralpak® AS-RH, IA, IC, Chiralcel® OD-
RH, OJ-RH and LuxTM Cellulose-3 columns  
 
Table 2.34 Thermodynamic data of reversed phase enantioseparation of seven chiral benzyl alcohols 
on Chiralpak® OD-RH column 
Analytes Mobile phase ∆H1(KJ) ∆∆H(KJ) ∆∆S(J) ∆∆G25(KJ) 
PPOH MeOH/H2O 60:40 -15.02 -1.22 -10.1 1.79 
MeOH/H2O 55:45 -15.67 -1.18 -9.84 1.76 
MeOH/H2O 50:50 -16.44 -1.20 -10.0 1.78 
EtOH/H2O 55:45 -11.67 -1.16 -9.62 1.71 
EtOH/H2O 50:50 -13.63 -1.20 -9.95 1.77 
EtOH/H2O 45:55 -17.28 -1.23 -10.3 1.84 
PVOH MeOH/H2O 60:40 -14.97 -1.48 -12.4 2.22 
MeOH/H2O 55:45 -15.88 -1.56 -12.9 2.29 
MeOH/H2O 50:50 -16.85 -1.55 -12.9 2.30 
EtOH/H2O 55:45 -11.67 -1.33 -11.1 1.99 
EtOH/H2O 50:50 -13.63 -1.39 -11.6 2.07 
EtOH/H2O 45:55 -17.35 -1.43 -11.9 2.12 
PAEtOH MeOH/H2O 60:40 -15.92 -2.92 -24.3 4.33 
MeOH/H2O 55:45 -16.76 -3.01 -25.0 4.44 
MeOH/H2O 50:50 -17.78 -2.83 -23.5 4.18 
EtOH/H2O 55:45 -13.09 -2.74 -22.8 4.06 
EtOH/H2O 50:50 -15.06 -2.70 -22.4 3.98 
EtOH/H2O 45:55 -18.84 -2.76 -23.0 4.10 
PCF3OH MeOH/H2O 60:40 -16.12 -3.94 -32.80 5.84 
MeOH/H2O 55:45 -17.79 -4.02 -33.40 5.94 
MeOH/H2O 50:50 -19.12 -3.99 -33.14 5.89 
EtOH/H2O 55:45 -13.44 -2.76 -22.93 4.08 
EtOH/H2O 50:50 -15.92 -2.8 -23.26 4.13 
EtOH/H2O 45:55 -19.69 -2.82 -23.46 4.17 
BPthiOH MeOH/H2O 65:35 -17.93 -0.78 -6.49 1.15 
MeOH/H2O 60:40 -21.09 -0.77 -6.36 1.13 
MeOH/H2O 55:45 -22.32 -0.78 -6.46 1.15 
EtOH/H2O 60:40 -11.91 -0.57 -4.75 0.85 
EtOH/H2O 55:45 -13.98 -0.70 -5.85 1.03 
EtOH/H2O 50:50 -18.72 -0.61 -5.08 0.91 
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Table 2.35 Thermodynamic data of reversed phase enantioseparation of seven chiral benzyl alcohols 
on Chiralcel
®
 OJ-RH column 
Analytes Mobile phase ∆H1(KJ) ∆∆H(KJ) ∆∆S(J) ∆∆G25(KJ) 
PPOH MeOH/H2O 65:35 -17.27 -0.24 -0.23 -0.18 
MeOH/H2O 60:40 -18.10 -0.33 -0.45 -0.19 
MeOH/H2O 55:45 -21.77 -0.22 -0.091 -0.19 
EtOH/H2O 60:40 -14.98 -0.85 -2.09 -0.23 
EtOH/H2O 55:45 -16.69 -0.77 -1.80 -0.23 
EtOH/H2O 50:50 -18.19 -0.79 -1.86 -0.23 
PVOH MeOH/H2O 65:35 -19.01 -0.66 -1.01 -0.36 
MeOH/H2O 60:40 -19.97 -0.79 -1.40 -0.37 
EtOH/H2O 65:35 -13.8 -1.86 -4.58 -0.49 
EtOH/H2O 60:40 -16.84 -1.75 -4.24 -0.49 
EtOH/H2O 55:45 -18.40 -1.78 -4.31 -0.49 
PAEtOH MeOH/H2O 65:35 -17.88 -1.15 -3.62 -0.07 
MeOH/H2O 60:40 -18.8 -0.86 -2.64 -0.07 
MeOH/H2O 55:45 -21.45 -0.95 -2.90 -0.08 
EtOH/H2O 60:40 -17.38 - - - 
EtOH/H2O 55:45 -18.87 - - - 
PCF3OH MeOH/H2O 70:30 -19.44 -1.29 -1.87 -0.74 
MeOH/H2O 65:35 -20.84 -1.31 -1.91 -0.74 
MeOH/H2O 60:40 -23.17 -1.63 -2.87 -0.77 
EtOH/H2O 65:35 -15.87 -3.10 -7.44 -0.88 
EtOH/H2O 60:40 -19.06 -3.24 -7.80 -0.91 
EtOH/H2O 55:45 -21.44 -2.91 -6.68 -0.92 
PNBOC
OH 
MeOH/H2O 65:35 -17.57 -1.27 -3.80 -0.14 
MeOH/H2O 60:40 -20.24 -0.97 -2.76 -0.15 
MeOH/H2O 55:45 -22.96 -0.83 -2.28 -0.15 
EtOH/H2O 60:40 -13.68 -1.89 -5.90 -0.14 
EtOH/H2O 55:45 -16.40 -1.44 -4.32 -0.15 
EtOH/H2O 50:50 -18.84 -1.30 -3.83 -0.16 
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Table 2.36 Thermodynamic data of reversed phase enantioseparation of seven chiral benzyl alcohols 
on LuxTM Cellulose-3 column 
Analytes Mobile phase ∆H1(KJ) ∆∆H(KJ) ∆∆S(J) ∆∆G25(KJ) 
PPOH MeOH/H2O 65:35 -15.56 -0.42 -0.71 -0.21 
MeOH/H2O 60:40 -15.15 -0.43 -0.72 -0.22 
MeOH/H2O 55:45 -18.30 -0.43 -0.69 -0.22 
EtOH/H2O 55:45 -15.27 -0.81 -1.95 -0.23 
EtOH/H2O 50:50 -16.74 -0.88 -2.15 -0.24 
EtOH/H2O 45:55 -21.85 -0.89 -2.15 -0.25 
PVOH MeOH/H2O 65:35 -17.33 -0.75 -1.21 -0.39 
MeOH/H2O 60:40 -17.02 -0.71 -1.05 -0.40 
MeOH/H2O 55:45 -20.49 -0.88 -1.58 -0.41 
EtOH/H2O 60:40 -15.80 -1.58 -3.62 -0.50 
EtOH/H2O 55:45 -16.26 -1.67 -3.92 -0.50 
EtOH/H2O 50:50 -19.12 -1.50 -3.35 -0.50 
PAEtOH MeOH/H2O 65:35 -16.24 -0.90 -2.74 -0.08 
MeOH/H2O 60:40 -16.15 -0.60 -1.79 -0.07 
MeOH/H2O 55:45 -19.45 -0.76 -2.25 -0.09 
PCF3OH MeOH/H2O 70:30 -17.12 -1.79 -3.16 -0.85 
MeOH/H2O 65:35 -18.88 -2.08 -4.04 -0.88 
MeOH/H2O 60:40 -18.84 -1.73 -2.81 -0.89 
MeOH/H2O 55:45 -23.01 -2.31 -4.57 -0.94 
EtOH/H2O 60:40 -18.01 -3.06 -7.01 -0.97 
EtOH/H2O 55:45 -19.08 -3.11 -7.08 -1.00 
EtOH/H2O 50:50 -20.72 -3.2 -7.31 -1.02 
PNBOC
OH 
MeOH/H2O 65:35 -14.97 -1.22 -3.60 -0.15 
MeOH/H2O 60:40 -15.58 -0.87 -2.43 -0.15 
MeOH/H2O 55:45 -18.91 -0.98 -2.74 -0.16 
EtOH/H2O 55:45 -15.04 -1.40 -4.12 -0.17 
EtOH/H2O 50:50 -17.51 -1.22 -3.53 -0.17 
EtOH/H2O 45:55 -23.93 -1.13 -3.22 -0.17 
BPthiOH MeOH/H2O 65:35 -15.56 - - - 
MeOH/H2O 60:40 -15.98 - - - 
MeOH/H2O 55:45 -19.70 -0.55 -1.66 -0.06 
EtOH/H2O 55:45 -14.05 - - - 
EtOH/H2O 50:50 -16.53 - - - 
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Table 2.37 Thermodynamic data of reversed phase enantioseparation of seven chiral benzyl alcohols 
on Chiralpak
®
 IA column 
Analytes Mobile phase ∆H1(KJ) ∆∆H(KJ) ∆∆S(J) ∆∆G25(KJ) 
PPOH MeOH/H2O 60:40 -14.18 -0.41 -1.12 -0.08 
MeOH/H2O 55:45 -13.73 -0.33 -0.84 -0.08 
MeOH/H2O 50:50 -15.68 -0.21 -0.47 -0.07 
EtOH/H2O 55:45 -10.67 -0.64 -1.64 -0.15 
EtOH/H2O 50:50 -11.79 -0.35 -0.72 -0.14 
EtOH/H2O 45:55 -14.20 -0.24 -0.43 -0.13 
PVOH MeOH/H2O 60:40 -13.88 -0.26 -0.70 -0.05 
MeOH/H2O 55:45 -14.02 -0.21 -0.52 -0.05 
MeOH/H2O 50:50 -16.23    
EtOH/H2O 55:45 -10.25 -0.47 -1.30 -0.08 
EtOH/H2O 50:50 -12.39 -0.29 -0.69 -0.08 
EtOH/H2O 45:55 -14.60 -0.27 -0.64 -0.08 
PAEtOH MeOH/H2O 60:40 -16.76 -0.60 -1.51 -0.15 
MeOH/H2O 55:45 -16.42 -0.51 -1.20 -0.15 
MeOH/H2O 50:50 -18.69 -0.65 -1.57 -0.17 
EtOH/H2O 55:45 -13.86    
EtOH/H2O 50:50 -14.37    
PNBOC
OH 
MeOH/H2O 65:35 -14.37 -0.52 -0.95 -0.24 
MeOH/H2O 60:40 -19.65 -0.58 -1.15 -0.24 
MeOH/H2O 55:45 -19.36 -0.49 -0.88 -0.23 
EtOH/H2O 60:40 -12.72    
EtOH/H2O 55:45 -15.27    
EtOH/H2O 50:50 -25.74    
BPthiOH MeOH/H2O 70:30 -17.74 -1.06 -1.91 -0.49 
MeOH/H2O 65:35 -16.71 -1.34 -2.87 -0.48 
MeOH/H2O 60:40 -12.68 -1.0 -1.78 -0.47 
MeOH/H2O 55:45 -16.13 -0.96 -1.56 -0.49 
DFPPOH EtOH/H2O 60:40 -14.78 -0.31 -0.62 -0.13 
EtOH/H2O 55:45 -16.58 -0.34 -0.72 -0.13 
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Table 2.38 Thermodynamic data of reversed phase enantioseparation of seven chiral benzyl alcohols 
on Chiralpak
®
 AS-RH column 
Analytes Mobile phase ∆H1(KJ) ∆∆H(KJ) ∆∆S(J) ∆∆G25(KJ) 
PPOH MeOH/H2O 60:40 -12.99 -0.65 -1.52 -0.20 
MeOH/H2O 55:45 -18.53 -0.81 -1.97 -0.22 
MeOH/H2O 50:50 -18.09 -0.71 -1.68 -0.21 
MeOH/H2O 45:55 -22.78 -0.92 -2.33 -0.22 
EtOH/H2O 55:45 -8.00 -0.77 -1.75 -0.25 
EtOH/H2O 50:50 -13.15 -1.16 -3.02 -0.26 
EtOH/H2O 45:55 -16.90 -1.24 -3.26 -0.27 
PVOH MeOH/H2O 60:40 -13.61    
MeOH/H2O 55:45 -18.96    
MeOH/H2O 50:50 -18.65    
MeOH/H2O 45:55 -23.07    
EtOH/H2O 50:50 -14.15    
EtOH/H2O 45:55 -17.61 -0.78 -2.37 -0.07 
PAEtOH MeOH/H2O 60:40 -16.16 -0.56 -1.18 -0.21 
MeOH/H2O 55:45 -22.46 -0.26 -0.21 -0.20 
MeOH/H2O 50:50 -21.79 -0.45 -0.82 -0.21 
MeOH/H2O 45:55 -27.08 -0.50 -1.0 -0.20 
EtOH/H2O 55:45 -12.00 -0.21 -0.09 -0.18 
EtOH/H2O 50:50 -16.56 -0.28 -0.31 -0.19 
EtOH/H2O 45:55 -20.36 -0.21 -0.07 -0.19 
PCF3OH MeOH/H2O 60:40 -14.33    
MeOH/H2O 55:45 -21.04    
MeOH/H2O 50:50 -20.28 -0.74 -2.31 -0.05 
MeOH/H2O 45:55 -25.37 -0.8 -2.48 -0.06 
BPthiOH MeOH/H2O 60:40 -17.88 0.75 2.85 -0.11 
MeOH/H2O 55:45 -24.70 0.64 2.70 -0.16 
MeOH/H2O 50:50 -25.34 0.34 1.62 -0.14 
DFPPOH MeOH/H2O 60:40 -19.92    
MeOH/H2O 55:45 -30.05    
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Table 2.39 Thermodynamic data of reversed phase enantioseparation of seven chiral benzyl alcohols 
on Chiralpak
®
 IC column 
Analytes Mobile phase ∆H1(KJ) ∆∆H(KJ) ∆∆S(J) ∆∆G25(KJ) 
DFPPOH MeOH/H2O 65:35 -10.44 -0.48 -1.23 -0.12 
MeOH/H2O 60:40 -14.50 -0.48 -1.18 -0.13 
MeOH/H2O 55:45 -15.66 -0.37 -0.80 -0.13 
EtOH/H2O 60:40 -11.43 -0.43 -1.20 -0.08 
EtOH/H2O 55:45 -14.87 -0.40 -0.90 -0.12 
PNBOC
OH 
MeOH/H2O 65:35 -11.55 -0.51 -0.75 -0.29 
MeOH/H2O 60:40 -15.65 -0.60 -0.98 -0.30 
MeOH/H2O 55:45 -16.58 -0.55 -0.78 -0.31 
EtOH/H2O 55:45 -13.35 -0.67 -1.19 -0.32 
EtOH/H2O 50:50 -16.40 -0.63 -1.02 -0.33 
BPthiOH MeOH/H2O 60:40 -16.25    
MeOH/H2O 55:45 -16.28    
EtOH/H2O 55:45 -10.00    
EtOH/H2O 50:50 -12.94    
PAEtOH MeOH/H2O 60:40 -13.00    
MeOH/H2O 55:45 -13.19    
60%MeOH -9.00    
55%MeOH -9.89    
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Table 2.40 Retention (K1) and Thermodynamic (∆H1o) data of first eluent of racemic PPOH, PVOH, 
PAEtOH and PCF3OH analyzed on Chiralpak
®
 AS-RH (150x4.6mm, 5µm), 0.6mL/min (MeOH/H2O)  
AS-RH PPOH PVOH PAEtOH PCF
3
OH 
M.P. K1
 
 
(20oC) 
∆H
1
o 
(KJ/mol) 
K1 
(20oC) 
∆H
1
o 
 (KJ/mol) 
K1
 
 
 (20oC) 
∆H
1
o  
(KJ/mol) 
K1
 
 
 (20oC) 
∆H
1
o 
 (KJ/mol) 
MeOH/H2O 
60:40  
1.06 -12.99 0.99 -13.61 1.04 -16.16 1.05 -14.33 
MeOH/H2O 
55:45 
1.90 -18.53 1.72 -18.96 1.85 -22.46 1.97 -21.04 
MeOH/H2O 
50:50 
2.63 -18.09 2.35 -18.65 2.51 -21.79 2.9 -20.28 
MeOH/H2O 
45:55  
4.68 -22.78 4.03 -23.07 4.45 -27.08 5.49 -25.37 
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APPENDIX IV 
Tables 2.41 – 2.46 Thermodynamic data of enantioseparation of racemic 
PPOH, PVOH, PCF3OH, PNBOCOH, PAEtOH, BPthiOH and DFPPOH 
on Chiralpak® AS-RH, IA, IC, Chiralcel® OD-RH, OJ-RH and LuxTM 
Cellulose-3 columns 
 
Table 2.41 Thermodynamic data of enantioseparation of racemic PPOH on LuxTM Cellulose-3 (150 x 
4.6mm, 3 µm), 0.6mL/min (MeOH/H
2
O) or 0.4 mL/min (EtOH/H2O).  
M.P. ∆∆H
o
 (KJ/mol) ∆∆S
o
(J/mol·K) ∆∆G
25
o
 (KJ/mol) α  (25
o
C) 
MeOH/H2O 60:40  -0.42 -0.71 -0.21 1.09 
MeOH/H2O 55:45 -0.43 -0.72 -0.22 1.09 
MeOH/H2O 50:50 -0.43 -0.69 -0.22 1.10 
EtOH/H2O 55:45 -0.81 -1.95 -0.23 1.12 
EtOH/H2O 50:50 -0.88 -2.15 -0.24 1.13 
EtOH/H2O 45:55 -0.89 -2.15 -0.25 1.13 
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Table 2.42 Thermodynamic data of enantioseparation of racemic PCF3OH on Chiralcel
®
 OD-RH (150 
x 4.6mm, 5 µm), 0.6mL/min (MeOH/H
2
O) or 0.4 mL/min (EtOH/H2O). 
M.P. ∆∆H
o
 (KJ/mol) ∆∆S
o
(J/mol·K) ∆∆G
25
o
 (KJ/mol) α  (25
o
C) 
MeOH/H2O 60:40  -3.94 -32.80 5.84 1.40 
MeOH/H2O 55:45 -4.02 -33.40 5.94 1.40 
MeOH/H2O 50:50 -3.99 -33.14 5.89 1.40 
EtOH/H2O 55:45 -2.76 -22.93 4.08 1.46 
EtOH/H2O 50:50 -2.8 -23.26 4.13 1.48 
EtOH/H2O 45:55 -2.82 -23.46 4.17 1.48 
 
 
Table 2.43 Thermodynamic data of enantioseparation of racemic PNBOCOH on Chiralcel
®
 OJ-RH 
(150 x 4.6mm, 5 µm), 0.6 mL/min (MeOH/H
2
O) or 0.4 mL/min (EtOH/H2O). 
M.P. ∆∆H
o
 (KJ/mol) ∆∆S
o
(J/mol·K) ∆∆G
25
o
 (KJ/mol) α  (25
o
C) 
MeOH/H2O 65:35  -1.27 -3.80 -0.14 1.06 
MeOH/H2O 60:40 -0.97 -2.76 -0.15 1.06 
MeOH/H2O 55:45 -0.83 -2.28 -0.15 1.07 
EtOH/H2O 60:40 -1.89 -5.90 -0.14 1.07 
EtOH/H2O 55:45 -1.44 -4.32 -0.15 1.07 
EtOH/H2O 50:50 -1.30 -3.83 -0.16 1.08 
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Table 2.44 Thermodynamic data of enantioseparation of racemic PCF3OH on LuxTM Cellulose-3 (150 
x 4.6mm, 5 µm), 0.6mL/min (MeOH/H
2
O) 
M.P. ∆∆H
o
 (KJ/mol) ∆∆S
o
(J/mol·K) ∆∆G
25
o
 (KJ/mol) α  (25
o
C) 
MeOH/H2O 65:35  -1.79 -3.16 -0.85 1.43 
MeOH/H2O 60:40 -2.08 -4.04 -0.88 1.44 
MeOH/H2O 55:45 -1.73 -2.81 -0.89 1.47 
MeOH/H2O 65:35  -2.31 -4.57 -0.94 1.50 
 
 
Table 2.45 Thermodynamic data of enantioseparation of racemic BPthiOH on Chiralcel® OD-RH 
(150x4.6mm, 5µm), under various composition of EtOH/H2O (0.4mL/min) and MeOH/H2O 
(0.6mL/min)   
M.P. ∆∆H
o
 (KJ/mol) ∆∆S
o
(J/mol·K) ∆∆G
25
o
 (KJ/mol) α  (25
o
C) 
MeOH/H2O 65:35  -0.78 -6.49 1.15 1.12 
MeOH/H2O 60:40 -0.77 -6.36 1.13 1.12 
MeOH/H2O 55:45 -0.78 -6.46 1.15 1.12 
EtOH/H2O 60:40 -0.57 -4.75 0.85 1.11 
EtOH/H2O 55:45 -0.70 -5.85 1.03 1.13 
EtOH/H2O 50:50 -0.61 -5.08 0.91 1.13 
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Table 2.46 Thermodynamic data of enantioseparation of racemic PAEtOH on Chiralpak® AS-RH 
(150x4.6mm, 5µm), under various composition of EtOH/H2O (0.4ml/min) and MeOH/H2O 
(0.6mL/min)   
M.P. ∆∆H
o
 (KJ/mol) ∆∆S
o
(J/mol·K) ∆∆G
25
o
 (KJ/mol) α  (25
o
C) 
MeOH/H2O 65:35  -0.56 -1.18 -0.21 1.09 
MeOH/H2O 60:40 -0.26 -0.21 -0.20 1.08 
MeOH/H2O 55:45 -0.45 -0.82 -0.21 1.09 
MeOH/H2O 65:35  -0.50 -1.0 -0.20 1.09 
EtOH/H2O 55:45 -0.21 -0.09 -0.18 1.08 
EtOH/H2O 50:50 -0.28 -0.31 -0.19 1.08 
 
